Deleted HCPCS Codes

Pressure sensor system, includes all components (e.g., introducer, sensor), intramuscular (implantable), excludes mobile (wireless) software application

01 Apr 2023

C1841

Retinal prosthesis, includes all internal and external components

01 Jan 2023

C1842

Retinal prosthesis, includes all internal and external components; add-on to c1841

01 Jan 2023

C1849

Skin substitute, synthetic, resorbable, per square centimeter

01 Jan 2023

C1850

Descriptor not available

01 Jan 2002

C1851

Descriptor not available

01 Jan 2002

C1852

Descriptor not available

01 Jan 2002

C1853

Descriptor not available

01 Jan 2002

C1854

Descriptor not available

01 Jan 2002

C1855

Descriptor not available

01 Jan 2002

C1856

Descriptor not available

01 Jan 2002

C1857

Descriptor not available

01 Jan 2002

C1858

Descriptor not available

01 Jan 2002

C1859

Descriptor not available

01 Jan 2002

C1860

Descriptor not available

01 Jan 2002

C1861

Descriptor not available

01 Jan 2002

C1862

Descriptor not available

01 Jan 2002

C1863

Descriptor not available

01 Jan 2002

C1864

Descriptor not available

01 Jan 2002

C1865

Descriptor not available

01 Jan 2002

C1866

Descriptor not available

01 Jan 2002

C1867

Descriptor not available

01 Jan 2002

C1868

Descriptor not available

01 Jan 2002

C1869

Descriptor not available

01 Jan 2002

C1870

Descriptor not available

01 Jan 2002

C1871

Descriptor not available

01 Jan 2002

C1872

Descriptor not available

01 Jan 2002

C1873

Descriptor not available

01 Jan 2002

C1879

Tissue marker (implantable)

01 Jul 2013

C1929

Descriptor not available

01 Jan 2002

C1930

Descriptor not available

01 Jan 2002

C1931

Descriptor not available

01 Jan 2002

C1932

Descriptor not available

01 Jan 2002

C1933

Descriptor not available

01 Jan 2002

C1934

Descriptor not available

01 Jan 2002

C1935

Descriptor not available

01 Jan 2002

C1936

Descriptor not available

01 Jan 2002

C1937

Descriptor not available

01 Jan 2002

C1938

Descriptor not available

01 Jan 2002

C1939

Descriptor not available

01 Jan 2002

C1940

Descriptor not available

01 Jan 2002

C1941

Descriptor not available

01 Jan 2002

C1942

Descriptor not available

01 Jan 2002

C1943

Descriptor not available

01 Jan 2002

C1944

Descriptor not available

01 Jan 2002

C1945

Descriptor not available

01 Jan 2002

C1946

Descriptor not available

01 Jan 2002

C1947

Descriptor not available

01 Jan 2002

C1948

Descriptor not available

01 Jan 2002

C1949

Descriptor not available

01 Jan 2002

C1979

Descriptor not available

01 Jan 2002

C1980

Descriptor not available

01 Jan 2002

C1981

Descriptor not available

01 Jan 2002

C2000

Descriptor not available

01 Jan 2002

C2001

Descriptor not available

01 Jan 2002

C2002

Descriptor not available

01 Jan 2002

C2003

Descriptor not available

01 Jan 2002

C2004

Descriptor not available

01 Jan 2002

C2005

Descriptor not available

01 Jan 2002

C2006

Descriptor not available

01 Jan 2002

C2007

Descriptor not available

01 Jan 2002

C2008

Descriptor not available

01 Jan 2002

C2009

Descriptor not available

01 Jan 2002

C2010

Descriptor not available

01 Jan 2002

C2011

Descriptor not available

01 Jan 2002

C2012

Descriptor not available

01 Jan 2002

C2013

Descriptor not available

01 Jan 2002

C2014

Descriptor not available

01 Jan 2002

C2015

Descriptor not available

01 Jan 2002

C2016

Descriptor not available

01 Jan 2002

C2017

Descriptor not available

01 Jan 2002

C2018

Descriptor not available

01 Jan 2002

C2019

Descriptor not available

01 Jan 2002

C2020

Descriptor not available

01 Jan 2002

C2021

Descriptor not available

01 Jan 2002

C2022

Descriptor not available

01 Jan 2002

C2023

Descriptor not available

01 Jan 2002

C2100

Descriptor not available

01 Jan 2002

C2101

Descriptor not available

01 Jan 2002

C2102

Descriptor not available

01 Jan 2002

C2103

Descriptor not available

01 Jan 2002

C2104

Descriptor not available

01 Jan 2002

C2151

Descriptor not available

01 Jan 2002

C2152

Descriptor not available

01 Jan 2002

C2153

Descriptor not available

01 Jan 2002

C2200

Descriptor not available

01 Jan 2002

C2300

Descriptor not available

01 Jan 2002

C2597

Descriptor not available

01 Jan 2002

C2598

Descriptor not available

01 Jan 2002

C2599

Descriptor not available

01 Jan 2002

C2600

Descriptor not available

01 Jan 2002

C2601

Descriptor not available

01 Jan 2002

C2602

Descriptor not available

01 Jan 2002

C2603

Descriptor not available

01 Jan 2002

C2604

Descriptor not available

01 Jan 2002

C2605

Descriptor not available

01 Jan 2002

C2606

Descriptor not available

01 Jan 2002

C2607

Descriptor not available

01 Jan 2002

C2608

Descriptor not available

01 Jan 2002

C2609

Descriptor not available

01 Jan 2002

C2610

Descriptor not available

01 Jan 2002

C2611

Descriptor not available

01 Jan 2002

C2612

Descriptor not available

01 Jan 2002

C2632

Brachytherapy solution

01 Jan 2007

C2633

Brachytherapy source

01 Jul 2007

C2676

Descriptor not available

01 Jan 2002

C2700

Descriptor not available

01 Jan 2002

C2701

Descriptor not available

01 Jan 2002

C2702

Descriptor not available

01 Jan 2002

C2703

Descriptor not available

01 Jan 2002

C2704

Descriptor not available

01 Jan 2002

C2801

Descriptor not available

01 Jan 2002

C2802

Descriptor not available

01 Jan 2002

C2803

Descriptor not available

01 Jan 2002

C2804

Descriptor not available

01 Jan 2002

C2805

Descriptor not available

01 Jan 2002

C2806

Descriptor not available

01 Jan 2002

C2807

Descriptor not available

01 Jan 2002

C2808

Descriptor not available

01 Jan 2002

C3001

Descriptor not available

01 Jan 2002

C3002

Descriptor not available

01 Jan 2002

C3003

Descriptor not available

01 Jan 2002

C3004

Descriptor not available

01 Jan 2002

C3400

Descriptor not available

01 Jan 2002

C3401

Descriptor not available

01 Jan 2002

C3500

Descriptor not available

01 Jan 2002

C3510

Descriptor not available

01 Jan 2002

C3551

Descriptor not available

01 Jan 2002

C3552

Descriptor not available

01 Jan 2002

C3553

Descriptor not available

01 Jan 2002

C3554

Descriptor not available

01 Jan 2002

C3555

Descriptor not available

01 Jan 2002

C3556

Descriptor not available

01 Jan 2002

C3557

Descriptor not available

01 Jan 2002

C3800

Descriptor not available

01 Jan 2002

C3801

Descriptor not available

01 Jan 2002

C3851

Descriptor not available

01 Jan 2002

C4000

Descriptor not available

01 Jan 2002

C4001

Descriptor not available

01 Jan 2002

C4002

Descriptor not available

01 Jan 2002

C4003

Descriptor not available

01 Jan 2002

C4004

Descriptor not available

01 Jan 2002

C4005

Descriptor not available

01 Jan 2002

C4006

Descriptor not available

01 Jan 2002

C4007

Descriptor not available

01 Jan 2002

C4008

Descriptor not available

01 Jan 2002

C4009

Descriptor not available

01 Jan 2002

C4300

Descriptor not available

01 Jan 2002

C4301

Descriptor not available

01 Jan 2002

C4302

Descriptor not available

01 Jan 2002

C4303

Descriptor not available

01 Jan 2002

C4304

Descriptor not available

01 Jan 2002

C4305

Descriptor not available

01 Jan 2002

C4306

Descriptor not available

01 Jan 2002

C4307

Descriptor not available

01 Jan 2002

C4308

Descriptor not available

01 Jan 2002

C4309

Descriptor not available

01 Jan 2002

C4310

Descriptor not available

01 Jan 2002

C4311

Descriptor not available

01 Jan 2002

C4312

Descriptor not available

01 Jan 2002

C4313

Descriptor not available

01 Jan 2002

C4314

Descriptor not available

01 Jan 2002

C4315

Descriptor not available

01 Jan 2002

C4316

Descriptor not available

01 Jan 2002

C4317

Descriptor not available

01 Jan 2002

C4600

Descriptor not available

01 Jan 2002

C4601

Descriptor not available

01 Jan 2002

C4602

Descriptor not available

01 Jan 2002

C4603

Descriptor not available

01 Jan 2002

C4604

Descriptor not available

01 Jan 2002

C4605

Descriptor not available

01 Jan 2002

C4606

Descriptor not available

01 Jan 2002

C4607

Descriptor not available

01 Jan 2002

C5000

Descriptor not available

01 Jan 2002

C5001

Descriptor not available

01 Jan 2002

C5002

Descriptor not available

01 Jan 2002

C5003

Descriptor not available

01 Jan 2002

C5004

Descriptor not available

01 Jan 2002

C5005

Descriptor not available

01 Jan 2002

C5006

Descriptor not available

01 Jan 2002

C5007

Descriptor not available

01 Jan 2002

C5008

Descriptor not available

01 Jan 2002

C5009

Descriptor not available

01 Jan 2002

C5010

Descriptor not available

01 Jan 2002

C5011

Descriptor not available

01 Jan 2002

C5012

Descriptor not available

01 Jan 2002

C5013

Descriptor not available

01 Jan 2002

C5014

Descriptor not available

01 Jan 2002

C5015

Descriptor not available

01 Jan 2002

C5016

Descriptor not available

01 Jan 2002

C5017

Descriptor not available

01 Jan 2002

C5018

Descriptor not available

01 Jan 2002

C5019

Descriptor not available

01 Jan 2002

C5020

Descriptor not available

01 Jan 2002

C5021

Descriptor not available

01 Jan 2002

C5022

Descriptor not available

01 Jan 2002

C5023

Descriptor not available

01 Jan 2002

C5024

Descriptor not available

01 Jan 2002

C5025

Descriptor not available

01 Jan 2002

C5026

Descriptor not available

01 Jan 2002

C5027

Descriptor not available

01 Jan 2002

C5028

Descriptor not available

01 Jan 2002

C5029

Descriptor not available

01 Jan 2002

C5030

Descriptor not available

01 Jan 2002

C5031

Descriptor not available

01 Jan 2002

C5032

Descriptor not available

01 Jan 2002

C5033

Descriptor not available

01 Jan 2002

C5034

Descriptor not available

01 Jan 2002

C5035

Descriptor not available

01 Jan 2002

C5036

Descriptor not available

01 Jan 2002

C5037

Descriptor not available

01 Jan 2002

C5038

Descriptor not available

01 Jan 2002

C5039

Descriptor not available

01 Jan 2002

C5040

Descriptor not available

01 Jan 2002

C5041

Descriptor not available

01 Jan 2002

C5042

Descriptor not available

01 Jan 2002

C5043

Descriptor not available

01 Jan 2002

C5044

Descriptor not available

01 Jan 2002

C5045

Descriptor not available

01 Jan 2002

C5046

Descriptor not available

01 Jan 2002

C5047

Descriptor not available

01 Jan 2002

C5048

Descriptor not available

01 Jan 2002

C5130

Descriptor not available

01 Jan 2002

C5131

Descriptor not available

01 Jan 2002

C5132

Descriptor not available

01 Jan 2002

C5133

Descriptor not available

01 Jan 2002

C5134

Descriptor not available

01 Jan 2002

C5279

Descriptor not available

01 Jan 2002

C5280

Descriptor not available

01 Jan 2002

C5281

Descriptor not available

01 Jan 2002

C5282

Descriptor not available

01 Jan 2002

C5283

Descriptor not available

01 Jan 2002

C5284

Descriptor not available

01 Jan 2002

C5600

Descriptor not available

01 Jan 2002

C5601

Descriptor not available

01 Jan 2002

C6001

Descriptor not available

01 Jan 2002

C6002

Descriptor not available

01 Jan 2002

C6003

Descriptor not available

01 Jan 2002

C6004

Descriptor not available

01 Jan 2002

C6005

Descriptor not available

01 Jan 2002

C6006

Descriptor not available

01 Jan 2002

C6012

Descriptor not available

01 Jan 2002

C6013

Descriptor not available

01 Jan 2002

C6014

Descriptor not available

01 Jan 2002

C6015

Descriptor not available

01 Jan 2002

C6016

Descriptor not available

01 Jan 2002

C6017

Descriptor not available

01 Jan 2002

C6018

Descriptor not available

01 Jan 2002

C6019

Descriptor not available

01 Jan 2002

C6020

Descriptor not available

01 Jan 2002

C6021

Descriptor not available

01 Jan 2002

C6022

Descriptor not available

01 Jan 2002

C6023

Descriptor not available

01 Jan 2002

C6024

Descriptor not available

01 Jan 2002

C6025

Descriptor not available

01 Jan 2002

C6026

Descriptor not available

01 Jan 2002

C6027

Descriptor not available

01 Jan 2002

C6028

Descriptor not available

01 Jan 2002

C6029

Descriptor not available

01 Jan 2002

C6030

Descriptor not available

01 Jan 2002

C6031

Descriptor not available

01 Jan 2002

C6032

Descriptor not available

01 Jan 2002

C6033

Descriptor not available

01 Jan 2002

C6034

Descriptor not available

01 Jan 2002

C6035

Descriptor not available

01 Jan 2002

C6036

Descriptor not available

01 Jan 2002

C6037

Descriptor not available

01 Jan 2002

C6038

Descriptor not available

01 Jan 2002

C6039

Descriptor not available

01 Jan 2002

C6040

Descriptor not available

01 Jan 2002

C6041

Descriptor not available

01 Jan 2002

C6050

Descriptor not available

01 Jan 2002

C6051

Descriptor not available

01 Jan 2002

C6052

Descriptor not available

01 Jan 2002

C6053

Descriptor not available

01 Jan 2002

C6054

Descriptor not available

01 Jan 2002

C6055

Descriptor not available

01 Jan 2002

C6056

Descriptor not available

01 Jan 2002

C6057

Descriptor not available

01 Jan 2002

C6058

Descriptor not available

01 Jan 2002

C6080

Descriptor not available

01 Jan 2002

C6200

Descriptor not available

01 Jan 2002

C6201

Descriptor not available

01 Jan 2002

C6202

Descriptor not available

01 Jan 2002

C6203

Descriptor not available

01 Jan 2002

C6204

Descriptor not available

01 Jan 2002

C6205

Descriptor not available

01 Jan 2002

C6206

Descriptor not available

01 Jan 2002

C6207

Descriptor not available

01 Jan 2002

C6208

Descriptor not available

01 Jan 2002

C6209

Descriptor not available

01 Jan 2002

C6210

Descriptor not available

01 Jan 2002

C6300

Descriptor not available

01 Jan 2002

C6500

Descriptor not available

01 Jan 2002

C6501

Descriptor not available

01 Jan 2002

C6502

Descriptor not available

01 Apr 2002

C6525

Descriptor not available

01 Jan 2002

C6600

Descriptor not available

01 Jan 2002

C6650

Descriptor not available

01 Jan 2002

C6651

Descriptor not available

01 Jan 2002

C6652

Descriptor not available

01 Jan 2002

C6700

Descriptor not available

01 Jan 2002

C7558

Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with pharmacologic agent administration (eg, inhaled nitric oxide, intravenous infusion of nitroprusside, dobutamine, milrinone, or other agent) including assessing hemodynamic measurements before, during, after and repeat pharmacologic agent administration, when performed

01 Jan 2025

C8099

Descriptor not available

01 Jan 2002

C8100

Descriptor not available

01 Jan 2002

C8102

Descriptor not available

01 Jan 2002

C8103

Descriptor not available

01 Jan 2001

C8500

Descriptor not available

01 Jan 2002

C8501

Descriptor not available

01 Jan 2002

C8502

Descriptor not available

01 Jan 2002

C8503

Descriptor not available

01 Jan 2002

C8504

Descriptor not available

01 Jan 2002

C8505

Descriptor not available

01 Jan 2002

C8506

Descriptor not available

01 Jan 2002

C8507

Descriptor not available

01 Jan 2002

C8508

Descriptor not available

01 Jan 2002

C8509

Descriptor not available

01 Jan 2002

C8510

Descriptor not available

01 Jan 2002

C8511

Descriptor not available

01 Jan 2002

C8512

Descriptor not available

01 Jan 2002

C8513

Descriptor not available

01 Jan 2002

C8514

Descriptor not available

01 Jan 2002

C8515

Descriptor not available

01 Oct 2001

C8516

Descriptor not available

01 Jan 2002

C8517

Descriptor not available

01 Oct 2001

C8518

Descriptor not available

01 Jan 2002

C8519

Descriptor not available

01 Jan 2002

C8520

Descriptor not available

01 Jan 2002

C8521

Descriptor not available

01 Jan 2002

C8522

Descriptor not available

01 Jan 2002

C8523

Descriptor not available

01 Jan 2002

C8524

Descriptor not available

01 Jan 2002

C8525

Descriptor not available

01 Jan 2002

C8526

Descriptor not available

01 Jan 2002

C8528

Descriptor not available

01 Jan 2002

C8529

Descriptor not available

01 Jan 2002

C8530

Descriptor not available

01 Jan 2002

C8531

Descriptor not available

01 Jan 2002

C8532

Descriptor not available

01 Jan 2002

C8533

Descriptor not available

01 Jan 2002

C8534

Descriptor not available

01 Jan 2002

C8535

Descriptor not available

01 Jan 2002

C8536

Descriptor not available

01 Jan 2002

C8539

Descriptor not available

01 Jan 2002

C8540

Descriptor not available

01 Jan 2002

C8541

Descriptor not available

01 Jan 2002

C8542

Descriptor not available

01 Jan 2002

C8543

Descriptor not available

01 Jan 2002

C8550

Descriptor not available

01 Jan 2002

C8551

Descriptor not available

01 Jan 2002

C8552

Descriptor not available

01 Jan 2002

C8597

Descriptor not available

01 Jan 2002

C8598

Descriptor not available

01 Jan 2002

C8599

Descriptor not available

01 Jan 2002

C8600

Descriptor not available

01 Jan 2002

C8650

Descriptor not available

01 Jan 2002

C8724

Descriptor not available

01 Jan 2002

C8725

Descriptor not available

01 Jan 2002

C8748

Descriptor not available

01 Jan 2002

C8749

Descriptor not available

01 Jan 2002

C8750

Descriptor not available

01 Jan 2002

C8775

Descriptor not available

01 Jan 2002

C8776

Descriptor not available

01 Jan 2002

C8777

Descriptor not available

01 Jan 2002

C8800

Descriptor not available

01 Jan 2002

C8801

Descriptor not available

01 Jan 2002

C8802

Descriptor not available

01 Jan 2002

C8830

Descriptor not available

01 Jan 2002

C8890

Descriptor not available

01 Jan 2002

C8891

Descriptor not available

01 Jan 2002

C8904

Magnetic resonance imaging without contrast, breast; unilateral

01 Jan 2019

C8907

Magnetic resonance imaging without contrast, breast; bilateral

01 Jan 2019

C8915

Descriptor not available

01 Jan 2004

C8916

Descriptor not available

01 Jan 1999

C8917

Descriptor not available

01 Jan 1999

C8950

Intravenous infusion for therapy/diagnosis; up to 1 hour

01 Jan 2007

C8951

Intravenous infusion for therapy/diagnosis; each additional hour (list separately in addition to c8950)

01 Jan 2007

C8952

Therapeutic

01 Jan 2007

C8953

Chemotherapy administration

01 Jan 2007

C8954

Chemotherapy administration

01 Jan 2007

C8955

Chemotherapy administration

01 Jan 2007

C9000

Injection

01 Jan 2006

C9001

Descriptor not available

01 Jan 2002

C9002

Descriptor not available

01 Jan 2002

C9003

Palivizumab-rsv-igm

01 Jan 2009

C9004

Descriptor not available

01 Jan 2002

C9005

Descriptor not available

01 Jan 2002

C9006

Descriptor not available

01 Jan 2002

C9007

Baclofen intrathecal screening kit (1 amp)

01 Jan 2006

C9008

Baclofen intrathecal refill kit

01 Jan 2006

C9009

Baclofen intrathecal refill kit

01 Jan 2006

C9010

Descriptor not available

01 Jan 2004

C9011

Descriptor not available

01 Jan 2002

C9012

Descriptor not available

01 Jan 2002

C9013

Supply of co 57 cobaltous chloride

01 Jan 2006

C9014

Injection, cerliponase alfa, 1 mg

01 Jan 2019

C9015

Injection, c-1 esterase inhibitor (human), haegarda, 10 units

01 Jan 2019

C9016

Injection, triptorelin extended release, 3.75 mg

01 Jan 2019

C9017

Descriptor not available

01 Jan 2002

C9018

Descriptor not available

01 Jan 2002

C9019

Descriptor not available

01 Jan 2003

C9020

Descriptor not available

01 Jan 2003

C9021

Injection, obinutuzumab, 10 mg

01 Jan 2015

C9022

Injection, elosulfase alfa, 1mg

01 Jan 2015

C9023

Injection, testosterone undecanoate, 1 mg

01 Jan 2015

C9024

Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine

01 Jan 2019

C9025

Injection, ramucirumab, 5 mg

01 Jan 2016

C9026

Injection, vedolizumab, 1 mg

01 Jan 2016

C9027

Injection, pembrolizumab, 1 mg

01 Jan 2016

C9028

Injection, inotuzumab ozogamicin, 0.1 mg

01 Jan 2019

C9029

Injection, guselkumab, 1 mg

01 Jan 2019

C9030

Injection, copanlisib, 1 mg

01 Jan 2019

C9031

Lutetium lu 177, dotatate, therapeutic, 1 mci

01 Jan 2019

C9032

Injection, voretigene neparvovec-rzyl, 1 billion vector genome

01 Jan 2019

C9033

Injection, fosnetupitant 235 mg and palonosetron 0.25 mg

01 Jan 2019

C9034

Injection, dexamethasone 9%, intraocular, 1 mcg

01 Jan 2019

C9035

Injection, aripiprazole lauroxil (aristada initio), 1 mg

01 Oct 2019

C9036

Injection, patisiran, 0.1 mg

01 Oct 2019

C9037

Injection, risperidone (perseris), 0.5 mg

01 Oct 2019

C9038

Injection, mogamulizumab-kpkc, 1 mg

01 Oct 2019

C9039

Injection, plazomicin, 5 mg

01 Oct 2019

C9040

Injection, fremanezumab-vfrm, 1mg

01 Oct 2019

C9041

Injection, coagulation factor xa (recombinant), inactivated (andexxa), 10 mg

01 Jul 2020

C9042

Injection, bendamustine hcl (belrapzo), 1 mg

30 Jun 2019

C9043

Injection, levoleucovorin, 1 mg

31 Dec 2019

C9044

Injection, cemiplimab-rwlc, 1 mg

01 Oct 2019

C9045

Injection, moxetumomab pasudotox-tdfk, 0.01 mg

01 Oct 2019

C9048

Dexamethasone, lacrimal ophthalmic insert, 0.1 mg

01 Oct 2019

C9049

Injection, tagraxofusp-erzs, 10 mcg

01 Oct 2019

C9050

Injection, emapalumab-lzsg, 1 mg

01 Oct 2019

C9051

Injection, omadacycline, 1 mg

01 Oct 2019

C9052

Injection, ravulizumab-cwvz, 10 mg

01 Oct 2019

C9053

Injection, crizanlizumab-tmca, 1 mg

01 Jul 2020

C9054

Injection, lefamulin (xenleta), 1 mg

01 Jul 2020

C9055

Injection, brexanolone, 1mg

01 Oct 2020

C9056

Injection, givosiran, 0.5 mg

01 Jul 2020

C9057

Injection, cetirizine hydrochloride, 1 mg

01 Jul 2020

C9058

Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo) 0.5 mg

01 Jul 2020

C9059

Injection, meloxicam, 1 mg

01 Oct 2020

C9060

Fluoroestradiol f18, diagnostic, 1 mci

01 Jan 2021

C9061

Injection, teprotumumab-trbw, 10 mg

01 Oct 2020

C9062

Injection, daratumumab 10 mg and hyaluronidase-fihj

01 Jan 2021

C9063

Injection, eptinezumab-jjmr, 1 mg

01 Oct 2020

C9064

Mitomycin pyelocalyceal instillation, 1 mg

01 Jan 2021

C9065

Injection, romidepsin, non-lyophilized (e.g. liquid), 1mg

01 Oct 2021

C9066

Injection, sacituzumab govitecan-hziy, 2.5 mg

01 Jan 2021

C9068

Copper cu-64, dotatate, diagnostic, 1 millicurie

01 Apr 2021

C9069

Injection, belantamab mafodontin-blmf, 0.5 mg

01 Apr 2021

C9070

Injection, tafasitamab-cxix, 2 mg

01 Apr 2021

C9071

Injection, viltolarsen, 10 mg

01 Apr 2021

C9072

Injection, immune globulin (asceniv), 500 mg

01 Apr 2021

C9073

Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

01 Apr 2021

C9074

Injection, lumasiran, 0.5 mg

01 Jul 2021

C9075

Injection, casimersen, 10 mg

01 Oct 2021

C9076

Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

01 Oct 2021

C9077

Injection, cabotegravir and rilpivirine, 2mg/3mg

01 Oct 2021

C9078

Injection, trilaciclib, 1 mg

01 Oct 2021

C9079

Injection, evinacumab-dgnb, 5 mg

01 Oct 2021

C9080

Injection, melphalan flufenamide hydrochloride, 1 mg

01 Oct 2021

C9081

Idecabtagene vicleucel, up to 460 million autologous anti-bcma car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

01 Jan 2022

C9082

Injection, dostarlimab-gxly, 100 mg

01 Jan 2022

C9083

Injection, amivantamab-vmjw, 10 mg

01 Jan 2022

C9084

Injection, loncastuximab tesirine-lpyl, 0.1 mg

01 Apr 2022

C9085

Injection, avalglucosidase alfa-ngpt, 4 mg

01 Apr 2022

C9086

Injection, anifrolumab-fnia, 1 mg

01 Apr 2022

C9087

Injection, cyclophosphamide, (auromedics), 10 mg

01 Apr 2022

C9090

Injection, plasminogen, human-tvmh, 1 mg

01 Jul 2022

C9091

Injection, sirolimus protein-bound particles, 1 mg

01 Jul 2022

C9092

Injection, triamcinolone acetonide, suprachoroidal (xipere), 1 mg

01 Jul 2022

C9093

Injection, ranibizumab, via sustained release intravitreal implant (susvimo), 0.1 mg

01 Jul 2022

C9094

Inj, sutimlimab-jome, 10 mg

01 Oct 2022

C9095

Inj, tebentafusp-tebn, 1 mcg

01 Oct 2022

C9096

Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram

01 Oct 2022

C9097

Inj, faricimab-svoa, 0.1 mg

01 Oct 2022

C9098

Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

01 Oct 2022

C9100

Descriptor not available

01 Jan 2003

C9102

Supply of radiopharmaceutical diagnostic imaging agent

01 Jan 2006

C9103

Supply of radiopharmaceutical diagnostic imaging agent

01 Jan 2006

C9104

Descriptor not available

01 Jan 2002

C9105

Injection

01 Jan 2006

C9106

Descriptor not available

01 Jan 2002

C9107

Descriptor not available

01 Jan 2002

C9108

Descriptor not available

01 Jan 2003

C9109

Injection

01 Jan 2005

C9110

Descriptor not available

01 Jan 2003

C9111

Descriptor not available

01 Jan 2004

C9112

Injection

01 Jan 2006

C9113

Injection, pantoprazole sodium, per vial

01 Jul 2024

C9114

Descriptor not available

01 Jan 2003

C9115

Descriptor not available

01 Jan 2003

C9116

Descriptor not available

01 Jan 2004

C9117

Descriptor not available

01 Jan 2003

C9118

Descriptor not available

01 Jan 2003

C9119

Descriptor not available

01 Jul 2003

C9120

Descriptor not available

01 Jan 2004

C9121

Injection, argatroban, per 5 mg

01 Jan 2017

C9122

Mometasone furoate sinus implant, 10 micrograms (sinuva)

01 Apr 2021

C9123

Human fibroblast derived temporary skin substitute

01 Jan 2006

C9124

Injection

01 Jan 2005

C9125

Injection

01 Jan 2005

C9126

Injection

01 Apr 2005

C9127

Injection

01 Jan 2006

C9128

Injection

01 Jan 2006

C9129

Injection

01 Jan 2006

C9130

Injection, immune globulin (bivigam), 500 mg

01 Jan 2014

C9131

Injection, ado-trastuzumab emtansine, 1 mg

01 Jan 2014

C9132

Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity

01 Jul 2021

C9133

Factor ix (antihemophilic factor, recombinant), rixubis, per i.u.

01 Jan 2015

C9134

Factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u.

01 Jan 2015

C9135

Factor ix (antihemophilic factor, recombinant), alprolix, per i.u.

01 Jan 2015

C9136

Injection, factor viii, fc fusion protein, (recombinant), per i.u.

31 Mar 2015

C9137

Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u.

01 Jan 2017

C9138

Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u.

01 Jan 2017

C9139

Injection, factor ix, albumin fusion protein (recombinant), idelvion, 1 i.u.

01 Jan 2017

C9140

Injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u.

01 Jan 2018

C9141

Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u.

30 Jun 2019

C9142

Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg

01 Jan 2023

C9146

Injection, mirvetuximab soravtansine-gynx, 1 mg

01 Jul 2023

C9147

Injection, tremelimumab-actl, 1 mg

01 Jul 2023

C9148

Injection, teclistamab-cqyv, 0.5 mg

01 Jul 2023

C9149

Injection, teplizumab-mzwv, 5 mcg

01 Jul 2023

C9150

Xenon xe-129 hyperpolarized gas, diagnostic, per study dose

01 Oct 2024

C9151

Injection, pegcetacoplan, 1 mg

01 Oct 2023

C9152

Injection, aripiprazole, (abilify asimtufii), 1 mg

01 Jan 2024

C9153

Injection, amisulpride, 1 mg

01 Jan 2024

C9154

Injection, buprenorphine extended-release (brixadi), 1 mg

01 Jan 2024

C9155

Injection, epcoritamab-bysp, 0.16 mg

01 Jan 2024

C9156

Flotufolastat f 18, diagnostic, 1 millicurie

01 Jan 2024

C9157

Injection, tofersen, 1 mg

01 Jan 2024

C9158

Injection, risperidone, (uzedy), 1 mg

01 Jan 2024

C9159

Injection, prothrombin complex concentrate (human), balfaxar, per i.u. of factor ix activity

01 Apr 2024

C9160

Injection, daxibotulinumtoxina-lanm, 1 unit

01 Apr 2024

C9161

Injection, aflibercept hd, 1 mg

01 Apr 2024

C9162

Injection, avacincaptad pegol, 0.1 mg

01 Apr 2024

C9163

Injection, talquetamab-tgvs, 0.25 mg

01 Apr 2024

C9164

Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)

01 Apr 2024

C9165

Injection, elranatamab-bcmm, 1 mg

01 Apr 2024

C9166

Injection, secukinumab, intravenous, 1 mg

01 Jul 2024

C9167

Injection, adamts13, recombinant-krhn, 10 iu

01 Jul 2024

C9168

Injection, mirikizumab-mrkz, 1 mg

01 Jul 2024

C9169

Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram

01 Jan 2025

C9170

Injection, tarlatamab-dlle, 1 mg

01 Jan 2025

C9171

Injection, pegulicianine, 1 mg

01 Jan 2025

C9172

Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose

01 Jan 2025

C9200

Bilayered cellular matrix

01 Jan 2006

C9201

Human fibroblast-derived dermal substitute

01 Jan 2006

C9202

Injection

01 Jan 2006

C9203

Injection

01 Jan 2006

C9204

Descriptor not available

01 Jan 2004

C9205

Injection

01 Jan 2006

C9206

Collagen-glycosaminoglycan bilayer matrix

01 Jan 2006

C9207

Injection

01 Jan 2005

C9208

Injection

01 Jan 2005

C9209

Injection

01 Jan 2005

C9210

Injection

01 Jan 2005

C9211

Injection

01 Jan 2006

C9212

Injection

01 Jan 2006

C9213

Injection

01 Jan 2005

C9214

Injection

01 Jan 2005

C9215

Injection

01 Jan 2005

C9216

Injection

01 Jan 2005

C9217

Injection

01 Jan 2005

C9218

Injection

01 Jan 2006

C9219

Mycophenolic acid

01 Jan 2005

C9220

Sodium hyaluronate per 30 mg dose

01 Jan 2007

C9221

Acellular dermal tissue matrix

01 Jan 2007

C9222

Decellularized soft tissue scaffold

01 Jan 2007

C9223

Injection

01 Jan 2006

C9224

Injection

01 Jan 2007

C9225

Injection

01 Jan 2007

C9226

Injection

01 Jan 2006

C9227

Injection

01 Jan 2007

C9228

Injection

01 Jan 2007

C9229

Injection

01 Jan 2007

C9230

Injection

01 Jan 2007

C9231

Injection

01 Jan 2007

C9232

Injection

01 Jan 2008

C9233

Injection

01 Jan 2008

C9234

Injection

01 Jan 2008

C9235

Injection

01 Jan 2008

C9236

Injection

01 Jan 2008

C9237

Injection

01 Jan 2009

C9238

Injection

01 Jan 2009

C9239

Injection

01 Jan 2009

C9240

Injection

01 Jan 2009

C9241

Injection

01 Jan 2009

C9242

Injection

01 Jan 2009

C9243

Injection

01 Jan 2009

C9244

Injection

01 Jan 2009

C9245

Injection

01 Jan 2010

C9246

Injection

01 Jan 2010

C9247

Iobenguane

01 Jan 2010

C9249

Injection

01 Jan 2010

C9251

Injection

01 Jan 2010

C9252

Injection

01 Jan 2010

C9253

Injection

01 Jan 2010

C9255

Injection, paliperidone palmitate, 1 mg

01 Jan 2011

C9256

Injection, dexamethasone intravitreal implant, 0.1 mg

01 Jan 2011

C9258

Injection, telavancin, 10 mg

01 Jan 2011

C9259

Injection, pralatrexate, 1 mg

01 Jan 2011

C9260

Injection, ofatumumab, 10 mg

01 Jan 2011

C9261

Injection, ustekinumab, 1 mg

01 Jan 2011

C9262

Fludarabine phosphate, oral, 1 mg

01 Jul 2010

C9263

Injection, ecallantide, 1 mg

01 Jan 2011

C9264

Injection, tocilizumab, 1 mg

01 Jan 2011

C9265

Injection, romidepsin, 1 mg

01 Jan 2011

C9266

Injection, collagenase clostridium histolyticum, 0.1 mg

01 Jan 2011

C9267

Injection, von willebrand factor complex (human), wilate, per 100 iu vwf: rco

01 Jan 2011

C9268

Capsaicin, patch, 10cm2

01 Jan 2011

C9269

Injection, c-1 esterase inhibitor (human), berinert, 10 units

01 Jan 2011

C9270

Injection, immune globulin (gammaplex), intravenous, non-lyophilized (e.g. liquid), 500 mg

01 Jan 2012

C9271

Injection, velaglucerase alfa, 100 units

01 Jan 2011

C9272

Injection, denosumab, 1 mg

01 Jan 2012

C9273

Sipuleucel-t auto cd54+

01 Jul 2011

C9274

Crotalidae polyvalent immune fab (ovine), 1 vial

01 Jan 2012

C9275

Injection, hexaminolevulinate hydrochloride, 100 mg, per study dose

01 Jan 2019

C9276

Injection, cabazitaxel, 1 mg

01 Jan 2012

C9277

Injection, alglucosidase alfa (lumizyme), 1 mg

01 Jan 2012

C9278

Injection, incobotulinumtoxin a, 1 unit

04 Jan 2011

C9279

Injection, ibuprofen, 100 mg

01 Jan 2013

C9280

Injection, eribulin mesylate, 1 mg

01 Jan 2012

C9281

Injection, pegloticase, 1 mg

01 Jan 2012

C9282

Injection, ceftaroline fosamil, 10 mg

01 Jan 2012

C9283

Injection, acetaminophen, 10 mg

01 Jan 2012

C9284

Injection, ipilimumab, 1 mg

01 Jan 2012

C9286

Injection, belatacept, 1 mg

01 Jan 2013

C9287

Injection, brentuximab vedotin, 1 mg

01 Jan 2013

C9288

Injection, centruroides (scorpion) immune f(ab)2 (equine), 1 vial

01 Jan 2013

C9289

Injection, asparaginase erwinia chrysanthemi, 1,000 international units (i. u. )

01 Jan 2013

C9290

Injection, bupivacaine liposome, 1 mg

01 Jan 2025

C9291

Injection, aflibercept, 2 mg vial

01 Jul 2012

C9292

Injection, pertuzumab, 10 mg

01 Jan 2014

C9294

Injection, taliglucerase alfa, 10 units

01 Jan 2014

C9295

Injection, carfilzomib, 1 mg

01 Jan 2014

C9296

Injection, ziv-aflibercept, 1 mg

01 Jan 2014

C9297

Injection, omacetaxine mepesuccinate, 0.01 mg

01 Jan 2014

C9298

Injection, ocriplasmin, 0.125 mg

01 Jan 2014

C9349

Puraply, and puraply antimicrobial, any type, per square centimeter

01 Jan 2017

C9350

Microporous collagen tube of non-human origin

01 Jan 2008

C9351

Acellular dermal tissue matrix of non-human origin

01 Jan 2008

C9357

Dermal substitute

01 Jan 2009

C9365

Oasis ultra tri-layer matrix, per square centimeter

01 Jan 2012

C9366

Epifix, per square centimeter

01 Jan 2013

C9367

Skin substitute, endoform dermal template, per square centimeter

01 Jan 2013

C9368

Grafix core, per square centimeter

01 Jan 2013

C9369

Grafix prime, per square centimeter

01 Jan 2013

C9400

Supply of radiopharmaceutical diagnostic imaging agent

01 Jan 2006

C9401

Supply of therapeutic radiopharmaceutical

01 Jan 2006

C9402

Supply of radiopharmaceutical therapeutic imaging agent

01 Jan 2006

C9403

Supply of radiopharmaceutical diagnostic agent

01 Jan 2006

C9404

Supply of radiopharmaceutical diagnostic agent

01 Jan 2006

C9405

Supply of radiopharmaceutical therapeutic agent

01 Jan 2006

C9406

Iodine i-123 ioflupane, diagnostic, per study dose, up to 5 millicuries

01 Jan 2012

C9407

Iodine i-131 iobenguane, diagnostic, 1 millicurie

01 Jan 2020

C9408

Iodine i-131 iobenguane, therapeutic, 1 millicurie

01 Jan 2020

C9410

Injection

01 Jan 2006

C9411

Injection

01 Jan 2006

C9412

Ganciclovir

01 Jan 2005

C9413

Sodium hyaluronate

01 Jan 2006

C9414

Etoposide

01 Jan 2006

C9415

Doxorubicin hcl

01 Jan 2006

C9416

Descriptor not available

01 Jan 2004

C9417

Bleomycin sulfate

01 Jan 2006

C9418

Cisplatin

01 Jan 2006

C9419

Injection

01 Jan 2006

C9420

Cyclophosphamide

01 Jan 2006

C9421

Cyclophosphamide

01 Jan 2006

C9422

Cytarabine

01 Jan 2006

C9423

Dacarbazine

01 Jan 2006

C9424

Daunorubicin

01 Jan 2006

C9425

Etoposide

01 Jan 2006

C9426

Floxuridine

01 Jan 2006

C9427

Ifosfamide

01 Jan 2006

C9428

Mesna

01 Jan 2006

C9429

Idarubicin hydrochloride

01 Jan 2006

C9430

Leuprolide acetate

01 Jan 2006

C9431

Paclitaxel

01 Jan 2006

C9432

Mitomycin

01 Jan 2006

C9433

Thiotepa

01 Jan 2006

C9434

Descriptor not available

01 Jan 2004

C9435

Injection

01 Jan 2006

C9436

Azathioprine

01 Jan 2006

C9437

Carmustine

01 Jan 2006

C9438

Cyclosporine

01 Jan 2006

C9439

Diethylstilbestrol diphosphate

01 Jan 2006

C9440

Vinorelbine tartrate

01 Jan 2006

C9441

Injection, ferric carboxymaltose, 1 mg

30 Jun 2014

C9442

Injection, belinostat, 10 mg

01 Jan 2016

C9443

Injection, dalbavancin, 10 mg

01 Jan 2016

C9444

Injection, oritavancin, 10 mg

01 Jan 2016

C9445

Injection, c-1 esterase inhibitor (recombinant), ruconest, 10 units

01 Jan 2016

C9446

Injection, tedizolid phosphate, 1 mg

01 Jan 2016

C9447

Injection, phenylephrine and ketorolac, 4 ml vial

01 Oct 2019

C9448

Netupitant 300mg and palonosetron 0.5 mg, oral

30 Jun 2015

C9449

Injection, blinatumomab, 1 mcg

01 Jan 2016

C9450

Injection, fluocinolone acetonide intravitreal implant, 0.01 mg

01 Jan 2016

C9451

Injection, peramivir, 1 mg

01 Jan 2016

C9452

Injection, ceftolozane 50 mg and tazobactam 25 mg

01 Jan 2016

C9453

Injection, nivolumab, 1 mg

01 Jan 2016

C9454

Injection, pasireotide long acting, 1 mg

01 Jan 2016

C9455

Injection, siltuximab, 10 mg

01 Jan 2016

C9456

Injection, isavuconazonium sulfate, 1 mg

01 Jan 2016

C9457

Injection, sulfur hexafluoride lipid microsphere, per ml

01 Jan 2016

C9458

Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries

30 Jun 2016

C9459

Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries

30 Jun 2016

C9461

Choline c 11, diagnostic, per study dose

01 Jan 2017

C9463

Injection, aprepitant, 1 mg

01 Jan 2019

C9464

Injection, rolapitant, 0.5 mg

01 Jan 2019

C9465

Hyaluronan or derivative, durolane, for intra-articular injection, per dose

01 Jan 2019

C9466

Injection, benralizumab, 1 mg

01 Jan 2019

C9467

Injection, rituximab and hyaluronidase, 10 mg

01 Jan 2019

C9468

Injection, factor ix (antihemophilic factor, recombinant), glycopegylated, rebinyn, 1 i.u.

01 Jan 2019

C9469

Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg

01 Jul 2018

C9470

Injection, aripiprazole lauroxil, 1 mg

01 Jan 2017

C9471

Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg

01 Jan 2017

C9472

Injection, talimogene laherparepvec, 1 million plaque forming units (pfu)

01 Jan 2017

C9473

Injection, mepolizumab, 1 mg

01 Jan 2017

C9474

Injection, irinotecan liposome, 1 mg

01 Jan 2017

C9475

Injection, necitumumab, 1 mg

01 Jan 2017

C9476

Injection, daratumumab, 10 mg

01 Jan 2017

C9477

Injection, elotuzumab, 1 mg

01 Jan 2017

C9478

Injection, sebelipase alfa, 1 mg

01 Jan 2017

C9479

Instillation, ciprofloxacin otic suspension, 6 mg

01 Jan 2017

C9480

Injection, trabectedin, 0.1 mg

01 Jan 2017

C9481

Injection, reslizumab, 1 mg

01 Jan 2017

C9483

Injection, atezolizumab, 10 mg

01 Jan 2018

C9484

Injection, eteplirsen, 10 mg

01 Jan 2018

C9485

Injection, olaratumab, 10 mg

01 Jan 2018

C9486

Injection, granisetron extended release, 0.1 mg

01 Jan 2018

C9487

Ustekinumab, for intravenous injection, 1 mg

01 Jul 2017

C9489

Injection, nusinersen, 0.1 mg

01 Jan 2018

C9490

Injection, bezlotoxumab, 10 mg

01 Jan 2018

C9491

Injection, avelumab, 10 mg

01 Jan 2018

C9492

Injection, durvalumab, 10 mg

01 Jan 2019

C9493

Injection, edaravone, 1 mg

01 Jan 2019

C9494

Injection, ocrelizumab, 1 mg

01 Jan 2018

C9497

Loxapine, inhalation powder, 10 mg

01 Jan 2019

C9500

Descriptor not available

01 Jan 2002

C9501

Descriptor not available

01 Jan 2002

C9502

Descriptor not available

01 Jan 2002

C9503

Descriptor not available

01 Jan 2004

C9504

Descriptor not available

01 Jan 2002

C9505

Descriptor not available

01 Jan 2002

C9700

Descriptor not available

01 Jan 2002

C9701

Stretta system

01 Jan 2005

C9702

Descriptor not available

01 Jan 2002

C9703

Bard endoscopic suturing system

01 Jan 2005

C9704

Injection or insertion of inert substance for submucosal/intramuscular injection(s) into the upper gastrointestinal tract

01 Jan 2006

C9708

Descriptor not available

01 Jan 2003

C9711

Descriptor not available

01 Jan 2004

C9712

Insertion of a ph capsule for measurement and monitoring of gastroesophageal reflux disease

01 Jan 2005

C9713

Non-contact laser vaporization of prostate

01 Jan 2006

C9714

Placement of balloon catheter into the breast for interstitial radiation therapy following a partial mastectomy; concurrent/immediate (add-on)

01 Jan 2005

C9715

Placement of balloon catheter into the breast for interstitial radiation therapy following a partial mastectomy; delayed

01 Jan 2005

C9716

Creations of thermal anal lesions by radiofrequency energy

01 Jan 2013

C9717

Hemorrhoidopexy

01 Jan 2005

C9718

Kyphoplasty

01 Jan 2006

C9719

Kyphoplasty

01 Jan 2006

C9720

High-energy (greater than 0.22mj/mm2) extracorporeal shock wave (esw) treatment for chronic lateral epicondylitis (tennis elbow)

01 Jan 2006

C9721

High-energy (greater than 0.22mj/mm2) extracorporeal shock wave (esw) treatment for chronic plantar fasciitis

01 Jan 2006

C9722

Stereoscopic kv x-ray imaging with infrared tracking for localization of target volume (do not report c9722 in conjunction with g0173

01 Jan 2006

C9723

Dynamic infrared blood perfusion imaging (diri)

01 Jan 2009

C9724

Endoscopic full-thickness plication of the stomach using endoscopic plication system (eps); includes endoscopy

01 Jan 2016

C9729

Perq lamot/lam lumbar

01 Jul 2011

C9730

Bronchoscopic bronchial thermoplasty with imaging guidance (if performed), radiofrequency ablation of airway smooth muscle, 1 lobe

01 Jan 2012

C9731

Bronchoscopic bronchial thermoplasty with imaging guidance (if performed), radiofrequency ablation of airway smooth muscle, 2 or more lobes

01 Jan 2012

C9732

Insertion of ocular telescope prosthesis including removal of crystalline lens

01 Jul 2012

C9735

Anoscopy; with directed submucosal injection(s), any substance

01 Jan 2015

C9736

Laparoscopy, surgical, radiofrequency ablations of uterine fibroid(s), including intraoperative guidance and monitoring, when performed

01 Jan 2014

C9737

Laparoscopy, surgical, esophageal sphincter augmentation with device (eg, magnetic band)

30 Jun 2015

C9741

Right heart catheterization with implantation of wireless pressure sensor in the pulmonary artery, including any type of measurement, angiography, imaging supervision, interpretation, and report

01 Jan 2019

C9742

Laryngoscopy, flexible fiberoptic, with injection into vocal cord(s), therapeutic, including diagnostic laryngoscopy, if performed

01 Jan 2017

C9743

Injection/implantation of bulking or spacer material (any type) with or without image guidance (not to be used if a more specific code applies)

30 Jun 2016

C9744

Ultrasound, abdominal, with contrast

01 Jan 2019

C9745

Nasal endoscopy, surgical; balloon dilation of eustachian tube

01 Jan 2021

C9746

Transperineal implantation of permanent adjustable balloon continence device, with cystourethroscopy, when performed and/or fluoroscopy, when performed

30 Jun 2019

C9747

Ablation of prostate, transrectal, high intensity focused ultrasound (hifu), including imaging guidance

01 Jan 2021

C9748

Transurethral destruction of prostate tissue; by radiofrequency water vapor (steam) thermal therapy

01 Jan 2019

C9749

Repair of nasal vestibular lateral wall stenosis with implant(s)

01 Jan 2021

C9750

Insertion or removal and replacement of intracardiac ischemia monitoring system including imaging supervision and interpretation and peri-operative interrogation and programming; complete system (includes device and electrode)

01 Jan 2019

C9752

Destruction of intraosseous basivertebral nerve, first two vertebral bodies, including imaging guidance (e.g., fluoroscopy), lumbar/sacrum

01 Jan 2022

C9753

Destruction of intraosseous basivertebral nerve, each additional vertebral body, including imaging guidance (e.g., fluoroscopy), lumbar/sacrum (list separately in addition to code for primary procedure)

01 Jan 2022

C9754

Creation of arteriovenous fistula, percutaneous; direct, any site, including all imaging and radiologic supervision and interpretation, when performed and secondary procedures to redirect blood flow (e.g., transluminal balloon angioplasty, coil embolization, when performed)

01 Jul 2020

C9755

Creation of arteriovenous fistula, percutaneous using magnetic-guided arterial and venous catheters and radiofrequency energy, including flow-directing procedures (e.g., vascular coil embolization with radiologic supervision and interpretation, when performed) and fistulogram(s), angiography, venography, and/or ultrasound, with radiologic supervision and interpretation, when performed

01 Jul 2020

C9769

Cystourethroscopy, with insertion of temporary prostatic implant/stent with fixation/anchor and incisional struts

01 Jan 2025

C9770

Vitrectomy, mechanical, pars plana approach, with subretinal injection of pharmacologic/biologic agent

01 Jan 2024

C9771

Nasal/sinus endoscopy, cryoablation nasal tissue(s) and/or nerve(s), unilateral or bilateral

01 Jan 2024

C9786

Echocardiography image post processing for computer aided detection of heart failure with preserved ejection fraction, including interpretation and report

01 Jan 2025

C9787

Gastric electrophysiology mapping with simultaneous patient symptom profiling

01 Jul 2024

C9788

Opto-acoustic imaging, breast (including axilla when performed), unilateral, with image documentation, analysis and report, obtained with ultrasound examination

01 Jan 2024

C9790

Histotripsy (ie, non-thermal ablation via acoustic energy delivery) of malignant renal tissue, including image guidance

01 Jul 2024

C9794

Therapeutic radiology simulation-aided field setting; complex, including acquisition of pet and ct imaging data required for radiopharmaceutical-directed radiation therapy treatment planning (i.e., modeling)

01 Jan 2025

C9795

Stereotactic body radiation therapy, treatment delivery, per fraction to 1 or more lesions, including image guidance and real-time positron emissions-based delivery adjustments to 1 or more lesions, entire course not to exceed 5 fractions

01 Jan 2025

C9800

Dermal injection procedure(s) for facial lipodystrophy syndrome (lds) and provision of radiesse or sculptra dermal filler, including all items and supplies

01 Jan 2017

C9801

Smoking and tobacco cessation counseling visit for the asymptomatic patient; intermediate, greater than 3 minutes, up to 10 minutes

01 Jan 2011

C9802

Smoking and tobacco cessation counseling visit for the asymptomatic patient; intensive, greater than 10 minutes

01 Jan 2011

C9803

Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source

01 Jan 2024

CP

Adjunctive service related to a procedure assigned to a comprehensive ambulatory payment classification (c-apc) procedure, but reported on a different claim

01 Jan 2018

D1201

Topical application of fluoride (including prophylaxis)-child

01 Jan 2007

D1205

Topical application of fluoride (including prophylaxis)-adult

01 Jan 2007

D6020

Abutment placement or substitution: endosteal implant

01 Jan 2005

D6971

Cast post as part of bridge retainer

01 Jan 2007

D7281

Surgical exposure of impacted or unerupted tooth to aid eruption

01 Jan 2005

E0115

Descriptor not available

01 Jan 1992

E0120

Descriptor not available

01 Jan 1992

E0142

Descriptor not available

01 Jan 2004

E0145

Descriptor not available

01 Jan 2004

E0146

Descriptor not available

01 Jan 2004

E0150

Descriptor not available

01 Jan 1992

E0151

Descriptor not available

01 Jan 1992

E0164

Commode chair

01 Jan 2007

E0166

Commode chair

01 Jan 2007

E0169

Commode chair with seat lift mechanism

01 Jan 2006

E0176

Air pressure pad or cushion

01 Jan 2005

E0177

Water pressure pad or cushion

01 Jan 2005

E0178

Gel or gel-like pressure pad or cushion

01 Jan 2005

E0179

Dry pressure pad or cushion

01 Jan 2005

E0180

Pressure pad

01 Jan 2007

E0192

Low pressure and positioning equalization pad

01 Jan 2005

E0195

Descriptor not available

01 Jan 1992

E0220

Hot water bottle

01 Jan 2011

E0230

Ice cap or collar

01 Jan 2011

E0237

Descriptor not available

01 Jan 1995

E0238

Non-electric heat pad, moist

01 Jan 2011

E0252

Descriptor not available

01 Jan 1994

E0298

Descriptor not available

01 Jan 2002

E0330

Descriptor not available

01 Jan 1992

E0400

Descriptor not available

01 Jan 1993

E0405

Descriptor not available

01 Jan 1993

E0410

Descriptor not available

01 Jan 1993

E0415

Descriptor not available

01 Jan 1993

E0416

Descriptor not available

01 Jan 1993

E0450

Volume control ventilator, without pressure support mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube)

01 Jan 2016

E0451

Descriptor not available

01 Jan 1992

E0452

Descriptor not available

01 Jan 2000

E0453

Descriptor not available

01 Jan 2000

E0454

Pressure ventilator with pressure control

01 Jan 2005

E0456

Descriptor not available

01 Jan 1992

E0458

Descriptor not available

01 Jan 1992

E0460

Negative pressure ventilator; portable or stationary

01 Jan 2016

E0461

Volume control ventilator, without pressure support mode, may include pressure control mode, used with non-invasive interface (e.g., mask)

01 Jan 2016

E0463

Pressure support ventilator with volume control mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube)

01 Jan 2016

E0464

Pressure support ventilator with volume control mode, may include pressure control mode, used with non-invasive interface (e.g., mask)

01 Jan 2016

E0505

Descriptor not available

01 Jan 1992

E0510

Descriptor not available

01 Jan 1992

E0515

Descriptor not available

01 Jan 1992

E0571

Aerosol compressor, battery powered, for use with small volume nebulizer

01 Jan 2012

E0590

Dispensing fee covered drug administered through dme nebulizer

01 Jan 2006

E0608

Descriptor not available

01 Jan 2003

E0609

Descriptor not available

01 Jan 2002

E0628

Separate seat lift mechanism for use with patient owned furniture-electric

01 Jan 2017

E0674

Descriptor not available

01 Jan 1992

E0690

Descriptor not available

01 Jan 2003

E0701

Helmet with face guard and soft interface material

01 Jan 2007

E0750

Descriptor not available

01 Jan 1993

E0751

Descriptor not available

01 Jan 2001

E0752

Implantable neurostimulator electrode

01 Jan 2006

E0753

Descriptor not available

01 Jan 2002

E0754

Patient programmer (external) for use with implantable programmable neurostimulator pulse generator

01 Jan 2006

E0756

Implantable neurostimulator pulse generator

01 Jan 2006

E0757

Implantable neurostimulator radiofrequency receiver

01 Jan 2006

E0758

Radiofrequency transmitter (external) for use with implantable neurostimulator radiofrequency receiver

01 Jan 2006

E0759

Radiofrequency transmitter (external) for use with implantable sacral root neurostimulator receiver for bowel and bladder management

01 Jan 2006

E0777

Descriptor not available

01 Jan 1992

E0778

Descriptor not available

01 Jan 1992

E0790

Descriptor not available

01 Jan 1992

E0943

Descriptor not available

01 Jan 2004

E0962

1 cushion

01 Jan 2005

E0963

2 cushion

01 Jan 2005

E0964

3 cushion

01 Jan 2005

E0965

4 cushion

01 Jan 2005

E0972

Wheelchair accessory

01 Jan 2006

E0975

Descriptor not available

01 Jan 2004

E0976

Descriptor not available

01 Jan 2004

E0977

Wedge cushion

01 Jan 2007

E0979

Descriptor not available

01 Jan 2004

E0991

Descriptor not available

01 Jan 2004

E0993

Descriptor not available

01 Jan 2004

E0996

Tire

01 Jan 2006

E0997

Caster with a fork

01 Jan 2007

E0998

Caster without fork

01 Jan 2007

E0999

Pneumatic tire with wheel

01 Jan 2007

E1000

Tire

01 Jan 2006

E1001

Wheel

01 Jan 2006

E1012-1

Integrated seating system

01 Jan 2005

E1013

Integrated seating system

01 Jan 2005

E1019

Wheelchair accessory

01 Jan 2006

E1021

Wheelchair accessory

01 Jan 2006

E1025

Lateral thoracic support

01 Jan 2006

E1026

Lateral thoracic support

01 Jan 2006

E1027

Lateral/anterior support

01 Jan 2006

E1040

Descriptor not available

01 Jan 1992

E1065

Descriptor not available

01 Jan 2004

E1066

Descriptor not available

01 Jan 2004

E1067

Descriptor not available

01 Jan 1992

E1069

Descriptor not available

01 Jan 2004

E1080

Descriptor not available

01 Jan 1992

E1081

Descriptor not available

01 Jan 1992

E1082

Descriptor not available

01 Jan 1992

E1091

Descriptor not available

01 Jan 2003

E1210

Motorized wheelchair

01 Jan 2006

E1211

Motorized wheelchair

01 Jan 2006

E1212

Motorized wheelchair

01 Jan 2006

E1213

Motorized wheelchair

01 Jan 2006

E1299

Descriptor not available

01 Jan 1992

E1340

Repair or nonroutine service for durable medical equipment requiring the skill

01 Jan 2010

E1350

Descriptor not available

01 Jan 1997

E1351

Descriptor not available

01 Jan 1992

E1371

Descriptor not available

01 Jan 1992

E1373

Descriptor not available

01 Jan 1992

E1374

Descriptor not available

01 Jan 1992

E1375

Descriptor not available

01 Jan 2001

E1377

Descriptor not available

01 Jan 2001

E1378

Descriptor not available

01 Jan 2001

E1379

Descriptor not available

01 Jan 2001

E1380

Descriptor not available

01 Jan 2001

E1381

Descriptor not available

01 Jan 2001

E1382

Descriptor not available

01 Jan 2001

E1383

Descriptor not available

01 Jan 2001

E1384

Descriptor not available

01 Jan 2001

E1385

Descriptor not available

01 Jan 2001

E1388

Descriptor not available

01 Jan 1993

E1389

Descriptor not available

01 Jan 1993

E1393

Descriptor not available

01 Jan 1993

E1394

Descriptor not available

01 Jan 1993

E1395

Descriptor not available

01 Jan 1993

E1396

Descriptor not available

01 Jan 1993

E1397

Descriptor not available

01 Jan 1990

E1400

Descriptor not available

01 Jan 2000

E1401

Descriptor not available

01 Jan 2000

E1402

Descriptor not available

01 Jan 2000

E1403

Descriptor not available

01 Jan 2000

E1404

Descriptor not available

01 Jan 2000

E1638

Descriptor not available

01 Jan 2003

E1640

Descriptor not available

01 Jan 2002

E1900

Descriptor not available

01 Jan 2002

E2223

Manual wheelchair accessory

01 Jan 2010

E2300

Wheelchair accessory, power seat elevation system, any type

01 Apr 2024

E2320

Power wheelchair accessory

01 Jan 2007

E2393

Power wheelchair accessory

01 Jan 2010

E2399

Descriptor not available

01 Jan 2010

E2618

Wheelchair accessory

01 Jan 2008

G0001

Routine venipuncture for collection of specimen(s)

01 Jan 2005

G0002

Descriptor not available

01 Jan 2003

G0003

Descriptor not available

01 Jan 1990

G0004

Descriptor not available

01 Jan 2003

G0005

Descriptor not available

01 Jan 2003

G0006

Descriptor not available

01 Jan 2003

G0007

Descriptor not available

01 Jan 2003

G0015

Descriptor not available

01 Jan 2003

G0016

Descriptor not available

01 Jan 2002

G0020

Descriptor not available

01 Jan 1996

G0021

Descriptor not available

01 Jan 1996

G0025

Descriptor not available

01 Apr 2003

G0026

Descriptor not available

01 Jan 2003

G0028

Documentation of medical reason(s) for not screening for tobacco use (e.g., limited life expectancy, other medical reason)

01 Jan 2023

G0056

Optimizing chronic disease management mips value pathways

01 Jan 2024

G0072

Descriptor not available

01 Jan 1998

G0073

Descriptor not available

01 Jan 1998

G0074

Descriptor not available

01 Jan 1998

G0075

Descriptor not available

01 Jan 1998

G0091

Descriptor not available

01 Jan 1998

G0092

Descriptor not available

01 Jan 1998

G0093

Descriptor not available

01 Jan 1998

G0094

Descriptor not available

01 Jan 1998

G0095

Descriptor not available

01 Jan 1990

G0096

Descriptor not available

01 Jan 1990

G0097

Descriptor not available

01 Jan 1990

G0098

Descriptor not available

01 Jan 1990

G0100

Descriptor not available

01 Jan 1998

G0106

Colorectal cancer screening; alternative to g0104, screening sigmoidoscopy, barium enema

01 Jan 2025

G0107

Colorectal cancer screening; fecal-occult blood test

01 Jan 2007

G0110

Nett pulm-rehab; education/skills training

01 Jan 2006

G0111

Nett pulm-rehab; education/skills training

01 Jan 2006

G0112

Nett pulm-rehab; nutritional guidance

01 Jan 2006

G0113

Nett pulm-rehab; nutritional guidance

01 Jan 2006

G0114

Nett pulm-rehab; psychosocial consultation

01 Jan 2006

G0115

Nett pulm-rehab; psychological testing

01 Jan 2006

G0116

Nett pulm-rehab; psychosocial counselling

01 Jan 2006

G0120

Colorectal cancer screening; alternative to g0105, screening colonoscopy, barium enema.

01 Jan 2025

G0122

Colorectal cancer screening; barium enema

01 Jan 2025

G0125

Pet imaging regional or whole body; single pulmonary nodule

01 Apr 2005

G0126

Descriptor not available

01 Jan 2002

G0131

Descriptor not available

01 Jan 2003

G0132

Descriptor not available

01 Jan 2003

G0133

Descriptor not available

01 Jan 1999

G0154

Direct skilled nursing services of a licensed nurse (lpn or rn) in the home health or hospice setting, each 15 minutes

01 Jan 2016

G0163

Skilled services of a licensed nurse (lpn or rn) for the observation and assessment of the patient's condition, each 15 minutes (the change in the patient's condition requires skilled nursing personnel to identify and evaluate the patient's need for possible modification of treatment in the home health or hospice setting)

01 Jan 2017

G0164

Skilled services of a licensed nurse (lpn or rn), in the training and/or education of a patient or family member, in the home health or hospice setting, each 15 minutes

01 Jan 2017

G0165

Descriptor not available

01 Jan 2002

G0167

Descriptor not available

01 Jan 2004

G0169

Descriptor not available

01 Jan 2001

G0170

Descriptor not available

01 Jan 2001

G0171

Descriptor not available

01 Jan 2001

G0172

Descriptor not available

01 Jan 2001

G0173

Linear accelerator based stereotactic radiosurgery, complete course of therapy in one session

01 Jan 2015

G0174

Descriptor not available

01 Jan 2002

G0178

Descriptor not available

01 Jan 2002

G0184

Descriptor not available

01 Jan 2002

G0185

Descriptor not available

01 Jan 2003

G0187

Descriptor not available

01 Jan 2003

G0188

Descriptor not available

01 Jan 2002

G0190

Descriptor not available

01 Jan 2002

G0191

Descriptor not available

01 Jan 2002

G0192

Descriptor not available

01 Jan 2003

G0193

Descriptor not available

01 Jan 2003

G0194

Descriptor not available

01 Jan 2003

G0195

Descriptor not available

01 Jan 2003

G0196

Descriptor not available

01 Jan 2003

G0197

Descriptor not available

01 Jan 2003

G0198

Descriptor not available

01 Jan 2003

G0199

Descriptor not available

01 Jan 2003

G0200

Descriptor not available

01 Jan 2003

G0201

Descriptor not available

01 Jan 2003

G0202

Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed

01 Jan 2018

G0203

Descriptor not available

01 Jan 2002

G0204

Diagnostic mammography, including computer-aided detection (cad) when performed; bilateral

01 Jan 2018

G0205

Descriptor not available

01 Jan 2002

G0206

Diagnostic mammography, including computer-aided detection (cad) when performed; unilateral

01 Jan 2018

G0207

Descriptor not available

01 Jan 2002

G0210

Pet imaging whole body; diagnosis; lung cancer

01 Apr 2005

G0211

Pet imaging whole body; initial staging; lung cancer; non-small cell (replaces g0126)

01 Apr 2005

G0212

Pet imaging whole body; restaging; lung cancer; non-small

01 Apr 2005

G0213

Pet imaging whole body; diagnosis; colorectal

01 Apr 2005

G0214

Pet imaging whole body; initial staging; colorectal

01 Apr 2005

G0215

Pet imaging whole body; restaging; colorectal cancer (replaces g0163)

01 Apr 2005

G0216

Pet imaging whole body; diagnosis; melanoma

01 Apr 2005

G0217

Pet imaging whole body; initial staging; melanoma

01 Apr 2005

G0218

Pet imaging whole body; restaging; melanoma (replaces g0165)

01 Apr 2005

G0220

Pet imaging whole body; diagnosis; lymphoma

01 Apr 2005

G0221

Pet imaging whole body; initial staging; lymphoma (replaces g0164)

01 Apr 2005

G0222

Pet imaging whole body; restaging; lymphoma (replaces g0164)

01 Apr 2005

G0223

Pet imaging whole body or regional; diagnosis; head and neck cancer; excluding thyroid and cns cancers

01 Apr 2005

G0224

Pet imaging whole body or regional; initial staging; head and neck cancer; excluding thyroid and cns cancers

01 Apr 2005

G0225

Pet imaging whole body or regional; restaging; head and neck cancer

01 Apr 2005

G0226

Pet imaging whole body; diagnosis; esophageal cancer

01 Apr 2005

G0227

Pet imaging whole body; initial staging; esophageal cancer

01 Apr 2005

G0228

Pet imaging whole body; restaging; esophageal cancer

01 Apr 2005

G0229

Pet imaging; metabolic brain imaging for pre-surgical evaluation of refractory seizures

01 Apr 2005

G0230

Pet imaging; metabolic assessment for myocardial viability following inconclusive spect study

01 Apr 2005

G0231

Pet

01 Apr 2005

G0232

Pet

01 Apr 2005

G0233

Pet

01 Apr 2005

G0234

Pet

01 Apr 2005

G0236

Descriptor not available

01 Jan 2004

G0240

Descriptor not available

01 Jan 2003

G0241

Descriptor not available

01 Jan 2003

G0242

Multi-source photon stereotactic radiosurgery (cobalt 60 multi-source converging beams) plan

01 Jan 2006

G0243

Multi-source photon stereotactic radiosurgery

01 Jan 2007

G0244

Observation care provided by a facility to a patient with chf

01 Jan 2006

G0251

Linear accelerator based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, maximum five sessions per course of treatment

01 Jan 2015

G0253

Pet imaging for breast cancer

01 Apr 2005

G0254

Pet imaging for breast cancer

01 Apr 2005

G0256

Descriptor not available

01 Jan 2004

G0258

Intravenous infusion during separately payable observation stay

01 Jan 2006

G0261

Descriptor not available

01 Jan 2004

G0262

Descriptor not available

01 Jan 2004

G0263

Direct admission of patient with diagnosis of congestive heart failure

01 Jan 2006

G0264

Initial nursing assessment of patient directly admitted to observation with diagnosis other than chf

01 Jan 2006

G0265

Cryopreservation

01 Jan 2008

G0266

Thawing and expansion of frozen cells for therapeutic use

01 Jan 2008

G0267

Bone marrow or peripheral stem cell harvest

01 Jan 2008

G0272

Descriptor not available

01 Jan 2004

G0273

Descriptor not available

01 Jan 2004

G0274

Descriptor not available

01 Jan 2004

G0275

Renal angiography, non-selective, one or both kidneys, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of any catheter in the abdominal aorta at or near the origins (ostia) of the renal arteries, injection of dye, flush aortogram, production of permanent images, and radiologic supervision and interpretation (list separately in addition to primary procedure)

01 Jan 2014

G0279-1

Extracorporeal shock wave therapy; involving elbow epicondylitis

01 Jan 2006

G0280

Extracorporeal shock wave therapy; involving other than elbow epicondylitis or plantar fascitis

01 Jan 2006

G0290

Transcatheter placement of a drug eluting intracoronary stent(s), percutaneous, with or without other therapeutic intervention, any method; single vessel

01 Jan 2013

G0291

Transcatheter placement of a drug eluting intracoronary stent(s), percutaneous, with or without other therapeutic intervention, any method; each additional vessel

01 Jan 2013

G0292

Administration(s) of experimental drug(s) only in a medicare qualifying clinical trial (includes administration for chemotherapy and other types of therapy via infusion and/or other than infusion)

01 Jan 2005

G0296-1

Pet imaging

01 Apr 2005

G0297

Low dose ct scan (ldct) for lung cancer screening

01 Jan 2021

G0298

Hiv antigen/antibody, combination assay, screening

01 Jan 2016

G0298-1

Insertion of dual chamber pacing cardioverter defibrillator pulse generator

01 Jan 2008

G0299-1

Insertion or repositioning of electrode lead for single chamber pacing cardioverter defibrillator and insertion of pulse generator

01 Jan 2008

G0300-1

Insertion or repositioning of electrode lead(s) for dual chamber pacing cardioverter defibrillator and insertion of pulse generator

01 Jan 2008

G0308

Creation of subcutaneous pocket with insertion of 180 day implantable interstitial glucose sensor, including system activation and patient training

01 Jan 2023

G0309

Removal of implantable interstitial glucose sensor with creation of subcutaneous pocket at different anatomic site and insertion of new 180 day implantable sensor, including system activation

01 Jan 2023

G0319

End stage renal disease (esrd) related services during the course of treatment

01 Jan 2009

G0324

End stage renal disease (esrd) related services less than full month

01 Jan 2009

G0325

End stage renal disease (esrd) related services less than full month

01 Jan 2009

G0326

End stage renal disease (esrd) related services less than full month

01 Jan 2009

G0331

Descriptor not available

01 Apr 2005

G0332

Services for intravenous infusion of immunoglobulin prior to administration (this service is to be billed in conjunction with administration of immunoglobulin)

01 Jan 2009

G0336

Descriptor not available

01 Apr 2005

G0338

Linear-accelerator-based stereotactic radiosurgery plan

01 Jan 2006

G0344

Initial preventive physical examination; face-to-face visit

01 Jan 2009

G0345

Intravenous infusion

01 Jan 2006

G0346

Each additional hour

01 Jan 2006

G0347

Intravenous infusion

01 Jan 2006

G0348

Each additional hour

01 Jan 2006

G0349

Additional sequential infusion

01 Jan 2006

G0350

Concurrent infusion (list separately in addition to code for primary procedure) report only once per substance/drug regardless of duration

01 Jan 2006

G0351

Therapeutic or diagnostic injection (specify substance or drug); subcutaneous or intramuscular

01 Jan 2006

G0353

Intravenous push

01 Jan 2006

G0354

Each additional sequential intravenous push (list separately in addition to code for primary procedure)

01 Jan 2006

G0355

Chemotherapy administration

01 Jan 2006

G0356

Hormonal anti-neoplastic

01 Jan 2006

G0357

Intravenous

01 Jan 2006

G0358

Intravenous

01 Jan 2006

G0359

Chemotherapy administration

01 Jan 2006

G0360

Each additional hour

01 Jan 2006

G0361

Initiation of prolonged chemotherapy infusion (more than eight hours)

01 Jan 2006

G0362

Each additional sequential infusion (different substance/drug)

01 Jan 2006

G0363

Irrigation of implanted venous access device for drug delivery systems (do not report g0363 if an injection or infusion is provided on the same day)

01 Jan 2006

G0364

Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service

01 Jan 2018

G0365

Vessel mapping of vessels for hemodialysis access (services for preoperative vessel mapping prior to creation of hemodialysis access using an autogenous hemodialysis conduit, including arterial inflow and venous outflow)

01 Jan 2020

G0366

Electrocardiogram

01 Jan 2009

G0367

Tracing only

01 Jan 2009

G0368

Interpretation and report only

01 Jan 2009

G0369

Pharmacy supply fee for initial immunosuppressive drug(s) first month following transplant

01 Jan 2006

G0370

Pharmacy supply fee for oral anti-cancer

01 Jan 2006

G0371

Pharmacy dispensing fee for inhalation drug(s); per 30 days

01 Jan 2006

G0374

Pharmacy dispensing fee for inhalation drug(s); per 90 days

01 Jan 2006

G0375

Smoking and tobacco use cessation counseling visit; intermediate

01 Jan 2008

G0376

Smoking and tobacco use cessation counseling visit; intensive

01 Jan 2008

G0377

Administration of vaccine for part d drug

01 Jan 2008

G0389

Ultrasound b-scan and/or real time with image documentation; for abdominal aortic aneurysm (aaa) screening

01 Jan 2017

G0392

Transluminal balloon angioplasty

01 Jan 2010

G0393

Transluminal balloon angioplasty

01 Jan 2010

G0394

Blood occult test (e.g.

01 Jan 2009

G0417

Surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, 21-40 specimens

01 Jan 2015

G0418

Surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, 41-60 specimens

01 Jan 2015

G0419

Surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, >60 specimens

01 Jan 2015

G0424

Pulmonary rehabilitation, including exercise (includes monitoring), one hour, per session, up to two sessions per day

01 Jan 2022

G0430

Drug screen, qualitative; multiple drug classes other than chromatographic ,method, each procedure

01 Jan 2011

G0431

Drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter

01 Jan 2016

G0434

Drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter

01 Jan 2016

G0436

Smoking and tobacco cessation counseling visit for the asymptomatic patient; intermediate, greater than 3 minutes, up to 10 minutes

30 Sep 2016

G0437

Smoking and tobacco cessation counseling visit for the asymptomatic patient; intensive, greater than 10 minutes

30 Sep 2016

G0440

Application of tissue cultured allogeneic skin substitute or dermal substitute; for use on lower limb, includes the site preparation and debridement if performed; first 25 sq cm or less

01 Jan 2012

G0441

Application of tissue cultured allogeneic skin substitute or dermal substitute; for use on lower limb, includes the site preparation and debridement if performed; each additional 25 sq cm

01 Jan 2012

G0456

Negative pressure wound therapy, (e.g. vacuum assisted drainage collection) using a mechanically-powered device, not durable medical equipment, including provision of cartridge and dressing(s), topical application(s), wound assessment, and instructions for ongoing care, per session; total wounds(s) surface area less than or equal to 50 square centimeters

01 Jan 2015

G0457

Negative pressure wound therapy, (e.g. vacuum assisted drainage collection) using a mechanically-powered device, not durable medical equipment, including provision of cartridge and dressing(s), topical application(s), wound assessment, and instructions for ongoing care, per session; total wounds(s) surface area greater than 50 square centimeters

01 Jan 2015

G0461

Immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain

01 Jan 2015

G0462

Immunohistochemistry or immunocytochemistry, per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure)

01 Jan 2015

G0464

Colorectal cancer screening; stool-based dna and fecal occult hemoglobin (e.g., kras, ndrg4 and bmp3

01 Jan 2015

G0477

Drug test(s), presumptive, any number of drug classes; any number of devices or procedures, (e.g., immunoassay) capable of being read by direct optical observation only (e.g., dipsticks, cups, cards, cartridges), includes sample validation when performed, per date of service

01 Jan 2017

G0478

Drug test(s), presumptive, any number of drug classes; any number of devices or procedures, (e.g., immunoassay) read by instrument-assisted direct optical observation (e.g., dipsticks, cups, cards, cartridges), includes sample validation when performed, per date of service

01 Jan 2017

G0479

Drug test(s), presumptive, any number of drug classes; any number of devices or procedures by instrumented chemistry analyzers utilizing immunoassay, enzyme assay, tof, maldi, ldtd, desi, dart, ghpc, gc mass spectrometry), includes sample validation when performed, per date of service

01 Jan 2017

G0502

Initial psychiatric collaborative care management, first 70 minutes in the first calendar month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: outreach to and engagement in treatment of a patient directed by the treating physician or other qualified health care professional; initial assessment of the patient, including administration of validated rating scales, with the development of an individualized treatment plan; review by the psychiatric consultant with modifications of the plan if recommended; entering patient in a registry and tracking patient follow-up and progress using the registry, with appropriate documentation, and participation in weekly caseload consultation with the psychiatric consultant; and provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies

01 Jan 2018

G0503

Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation; participation in weekly caseload consultation with the psychiatric consultant; ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers; additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant; provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies; monitoring of patient outcomes using validated rating scales; and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment

01 Jan 2018

G0504

Initial or subsequent psychiatric collaborative care management, each additional 30 minutes in a calendar month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional (list separately in addition to code for primary procedure); (use g0504 in conjunction with g0502, g0503)

01 Jan 2018

G0505

Cognition and functional assessment using standardized instruments with development of recorded care plan for the patient with cognitive impairment, history obtained from patient and/or caregiver, in office or other outpatient setting or home or domiciliary or rest home

01 Jan 2018

G0507

Care management services for behavioral health conditions, at least 20 minutes of clinical staff time, directed by a physician or other qualified health care professional, per calendar month, with the following required elements: initial assessment or follow-up monitoring, including the use of applicable validated rating scales; behavioral health care planning in relation to behavioral/psychiatric health problems, including revision for patients who are not progressing or whose status changes; facilitating and coordinating treatment such as psychotherapy, pharmacotherapy, counseling and/or psychiatric consultation; and continuity of care with a designated member of the care team

01 Jan 2018

G0515

Development of cognitive skills to improve attention, memory, problem solving (includes compensatory training), direct (one-on-one) patient contact, each 15 minutes

01 Jan 2020

G0564

Creation of subcutaneous pocket with insertion of 365 day implantable interstitial glucose sensor, including system activation and patient training

31 Mar 2025

G0565

Removal of implantable interstitial glucose sensor with creation of subcutaneous pocket at different anatomic site and insertion of new 365 day implantable sensor, including system activation

31 Mar 2025

G0908

Most recent hemoglobin (hgb) level > 12.0 g/dl

01 Jan 2015

G0909

Hemoglobin level measurement not documented, reason not given

01 Jan 2015

G0910

Most recent hemoglobin level <= 12.0 g/dl

01 Jan 2015

G0911

Assessed level of activity and symptoms

01 Jan 2013

G0912

Level of activity and symptoms not assessed

01 Jan 2013

G0919

Influenza immunization ordered or recommended (to be given at alternate location or alternate provider); vaccine not available at time of visit

01 Jan 2015

G0920

Type, anatomic location, and activity all documented

01 Jan 2015

G0921

Documentation of patient reason(s) for not being able to assess (e.g., patient refuses endoscopic and/or radiologic assessment)

01 Jan 2015

G0922

No documentation of disease type, anatomic location, and activity, reason not given

01 Jan 2015

G1000

Clinical decision support mechanism applied pathways, as defined by the medicare appropriate use criteria program

01 Apr 2020

G1001

Clinical decision support mechanism evicore, as defined by the medicare appropriate use criteria program

01 Jan 2025

G1002

Clinical decision support mechanism medcurrent, as defined by the medicare appropriate use criteria program

01 Jan 2025

G1003

Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program

01 Jan 2025

G1004

Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program

01 Jan 2025

G1005

Clinical decision support mechanism national imaging associates, as defined by the medicare appropriate use criteria program

01 Jan 2021

G1006

Clinical decision support mechanism test appropriate, as defined by the medicare appropriate use criteria program

01 Jan 2021

G1007

Clinical decision support mechanism aim specialty health, as defined by the medicare appropriate use criteria program

01 Jan 2025

G1008

Clinical decision support mechanism cranberry peak, as defined by the medicare appropriate use criteria program

01 Jan 2025

G1009

Clinical decision support mechanism sage health management solutions, as defined by the medicare appropriate use criteria program

01 Apr 2022

G1010

Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program

01 Jan 2025

G1011

Clinical decision support mechanism, qualified tool not otherwise specified, as defined by the medicare appropriate use criteria program

01 Jan 2025

G1012

Clinical decision support mechanism agilemd, as defined by the medicare appropriate use criteria program

01 Jan 2025

G1013

Clinical decision support mechanism evidencecare imagingcare, as defined by the medicare appropriate use criteria program

01 Jan 2025

G1014

Clinical decision support mechanism inveniqa semantic answers in medicine, as defined by the medicare appropriate use criteria program

01 Jan 2025

G1015

Clinical decision support mechanism reliant medical group, as defined by the medicare appropriate use criteria program

01 Jan 2025

G1016

Clinical decision support mechanism speed of care, as defined by the medicare appropriate use criteria program

01 Jan 2025

G1017

Clinical decision support mechanism healthhelp, as defined by the medicare appropriate use criteria program

01 Jan 2025

G1018

Clinical decision support mechanism infinx, as defined by the medicare appropriate use criteria program

01 Jan 2025

G1019

Clinical decision support mechanism logicnets, as defined by the medicare appropriate use criteria program

01 Jan 2025

G1020

Clinical decision support mechanism curbside clinical augmented workflow, as defined by the medicare appropriate use criteria program

01 Jan 2025

G1021

Clinical decision support mechanism ehealthline clinical decision support mechanism, as defined by the medicare appropriate use criteria program

01 Jan 2025

G1022

Clinical decision support mechanism intermountain clinical decision support mechanism, as defined by the medicare appropriate use criteria program

01 Jan 2025

G1023

Clinical decision support mechanism persivia clinical decision support, as defined by the medicare appropriate use criteria program

01 Jan 2025

G1024

Clinical decision support mechanism radrite, as defined by the medicare appropriate use criteria program

01 Jan 2025

G2012

Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion

01 Jan 2025

G2023

Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source

11 May 2023

G2024

Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source

11 May 2023

G2058

Chronic care management services, each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (list separately in addition to code for primary procedure). (do not report g2058 for care management services of less than 20 minutes additional to the first 20 minutes of chronic care management services during a calendar month). (use g2058 in conjunction with 99490). (do not report 99490, g2058 in the same calendar month as 99487, 99489, 99491)).

01 Jan 2021

G2061

Qualified nonphysician healthcare professional online assessment and management service, for an established patient, for up to seven days, cumulative time during the 7 days; 5-10 minutes

01 Jan 2021

G2062

Qualified nonphysician healthcare professional online assessment and management service, for an established patient, for up to seven days, cumulative time during the 7 days; 11-20 minutes

01 Jan 2021

G2063

Qualified nonphysician healthcare professional online assessment and management service, for an established patient, for up to seven days, cumulative time during the 7 days; 21 or more minutes

01 Jan 2021

G2064

Comprehensive care management services for a single high-risk disease, e.g., principal care management, at least 30 minutes of physician or other qualified health care professional time per calendar month with the following elements: one complex chronic condition lasting at least 3 months, which is the focus of the care plan, the condition is of sufficient severity to place patient at risk of hospitalization or have been the cause of a recent hospitalization, the condition requires development or revision of disease-specific care plan, the condition requires frequent adjustments in the medication regimen, and/or the management of the condition is unusually complex due to comorbidities

01 Jan 2022

G2065

Comprehensive care management for a single high-risk disease services, e.g. principal care management, at least 30 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month with the following elements: one complex chronic condition lasting at least 3 months, which is the focus of the care plan, the condition is of sufficient severity to place patient at risk of hospitalization or have been cause of a recent hospitalization, the condition requires development or revision of disease-specific care plan, the condition requires frequent adjustments in the medication regimen, and/or the management of the condition is unusually complex due to comorbidities

01 Jan 2022

G2066

Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results

01 Jan 2024

G2070

Medication assisted treatment, buprenorphine (implant insertion); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)

01 Jan 2025

G2071

Medication assisted treatment, buprenorphine (implant removal); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)

01 Jan 2025

G2072

Medication assisted treatment, buprenorphine (implant insertion and removal); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)

01 Jan 2025

G2089

Most recent hemoglobin a1c (hba1c) level 7.0 to 9.0%

01 Jan 2021

G2095

Documentation of system reason(s) for not prescribing ace inhibitor or arb or arni therapy (e.g., other system reasons)

01 Jan 2023

G2102

Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist documented and reviewed

01 Jan 2021

G2103

Seven standard field stereoscopic photos with interpretation by an ophthalmologist or optometrist documented and reviewed

01 Jan 2021

G2104

Eye imaging validated to match diagnosis from seven standard field stereoscopic photos results documented and reviewed

01 Jan 2021

G2108

Patient age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 consecutive days during the measurement period

01 Jan 2024

G2109

Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period

01 Jan 2024

G2110

Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period

01 Jan 2024

G2114

Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period

01 Jan 2021

G2117

Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period

01 Jan 2021

G2119

Within the past 2 years, calcium and/or vitamin d optimization has been ordered or performed

01 Jan 2021

G2120

Within the past 2 years, calcium and/or vitamin d optimization has not been ordered or performed

01 Jan 2021

G2123

Patients 66-80 years of age and had at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period

01 Jan 2021

G2124

Patients 66-80 years of age and had at least one claim/encounter for frailty during the measurement period and a dispensed dementia medication

01 Jan 2021

G2130

Patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 days during the measurement period

01 Jan 2021

G2131

Patients 81 years and older with a diagnosis of frailty

01 Jan 2021

G2132

Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period

01 Jan 2021

G2133

Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period

01 Jan 2021

G2134

Patients 66 years of age or older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period

01 Jan 2021

G2135

Patients 66 years of age or older with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period

01 Jan 2021

G2153

In hospice or using hospice services during the measurement period

01 Jan 2021

G2154

Patient received at least one td vaccine or one tdap vaccine between nine years prior to the start of the measurement period and the end of the measurement period

01 Jan 2021

G2155

Patient had history of at least one of the following contraindications any time during or before the measurement period: anaphylaxis due to tdap vaccine, anaphylaxis due to td vaccine or its components; encephalopathy due to tdap or td vaccination (post tetanus vaccination encephalitis, post diphtheria vaccination encephalitis or post pertussis vaccination encephalitis.)

01 Jan 2021

G2156

Patient did not receive at least one td vaccine or one tdap vaccine between nine years prior to the start of the measurement period and the end of the measurement period; or have history of at least one of the following contraindications any time during or before the measurement period: anaphylaxis due to tdap vaccine, anaphylaxis due to td vaccine or its components; encephalopathy due to tdap or td vaccination (post tetanus vaccination encephalitis, post diphtheria vaccination encephalitis or post pertussis vaccination encephalitis.)

01 Jan 2021

G2157

Patients received both the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine at least 12 months apart, with the first occurrence after the age of 60 before or during the measurement period

01 Jan 2021

G2158

Patient had prior pneumococcal vaccine adverse reaction any time during or before the measurement period

01 Jan 2021

G2159

Patient did not receive both the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine at least 12 months apart, with the first occurrence after the age of 60 before or during measurement period; or have prior pneumococcal vaccine adverse reaction any time during or before the measurement period

01 Jan 2021

G2160

Patient received at least one dose of the herpes zoster live vaccine or two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement period

01 Jan 2021

G2161

Patient had prior adverse reaction caused by zoster vaccine or its components any time during or before the measurement period

01 Jan 2021

G2162

Patient did not receive at least one dose of the herpes zoster live vaccine or two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement period; or have prior adverse reaction caused by zoster vaccine or its components any time during or before the measurement period

01 Jan 2021

G2163

Patient received an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period

01 Jan 2021

G2164

Patient had a prior influenza virus vaccine adverse reaction any time before or during the measurement period

01 Jan 2021

G2165

Patient did not receive an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period; or did not have a prior influenza virus vaccine adverse reaction any time before or during the measurement period

01 Jan 2021

G2166

Patient refused to participate at admission and/or discharge; patient unable to complete the neck fs prom at admission or discharge due to cognitive deficit, visual deficit, motor deficit, language barrier, or low reading level, and a suitable proxy/recorder is not available; patient self-discharged early; medical reason

01 Jan 2021

G2170

Percutaneous arteriovenous fistula creation (avf), direct, any site, by tissue approximation using thermal resistance energy, and secondary procedures to redirect blood flow (e.g., transluminal balloon angioplasty, coil embolization) when performed, and includes all imaging and radiologic guidance, supervision and interpretation, when performed

01 Jan 2023

G2171

Percutaneous arteriovenous fistula creation (avf), direct, any site, using magnetic-guided arterial and venous catheters and radiofrequency energy, including flow-directing procedures (e.g., vascular coil embolization with radiologic supervision and interpretation, wen performed) and fistulogram(s), angiography, enography, and/or ultrasound, with radiologic supervision and interpretation, when performed

01 Jan 2023

G2198

Documentation of medical reason(s) for not screening for unhealthy alcohol use using a systematic screening method (e.g., limited life expectancy, other medical reasons)

01 Jan 2023

G2201

Documentation of medical reason(s) for not providing brief counseling (e.g., limited life expectancy, other medical reasons)

01 Jan 2023

G2203

Documentation of medical reason(s) for not providing brief counseling if identified as an unhealthy alcohol user (e.g., limited life expectancy, other medical reasons)

01 Jan 2023

G3001

Administration and supply of tositumomab, 450 mg

01 Jan 2017

G6018

Ileoscopy,through stoma; with transendoscopic stent placement (includes predilation)

01 Jan 2016

G6019

Colonoscopy through stoma; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique

01 Jan 2016

G6020

Colonoscopy through stoma; with transendoscopic stent placement (includes predilation)

01 Jan 2016

G6021

Unlisted procedure, intestine

01 Jan 2016

G6022

Sigmoidoscopy, flexible; with ablation of tumor(s), polyp(s), or other lesions(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique

01 Jan 2016

G6023

Sigmoidoscopy, flexible; with transendoscopic stent placement (includes predilation)

01 Jan 2016

G6024

Colonoscopy, flexible; proximal to splenic flexure; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare tehnique

01 Jan 2016

G6025

Colonoscopy, flexible, proximal to splenic flexure; with transendoscopic stent placement (includes predilation)

01 Jan 2016

G6027

Anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); diagnostic, including collection of specimen(s) by brushing or washing when performed

01 Jan 2016

G6028

Anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); with biopsy(ies)

01 Jan 2016

G6030

Amitriptyline

01 Jan 2016

G6031

Benzodiazepines

01 Jan 2016

G6032

Desipramine

01 Jan 2016

G6034

Doxepin

01 Jan 2016

G6035

Gold

01 Jan 2016

G6036

Assay of imipramine

01 Jan 2016

G6037

Nortriptyline

01 Jan 2016

G6038

Salicylate

01 Jan 2016

G6039

Acetaminophen

01 Jan 2016

G6040

Alcohol (ethanol); any specimen except breath

01 Jan 2016

G6041

Alkaloids, urine, quantitative

01 Jan 2016

G6042

Amphetamine or methamphetamine

01 Jan 2016

G6043

Barbiturates, not elsewhere specified

01 Jan 2016

G6044

Cocaine or metabolite

01 Jan 2016

G6045

Dihydrocodeinone

01 Jan 2016

G6046

Dihydromorphinone

01 Jan 2016

G6047

Dihydrotestosterone

01 Jan 2016

G6048

Dimethadione

01 Jan 2016

G6049

Epiandrosterone

01 Jan 2016

G6050

Ethchlorvynol

01 Jan 2016

G6051

Flurazepam

01 Jan 2016

G6052

Meprobamate

01 Jan 2016

G6053

Methadone

01 Jan 2016

G6054

Methsuximide

01 Jan 2016

G6055

Nicotine

01 Jan 2016

G6056

Opiate(s), drug and metabolites, each procedure

01 Jan 2016

G6057

Phenothiazine

01 Jan 2016

G6058

Drug confirmation, each procedure

01 Jan 2016

G8006

Acute myocardial infarction: patient documented to have received aspirin at ,arrival

01 Jan 2011

G8007

Acute myocardial infarction: patient not documented to have received aspirin at ,arrival

01 Jan 2011

G8008

Clinician documented that acute myocardial infarction patient was not an ,eligible candidate to receive aspirin at arrival measure

01 Jan 2011

G8009

Acute myocardial infarction: patient documented to have received beta-blocker ,at arrival

01 Jan 2011

G8010

Acute myocardial infarction: patient not documented to have received ,beta-blocker at arrival

01 Jan 2011

G8011

Clinician documented that acute myocardial infarction patient was not an ,eligible candidate for beta-blocker at arrival measure

01 Jan 2011

G8012

Pneumonia: patient documented to have received antibiotic within 4 hours of ,presentation

01 Jan 2011

G8013

Pneumonia: patient not documented to have received antibiotic within 4 hours of ,presentation

01 Jan 2011

G8014

Clinician documented that pneumonia patient was not an eligible candidate for ,antibiotic within 4 hours of presentation measure

01 Jan 2011

G8015

Diabetic patient with most recent hemoglobin a1c level (within the last 6 ,months) documented as greater than 9%

01 Jan 2011

G8016

Diabetic patient with most recent hemoglobin a1c level (within the last 6 ,months) documented as less than or equal to 9%

01 Jan 2011

G8017

Clinician documented that diabetic patient was not eligible candidate for ,hemoglobin a1c measure

01 Jan 2011

G8018

Clinician has not provided care for the diabetic patient for the required time ,for hemoglobin a1c measure (6 months)

01 Jan 2011

G8019

Diabetic patient with most recent low-density lipoprotein (within the last 12 ,months) documented as greater than or equal to 100 mg/dl

01 Jan 2011

G8020

Diabetic patient with most recent low-density lipoprotein (within the last 12 ,months) documented as less than 100 mg/dl

01 Jan 2011

G8021

Clinician documented that diabetic patient was not eligible candidate for ,low-density lipoprotein measure

01 Jan 2011

G8022

Clinician has not provided care for the diabetic patient for the required time ,for low-density lipoprotein measure (12 months)

01 Jan 2011

G8023

Diabetic patient with most recent blood pressure (within the last 6 months) ,documented as equal to or greater than 140 systolic or equal to or greater than ,80 mmhg diastolic

01 Jan 2011

G8024

Diabetic patient with most recent blood pressure (within the last 6 months) ,documented as less than 140 systolic and less than 80 diastolic

01 Jan 2011

G8025

Clinician documented that the diabetic patient was not eligible candidate for ,blood pressure measure

01 Jan 2011

G8026

Clinician has not provided care for the diabetic patient for the required time ,for blood pressure measure (within the last 6 months)

01 Jan 2011

G8027

Heart failure patient with left ventricular systolic dysfunction (lvsd) ,documented to be on either angiotensin-converting enzyme inhibitor or ,angiotensin-receptor blocker (ace-i or arb) therapy

01 Jan 2011

G8028

Heart failure patient with left ventricular systolic dysfunction (lvsd) not ,documented to be on either angiotensin-converting enzyme inhibitor or ,angiotensin-receptor blocker (ace-i or arb) therapy

01 Jan 2011

G8029

Clinician documented that heart failure patient was not an eligible candidate ,for either angiotensin-converting enzyme inhibitor or angiotensin-receptor ,blocker (ace-i or arb) therapy measure

01 Jan 2011

G8030

Heart failure patient with left ventricular systolic dysfunction (lvsd) ,documented to be on beta-blocker therapy

01 Jan 2011

G8031

Heart failure patient with left ventricular systolic dysfunction (lvsd) not ,documented to be on beta-blocker therapy

01 Jan 2011

G8032

Clinician documented that heart failure patient was not eligible candidate for ,beta-blocker therapy measure

01 Jan 2011

G8033

Prior myocardial infarction - coronary artery disease patient documented to be ,on beta-blocker therapy

01 Jan 2011

G8034

Prior myocardial infarction - coronary artery disease patient not documented to ,be on beta-blocker therapy

01 Jan 2011

G8035

Clinician documented that prior myocardial infarction - coronary artery disease ,patient was not eligible candidate for beta-blocker therapy measure

01 Jan 2011

G8036

Coronary artery disease patient documented to be on antiplatelet therapy

01 Jan 2011

G8037

Coronary artery disease patient not documented to be on antiplatelet therapy

01 Jan 2011

G8038

Clinician documented that coronary artery disease patient was not eligible ,candidate for antiplatelet therapy measure

01 Jan 2011

G8039

Coronary artery disease - patient with low-density lipoprotein documented to be ,greater than 100mg/dl

01 Jan 2011

G8040

Coronary artery disease - patient with low-density lipoprotein documented to be ,less than or equal to 100mg/dl

01 Jan 2011

G8041

Clinician documented that coronary artery disease patient was not eligible ,candidate for low-density lipoprotein measure

01 Jan 2011

G8051

Patient (female) documented to have been assessed for osteoporosis

01 Jan 2011

G8052

Patient (female) not documented to have been assessed for osteoporosis

01 Jan 2011

G8053

Clinician documented that (female) patient was not an eligible candidate for ,osteoporosis assessment measure

01 Jan 2011

G8054

Patient not documented for the assessment for falls within last 12 months

01 Jan 2011

G8055

Patient documented for the assessment for falls within last 12 months

01 Jan 2011

G8056

Clinician documented that patient was not an eligible candidate for the falls ,assessment measure within the last 12 months

01 Jan 2011

G8057

Patient documented to have received hearing assessment

01 Jan 2011

G8058

Patient not documented to have received hearing assessment

01 Jan 2011

G8059

Clinician documented that patient was not an eligible candidate for hearing ,assessment measure

01 Jan 2011

G8060

Patient documented for the assessment of urinary incontinence

01 Jan 2011

G8061

Patient not documented for the assessment of urinary incontinence

01 Jan 2011

G8062

Clinician documented that patient was not an eligible candidate for urinary ,incontinence assessment measure

01 Jan 2011

G8075

End stage renal disease patient with documented dialysis dose of urr greater ,than or equal to 65% (or kt/v greater than or equal to 1.2)

01 Jan 2011

G8076

End stage renal disease patient with documented dialysis dose of urr less than ,65% (or kt/v less than 1.2)

01 Jan 2011

G8077

Clinician documented that end stage renal disease patient was not an eligible ,candidate for urr or kt/v measure

01 Jan 2011

G8078

End stage renal disease patient with documented hematocrit greater than or ,equal to 33 (or hemoglobin greater than or equal to 11)

01 Jan 2011

G8079

End stage renal disease patient with documented hematocrit less than 33 (or ,hemoglobin less than 11)

01 Jan 2011

G8080

Clinician documented that end stage renal disease patient was not an eligible ,candidate for hematocrit (hemoglobin) measure

01 Jan 2011

G8081

End stage renal disease patient requiring hemodialysis vascular access ,documented to have received autogenous av fistula

01 Jan 2011

G8082

End stage renal disease patient requiring hemodialysis documented to have ,received vascular access other than autogenous av fistula

01 Jan 2011

G8085

End-stage renal disease patient requiring hemodialysis vascular access was not ,an eligible candidate for autogenous av fistula

01 Jan 2011

G8093

Newly diagnosed chronic obstructive pulmonary disease (copd) patient documented ,to have received smoking cessation intervention, within 3 months of diagnosis

01 Jan 2011

G8094

Newly diagnosed chronic obstructive pulmonary disease (copd) patient not ,documented to have received smoking cessation intervention, within 3 months of ,diagnosis

01 Jan 2011

G8099

Osteoporosis patient documented to have been prescribed calcium and vitamin d ,supplements

01 Jan 2011

G8100

Clinician documented that osteoporosis patient was not an eligible candidate ,for calcium and vitamin d supplement measure

01 Jan 2011

G8103

Newly diagnosed osteoporosis patients documented to have been treated with ,antiresorptive therapy and/or pth within 3 months of diagnosis

01 Jan 2011

G8104

Clinician documented that newly diagnosed osteoporosis patient was not an ,eligible candidate for antiresorptive therapy and/or pth treatment measure ,within 3 months of diagnosis

01 Jan 2011

G8106

Within 6 months of suffering a nontraumatic fracture, female patient 65 years ,of age or older documented to have undergone bone mineral density testing or to ,have been prescribed a drug to treat or prevent osteoporosis

01 Jan 2011

G8107

Clinician documented that female patient 65 years of age or older who suffered ,a nontraumatic fracture within the last 6 months was not an eligible candidate ,for measure to test bone mineral density or drug to treat or prevent ,osteoporosis

01 Jan 2011

G8108

Patient documented to have received influenza vaccination during influenza ,season

01 Jan 2011

G8109

Patient not documented to have received influenza vaccination during influenza ,season

01 Jan 2011

G8110

Clinician documented that patient was not an eligible candidate for influenza ,vaccination measure

01 Jan 2011

G8111

Patient (female) documented to have received a mammogram during the measurement ,year or prior year to the measurement year

01 Jan 2011

G8112

Patient (female) not documented to have received a mammogram during the ,measurement year or prior year to the measurement year

01 Jan 2011

G8113

Clinician documented that female patient was not an eligible candidate for ,mammography measure

01 Jan 2011

G8114

Clinician did not provide care to patient for the required time of mammography ,measure (i.e., measurement year or prior year)

01 Jan 2011

G8115

Patient documented to have received pneumococcal vaccination

01 Jan 2011

G8116

Patient not documented to have received pneumococcal vaccination

01 Jan 2011

G8117

Clinician documented that patient was not an eligible candidate for ,pneumococcal vaccination measure

01 Jan 2011

G8126

Patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase

01 Jan 2015

G8127

Patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase

01 Jan 2015

G8128

Clinician documented that patient was not an eligible candidate for antidepressant medication during the entire 12 week acute treatment phase measure

01 Jan 2015

G8129

Patient documented as being treated with antidepressant medication for at least ,6 months continuous treatment phase

01 Jan 2011

G8130

Patient not documented as being treated with antidepressant medication for at ,least 6 months continuous treatment phase

01 Jan 2011

G8131

Clinician documented that patient was not an eligible candidate for ,antidepressant medication for continuous treatment phase

01 Jan 2011

G8152

Patient documented to have received antibiotic prophylaxis one hour prior to ,incision time (two hours for vancomycin)

01 Jan 2011

G8153

Patient not documented to have received antibiotic prophylaxis one hour prior ,to incision time (two hours for vancomycin)

01 Jan 2011

G8154

Clinician documented that patient was not an eligible candidate for antibiotic ,prophylaxis one hour prior to incision time (two hours for vancomycin) measure

01 Jan 2011

G8155

Patient with documented receipt of thromboembolism prophylaxis

01 Jan 2011

G8156

Patient without documented receipt of thromboembolism prophylaxis

01 Jan 2011

G8157

Clinician documented that patient was not an eligible candidate for ,thromboembolism prophylaxis measure

01 Jan 2011

G8158

Patient documented to have received coronary artery bypass graft with use of internal mammary artery

01 Jul 2007

G8159

Patient documented to have received coronary artery bypass graft without use of ,internal mammary artery

01 Jan 2011

G8160

Clinician documented that patient was not an eligible candidate for coronary artery bypass graft with use of internal mammary artery measure

01 Jul 2007

G8161

Patient with isolated coronary artery bypass graft documented to have received pre-operative beta-blockade

01 Jul 2007

G8162

Patient with isolated coronary artery bypass graft not documented to have ,received pre-operative beta-blockade

01 Jan 2011

G8163

Clinician documented that patient with isolated coronary artery bypass graft was not an eligible candidate for pre-operative beta-blockade measure

01 Jul 2007

G8164

Patient with isolated coronary artery bypass graft documented to have prolonged ,intubation

01 Jan 2011

G8165

Patient with isolated coronary artery bypass graft not documented to have ,prolonged intubation

01 Jan 2011

G8166

Patient with isolated coronary artery bypass graft documented to have required ,surgical re-exploration

01 Jan 2011

G8167

Patient with isolated coronary artery bypass graft did not require surgical ,re-exploration

01 Jan 2011

G8170

Patient with isolated coronary artery bypass graft documented to have been ,discharged on aspirin or clopidogrel

01 Jan 2011

G8171

Patient with isolated coronary artery bypass graft not documented to have been ,discharged on aspirin or clopidogrel

01 Jan 2011

G8172

Clinician documented that patient with isolated coronary artery bypass graft ,was not an eligible candidate for antiplatelet therapy at discharge measure

01 Jan 2011

G8182

Clinician has not provided care for the cardiac patient for the required time ,for low-density lipoprotein measure (6 months)

01 Jan 2011

G8183

Patient with heart failure and atrial fibrillation documented to be on warfarin ,therapy

01 Jan 2011

G8184

Clinician documented that patient with heart failure and atrial fibrillation ,was not an eligible candidate for warfarin therapy measure

01 Jan 2011

G8185

Patients diagnosed with symptomatic osteoarthritis with documented annual ,assessment of function and pain

01 Jan 2011

G8186

Clinician documented that symptomatic osteoarthritis patient was not an ,eligible candidate for annual assessment of function and pain measure

01 Jan 2011

G8191

Clinician documented to have given order for prophylactic antibiotic to be given within one hour (if vancomycin

01 Jul 2007

G8192

Clinician documented to have given the prophylactic antibiotic within one hour (if vancomycin

01 Jul 2007

G8193

Clinician did not document that an order for prophylactic antibiotic to be ,given within one hour (if vancomycin, two hours) prior to surgical incision (or ,start of procedure when no incision is required) was given

01 Jan 2011

G8194

Clinician documented that patient was not an eligible candidate for prophylactic antibiotic

01 Jul 2007

G8195

Clinician documented to have given the prophylactic antibiotic within one hour (if vancomycin

01 Jul 2007

G8196

Clinician did not document a prophylactic antibiotic was administered within ,one hour (if vancomycin, two hours) prior to surgical incision (or start of ,procedure when no incision is required)

01 Jan 2011

G8197

Patient documented to have order for prophylactic antibiotic to be given within one hour (if vancomycin

01 Jul 2007

G8198

Patient documented to have order for cefazolin or cefuroxime for antimicrobial prophylaxis

01 Jul 2007

G8199

Clinician documented to have given cefazolin or cefuroxime for antimicrobial prophylaxis

01 Jul 2007

G8200

Order for cefazolin or cefuroxime for antimicrobial prophylaxis not documented

01 Jan 2011

G8201

Patient was not an eligible candidate for cefazolin or cefuroxime for antimicrobial prophylaxis

01 Jul 2007

G8202

Clinician documented an order was given to discontinue prophylactic antibiotics within 24 hours of surgical end time

01 Jul 2007

G8203

Clinician documented that prophylactic antibiotics were discontinued within 24 hours of surgical end time

01 Jul 2007

G8204

Clinician did not document an order was given to discontinue prophylactic ,antibiotics within 24 hours of surgical end time

01 Jan 2011

G8205

Clinician documented that patient was not an eligible candidate for prophylactic antibiotic discontinuation within 24 hours of surgical end time

01 Jul 2007

G8206

Clinician documented that prophylactic antibiotic was given

01 Jul 2007

G8207

Clinician documented an order was given to discontinue prophylactic antibiotics within 48 hours of surgical end time

01 Jul 2007

G8208

Clinician documented that prophylactic antibiotics were discontinued within 48 hours of surgical end time

01 Jul 2007

G8209

Clinician did not document an order was given to discontinue prophylactic ,antibiotics within 48 hours of surgical end time

01 Jan 2011

G8210

Clinician documented patient was not an eligible candidate for discontinuation of prophylactic antibiotic discontinuation within 48 hours of surgical end time

01 Jul 2007

G8211

Clinician documented that prophylactic antibiotic was given

01 Jul 2007

G8212

Clinician documented an order was given for appropriate venous thromboembolism (vte) prophylaxis to be given within 24 hrs prior to incision time or 24 hours after surgery end time

01 Jul 2007

G8213

Clinician documented to have given vte prophylaxis within 24 hrs prior to incision time or 24 hours after surgery end time

01 Jul 2007

G8214

Clinician did not document an order was given for appropriate venous ,thromboembolism (vte) prophylaxis to be given within 24 hrs prior to incision ,time or 24 hours after surgery end time

01 Jan 2011

G8215

Clinician documented that patient was not an eligible candidate for venous thromboembolism (vte) prophylaxis to be given within 24 hours prior to incision time or 24 hours after surgery end time

01 Jul 2007

G8216

Patient documented to have received dvt prophylaxis by end of hospital day two

01 Jul 2007

G8217

Patient not documented to have received dvt prophylaxis by end of hospital day 2

01 Jan 2011

G8218

Patient was not an eligible candidate for dvt prophylaxis by end of hospital day 2

01 Jul 2007

G8219

Patient documented to have received dvt prophylaxis by end of hospital day 2

01 Jan 2011

G8220

Patient not documented to have received dvt prophylaxis by end of hospital day 2

01 Jan 2011

G8221

Clinician documented that patient was not an eligible candidate for dvt ,prophylaxis by the end of hospital day 2, including physician documentation ,that patient is ambulatory

01 Jan 2011

G8222

Patient documented to have been prescribed antiplatelet therapy at discharge

01 Jul 2007

G8223

Patient not documented to have received prescription for antiplatelet therapy ,at discharge

01 Jan 2011

G8224

Clinician documented that patient was not an eligible candidate for antiplatelet therapy at discharge

01 Jul 2007

G8225

Patient documented to have been prescribed an anticoagulant at discharge

01 Jul 2007

G8226

Patient not documented to have received prescription for anticoagulant therapy ,at discharge

01 Jan 2011

G8227

Patient not documented to have permanent

01 Jul 2007

G8228

Clinician documented that patient was not an eligible candidate for anticoagulant therapy at discharge

01 Jul 2007

G8229

Patient documented to have been administered or considered for t-pa

01 Jul 2007

G8230

Patient not eligible for t-pa administration

01 Jul 2007

G8231

Patient not documented to have received t-pa or not documented to have been ,considered a candidate for t-pa administration

01 Jan 2011

G8232

Patient documented to have received dysphagia screening prior to taking any foods

01 Jul 2007

G8234

Patient not documented to have received dysphagia screening

01 Jan 2011

G8235

Patient not receiving or ineligible to receive food

01 Jul 2007

G8236

Clinician documented that patient was not an eligible candidate for dysphagia screening prior to taking any foods

01 Jul 2007

G8237

Patient documented to have received order for rehabilitation services or documentation of consideration for rehabilitation services

01 Jul 2007

G8238

Patient not documented to have received order for or consideration for ,rehabilitation services

01 Jan 2011

G8239

Internal carotid stenosis patient below 30%

01 Jul 2007

G8240

Internal carotid stenosis patient in the 30-99% range, and no documentation of ,reference to measurements of distal internal carotid diameter as the ,denominator for stenosis measurement

01 Jan 2011

G8241

Clinician documented that patient whose final report of the carotid imaging study performed (neck mra

01 Jul 2007

G8242

Patient documented to have received ct or mri with presence or absence of hemorrhage

01 Jul 2007

G8243

Patient not documented to have received ct or mri and the presence or absence ,of hemorrhage, mass lesion and acute infarction not documented in the final ,report

01 Jan 2011

G8245

Clinician documented presence or absence alarm symptoms

01 Jul 2007

G8246

Patient was not an eligible candidate for medical history review with ,assessment of new or changing moles

01 Jan 2011

G8247

Patient with alarm symptom(s) documented to have had upper endoscopy performed or referral for upper endoscopy

01 Jul 2007

G8248

Patient with at least one alarm symptom not documented to have had upper ,endoscopy or referral for upper endoscopy

01 Jan 2011

G8249

Clinician documented that patient was not an eligible candidate for upper endoscopy

01 Jul 2007

G8250

Descriptor not available

01 Jul 2007

G8251

Patient not documented to have received an esophageal biopsy when suspicion of ,barrett's esophagus is indicated in the endoscopy report

01 Jan 2011

G8252

Clinician documented that patient was not an eligible candidate for esophageal biopsy

01 Jul 2007

G8253

Patient documented to have received an order for a barium swallow test

01 Jul 2007

G8254

Patient with no documentation order for barium swallow test

01 Jan 2011

G8255

Clinician documentation that patient was an eligible candidate for barium swallow test

01 Jul 2007

G8256

Clinician documented reconciliation of discharge medications with current medication list in medical record

01 Jul 2007

G8257

Clinician has not documented reconciliation of discharge medications with ,current medication list in medical record

01 Jan 2011

G8258

Patient was not an eligible candidate for discharge medications review

01 Jul 2007

G8259

Patient documented to have surrogate decision maker or advance care plan in medical record

01 Jul 2007

G8260

Patient not documented to have surrogate decision maker or advance care plan in ,medical record

01 Jan 2011

G8261

Clinician documented that patient was not an eligible candidate for surrogate decision maker or advance care plan

01 Jul 2007

G8262

Patient documented to have been assessed for presence or absence of urinary incontinence

01 Jul 2007

G8263

Patient not documented to have been assessed for presence or absence of urinary ,incontinence

01 Jan 2011

G8264

Clinician documented that patient was not an eligible candidate for an assessment of the presence or absence of urinary incontinence

01 Jul 2007

G8265

Patient documented to have received characterization of urinary incontinence

01 Jul 2007

G8266

Patient not documented to have received characterization of urinary incontinence

01 Jan 2011

G8267

Patient documented to have received a plan of care for urinary incontinence

01 Jul 2007

G8268

Patient not documented to have received plan of care for urinary incontinence

01 Jan 2011

G8269

Clinician has not provided care for the patient for the required time to develop plan of care for urinary incontinence

01 Jul 2007

G8270

Patient documented to have received screening for fall risk (2 or more falls in the past year or any fall with injury in the past year)

01 Jul 2007

G8271

Patient with no documentation of screening for fall risks (2 or more falls in ,the past year or any fall with injury in the past year)

01 Jan 2011

G8272

Clinician documentation that patient was not an eligible candidate for fall risk screening

01 Jul 2007

G8273

Clinician has not provided care for the patient for the required time to screen for fall risk

01 Jul 2007

G8274

Clinician has not documented presence or absence of alarm symptoms

01 Jan 2011

G8275

Patient documented to have medical history taken which included assessment of new or changing moles

01 Jul 2007

G8276

Patient not documented to have received medical history with assessment of new ,or changing moles

01 Jan 2011

G8277

Patient was not an eligible candidate for medical history review with assessment of new or changing moles

01 Jul 2007

G8278

Patient documented to have received complete physical skin exam

01 Jul 2007

G8279

Patient not documented to have received a complete physical skin exam

01 Jan 2011

G8280

Patient was not an eligible candidate for complete physical skin exam during the reporting year

01 Jul 2007

G8281

Patient documented to have received counseling to perform a self-examination

01 Jul 2007

G8282

Patient not documented to have received counseling to perform a self-examination

01 Jan 2011

G8283

Patient was not an eligible candidate for counseling to perform self-examination

01 Jul 2007

G8284

Patient documented to have received a prescription for pharmacologic therapy for osteoporosis

01 Jul 2007

G8285

Patient not documented to have received pharmacologic therapy

01 Jan 2011

G8286

Clinician documented that patient was not an eligible candidate for pharmacologic therapy

01 Jul 2007

G8287

Clinician has not provided care for the patient for the required time for the pharmacologic therapy measure

01 Jul 2007

G8288

Patient documented to have received calcium and vitamin d or counseling on both calcium and vitamin d use

01 Jul 2007

G8289

Patient with no documentation of calcium and vitamin d use or counseling ,regarding both calcium and vitamin d use, or exercise

01 Jan 2011

G8290

Clinician documentation that patient was not an eligible candidate for calcium and vitamin d

01 Jul 2007

G8291

Clinician has not provided care for the patient for the required time for the calcium

01 Jul 2007

G8292

Copd patient with spirometry results documented

01 Jul 2007

G8293

Copd patient without spirometry results documented

01 Jan 2011

G8294

Copd patient was not eligible for spirometry results

01 Jul 2007

G8295

Copd patient documented to have received inhaled bronchodilator therapy

01 Jul 2007

G8296

Copd patient not documented to have inhaled bronchodilator therapy prescribed

01 Jan 2011

G8297

Copd patient was not eligible for inhaled bronchodilator therapy

01 Jul 2007

G8298

Patient documented to have received optic nerve head evaluation

01 Jan 2011

G8299

Patient not documented to have received optic nerve head evaluation

01 Jan 2011

G8300

Clinician documented that patient was not an eligible candidate for optic nerve head evaluation during the reporting year

01 Jul 2007

G8301

Clinician has not provided care for the primary open-angle glaucoma patient for the required time for optic nerve head evaluation measure

01 Jul 2007

G8302

Patient documented to have a specific target intraocular pressure range goal

01 Jan 2011

G8303

Patient not documented to have a specific target intraocular pressure range goal

01 Jan 2011

G8304

Clinician documented that patient was not an eligible candidate for a specific ,target intraocular pressure range goal

01 Jan 2011

G8305

Clinician has not provided care for the primary open-angle glaucoma patient for ,the required time for treatment range goal documentation measurement

01 Jan 2011

G8306

Primary open-angle glaucoma patient with intraocular pressure above the target ,range goal documented to have received plan of care

01 Jan 2011

G8307

Primary open-angle glaucoma patient with intraocular pressure at or below goal, no plan of care necessary

01 Jan 2011

G8308

Primary open-angle glaucoma patient with intraocular pressure above the target ,range goal, and not documented to have received plan of care during the ,reporting year

01 Jan 2011

G8309

Patient documented to have been prescribed/recommended antioxidant vitamin or mineral supplement

01 Jul 2007

G8310

Patient not documented to have been prescribed/recommended at least one ,antioxidant vitamin or mineral supplement during the reporting year

01 Jan 2011

G8311

Clinician documentation that patient was not an eligible candidate for antioxidant vitamin or mineral supplement during the reporting year

01 Jul 2007

G8312

Clinician has not provided care for the age-related macular degeneration patient for the required time for antioxidant supplement prescription/recommended measure

01 Jul 2007

G8313

Patient documented to have received macular exam

01 Jul 2007

G8314

Patient not documented to have received macular exam with documentation of ,presence or absence of macular thickening or hemorrhage and no documentation of ,level of macular degeneration severity

01 Jan 2011

G8315

Clinician documentation that patient was not an eligible candidate for macular examination during the reporting year

01 Jul 2007

G8316

Clinician has not provided care for the age-related macular degeneration patient for the required time for macular examination measurement

01 Jul 2007

G8317

Patient documented to have visual functional status assessed

01 Jul 2007

G8318

Patient documented not to have visual functional status assessed

01 Jan 2011

G8319

Clinician documented that patient was not an eligible candidate for assessment of visual functional status

01 Jul 2007

G8320

Clinician has not provided care for the cataract patient for the required time for assessment of visual functional status measurement

01 Jul 2007

G8321

Patient documented to have had pre-surgical axial length

01 Jul 2007

G8322

Patient not documented to have had pre-surgical axial length, corneal power ,measurement and method of intraocular lens power calculation

01 Jan 2011

G8323

Clinician documentation that patient was not an eligible candidate for pre-surgical axial length

01 Jul 2007

G8324

Clinician has not provided care for the cataract patient for the required time for pre-surgical measurement and intraocular lens power calculation measure

01 Jul 2007

G8325

Patient documented to have received fundus evaluation within six months prior to cataract surgery

01 Jul 2007

G8326

Patient not documented to have received fundus evaluation within six months ,prior to cataract surgery

01 Jan 2011

G8327

Patient was not an eligible candidate for pre-surgical fundus evaluation

01 Jul 2007

G8328

Clinician has not provided care for the cataract patient for the required time for fundus evaluation measurement

01 Jul 2007

G8329

Patient documented to have received dilated macular or fundus exam with level of severity of retinopathy and the presence or absence of macular edema documented

01 Jul 2007

G8330

Patient not documented to have received dilated macular or fundus exam with ,level of severity of retinopathy and the presence or absence of macular edema ,not documented

01 Jan 2011

G8331

Clinician documentation that patient was not an eligible candidate for dilated macular or fundus exam during the reporting year

01 Jul 2007

G8332

Clinician has not provided care for the diabetic retinopathy patient for the required time for macular edema and retinopathy measurement

01 Jul 2007

G8333

Patient documented to have had findings of macular or fundus exam communicated to the physician managing the diabetes care

01 Jul 2007

G8334

Documentation of findings of macular or fundus exam not communicated to the ,physician managing the patient's ongoing diabetes care

01 Jan 2011

G8335

Clinician documentation that patient was not an eligible candidate for the findings of their macular or fundus exam being communicated to the physician managing their diabetes care during the reporting year

01 Jul 2007

G8336

Clinician has not provided care for the diabetic retinopathy patient for the required time for physician communication measurement

01 Jul 2007

G8337

Clinician documented that communication was sent to the physician managing ongoing care of patient that a fracture occurred and that the patient was or should be tested or treated for osteoporosis

01 Jul 2007

G8338

Clinician has not documented that communication was sent to the physician ,managing ongoing care of patient that a fracture occurred and that the patient ,was or should be tested or treated for osteoporosis

01 Jan 2011

G8339

Descriptor not available

01 Jul 2007

G8340

Patient documented to have had central dexa performed and results documented or central dexa ordered or pharmacologic therapy prescribed

01 Jul 2007

G8341

Patient not documented to have had central dexa measurement or pharmacologic ,therapy

01 Jan 2011

G8342

Clinician documented that patient was not an eligible candidate for central dexa measurement or prescribing pharmacologic

01 Jul 2007

G8343

Clinician has not provided care for the patient for the required time for central dexa measurement or pharmacological therapy measure

01 Jul 2007

G8344

Patient documented to have had central dexa ordered or performed and results documented or pharmacological therapy prescribed

01 Jul 2007

G8345

Patient not documented to have had central dexa measurement ordered or ,performed or pharmacologic therapy

01 Jan 2011

G8346

Clinician documented that patient was not an eligible candidate for central dexa measurement or pharmacologic therapy

01 Jul 2007

G8347

Clinician has not provided care for the patient for the required time for central dexa measurement or pharmacological therapy measure

01 Jul 2007

G8348

Internal carotid stenosis patient in the 30-99% range documented to have reference to measurements of distal internal carotid diameter as the denominator for stenosis measurement

01 Jul 2007

G8349

Patient was not an eligible candidate for documentation of presence or absence of alarm symptoms

01 Jul 2007

G8350

Patient documented to have had 12-lead ecg performed

01 Jul 2007

G8351

Patient not documented to have had ecg

01 Jan 2011

G8352

Clinician documented that patient was not an eligible candidate for ecg

01 Jul 2007

G8353

Patient documented to have received or taken aspirin 24 hours before emergency department arrival or during emergency department stay

01 Jul 2007

G8354

Patient not documented to have received or taken aspirin 24 hours before ,emergency department arrival or during emergency department stay

01 Jan 2011

G8355

Clinician documented that patient was not an eligible candidate to receive aspirin

01 Jul 2007

G8356

Patient documented to have had ecg performed

01 Jul 2007

G8357

Patient not documented to have had ecg

01 Jan 2011

G8358

Clinician documented that patient was not an eligible candidate for ecg

01 Jul 2007

G8359

Patient documented to have had vital signs recorded and reviewed

01 Jul 2007

G8360

Patient not documented to have vital signs recorded and reviewed

01 Jan 2011

G8361

Patient documented to have oxygen saturation assessed

01 Jul 2007

G8362

Patient not documented to have oxygen saturation assessed

01 Jan 2011

G8363

Clinician documented that patient was not an eligible candidate for oxygen saturation assessment

01 Jul 2007

G8364

Patient documented to have mental status assessed

01 Jul 2007

G8365

Patient not documented to have mental status assessed

01 Jan 2011

G8366

Patient documented to have appropriate empiric antibiotic prescribed

01 Jul 2007

G8367

Patient not documented to have appropriate empiric antibiotic prescribed

01 Jan 2011

G8368

Clinician documented that patient was not an eligible candidate for appropriate empiric antibiotic

01 Jul 2007

G8370

Asthma patients with numeric frequency of symptoms or patient completion of an ,asthma assessment tool/survey/questionnaire not documented

01 Jan 2011

G8371

Chemotherapy documented as not received or prescribed for stage iii colon ,cancer patients

01 Jan 2011

G8372

Chemotherapy documented as received or prescribed for stage iii colon cancer ,patients

01 Jan 2011

G8373

Chemotherapy plan documented prior to chemotherapy administration

01 Jan 2011

G8374

Chemotherapy plan not documented prior to chemotherapy administration

01 Jan 2011

G8375

Chronic lymphocytic leukemia (cll) patient with no documentation of baseline ,flow cytometry performed

01 Jan 2011

G8376

Clinician documentation that breast cancer patient was not eligible for ,tamoxifen or aromatase inhibitor therapy measure

01 Jan 2011

G8377

Clinician documentation that colon cancer patient is not eligible for ,chemotherapy measure

01 Jan 2011

G8378

Clinician documentation that patient was not an eligible candidate for ,radiation therapy measure

01 Jan 2011

G8379

Documentation of radiation therapy recommended within 12 months of first office ,visit

01 Jan 2011

G8380

For patients with er or pr positive, stage ic-iii breast cancer, clinician did ,not document that the patient received or was prescribed tamoxifen or aromatase ,inhibitor

01 Jan 2011

G8381

For patients with er or pr positive, stage ic-iii breast cancer, clinician ,documented or prescribed that the patient is receiving tamoxifen or aromatase ,inhibitor

01 Jan 2011

G8382

Multiple myeloma patients with no documentation of prescribed or received ,intravenous bisphosphonate therapy

01 Jan 2011

G8383

No documentation of radiation therapy recommended within 12 months of first ,office visit

01 Jan 2011

G8384

Baseline cytogenetic testing not performed in patients with myelodysplastic ,syndrome (mds) or acute leukemias

01 Jan 2011

G8385

Diabetic patients with no documentation of hemoglobin a1c level (within the ,last 12 months)

01 Jan 2011

G8386

Diabetic patients with no documentation of low-density lipoprotein (within the ,last 12 months)

01 Jan 2011

G8387

End-stage renal disease patient with a hematocrit or hemoglobin not documented

01 Jan 2011

G8388

End-stage renal disease patient with urr or kt/v value not documented, but ,otherwise eligible for measure

01 Jan 2011

G8389

Myelodysplastic syndrome (mds) patients with no documentation of iron stores ,prior to receiving erythropoietin therapy

01 Jan 2011

G8390

Diabetic patients with no documentation of blood pressure measurement (within ,the last 12 months)

01 Jan 2011

G8391

Patients with persistent asthma, no documentation of preferred long term ,control medication or acceptable alternative treatment prescribed

01 Jan 2011

G8398

Dilated macular or fundus exam not performed

01 Jan 2021

G8401

Clinician documented that patient was not an eligible candidate for screening

01 Jan 2017

G8402

Tobacco (smoke) use cessation intervention, counseling

01 Jan 2011

G8403

Tobacco (smoke) use cessation intervention not counseled

01 Jan 2011

G8406

Clinician documented that patient was not an eligible candidate for lower extremity neurological exam measure

01 Jan 2015

G8407

Abi measured and documented

01 Jan 2011

G8408

Abi measurement was not obtained

01 Jan 2011

G8409

Clinician documented that patient was not an eligible candidate for abi ,measurement measure

01 Jan 2011

G8422

Bmi not documented, documentation the patient is not eligible for bmi calculation

01 Jan 2022

G8423

Documented that patient was screened and either influenza vaccination status is ,current or patient was counseled

01 Jan 2011

G8424

Influenza vaccine status was not screened

01 Jan 2011

G8425

Influenza vaccine status screened, patient not current and counseling was not ,provided

01 Jan 2011

G8426

Documented that patient was not appropriate for screening and/or counseling ,about the influenza vaccine (e.g., allergy to eggs)

01 Jan 2011

G8429

Incomplete or no provider documentation that patient's current medications with ,dosages (includes prescription, over-the-counter, herbals, vitamin/mineral/dietary [nutritional] supplements) were assessed

01 Jan 2011

G8434

Documentation of cognitive impairment screening using a standardized tool

01 Jan 2011

G8435

No documentation of cognitive impairment screening using a standardized tool

01 Jan 2011

G8436

Patient not eligible/not appropriate for cognitive impairment screening

01 Jan 2011

G8437

Documentation of clinician and patient involvement with the development of a ,plan of care including signature by the practitioner/therapist and either a ,co-signature by the patient or documented verbal agreement obtained from the ,patient or, when necessary, an authorized representative

01 Jan 2011

G8438

No documentation of clinician and patient involvement with the development of a ,plan of care including signature by the practitioner/therapist and either a ,co-signature by the patient or documented verbal agreement obtained from the ,patient or, when necessary, an authorized representative

01 Jan 2011

G8439

Documentation that patient is not eligible for co-developing a plan of care ,including signature by the practitioner/therapist and either a co-signature by ,the patient or documented verbal agreement obtained from the patient or, when ,necessary, an authorized representative

01 Jan 2011

G8440

Documentation of pain assessment (including location, intensity and description) prior to initiation of therapy or documentation of the absence of pain as a result of assessment through discussion with the patient including the use of a standardized tool and a follow-up plan is documented

01 Jan 2012

G8441

No documentation of pain assessment (including location, intensity and description) prior to initiation of therapy

01 Jan 2012

G8442

Pain assessment not documented as being performed, documentation the patient is not eligible for a pain assessment using a standardized tool at the time of the encounter

01 Jan 2021

G8443

All prescriptions created during the encounter were generated using a qualified ,e-prescribing system

01 Jan 2011

G8445

No prescriptions were generated during the encounter, provider does have access ,to a qualified e-prescribing system

01 Jan 2011

G8446

Provider does have access to a qualified e-prescribing system and some or all ,of the prescriptions generated during the encounter were printed or phoned in ,as required by state or federal law or regulations, patient request or pharmacy ,system being unable to receive electronic transmission; or because they were ,for narcotics or other controlled substances

01 Jan 2011

G8447

Patient encounter was documented using an ehr system that has been certified by an authorized testing and certification body (atcb)

01 Jan 2013

G8448

Patient encounter was documented using a pqri qualified ehr or other acceptable systems

01 Jan 2013

G8449

Patient encounter was not documented using an emr due to system reasons such ,as, the system being inoperable at the time of the visit; use of this code ,implies that an emr is in place and generally available

01 Jan 2011

G8453

Tobacco use cessation intervention, counseling

01 Jan 2011

G8454

Tobacco use cessation intervention not counseled, reason not specified

01 Jan 2011

G8455

Current tobacco smoker

01 Jan 2011

G8456

Current smokeless tobacco user

01 Jan 2011

G8457

Current tobacco non-user

01 Jan 2011

G8458

Clinician documented that patient is not an eligible candidate for genotype testing; patient not receiving antiviral treatment for hepatitis c during the measurement period (e.g. genotype test done prior to the reporting period, patient declines, patient not a candidate for antiviral treatment)

01 Jan 2017

G8459

Clinician documented that patient is receiving antiviral treatment for hepatitis c

01 Jan 2014

G8460

Clinician documented that patient is not an eligible candidate for quantitative rna testing at week 12; patient not receiving antiviral treatment for hepatitis c

01 Jan 2017

G8461

Patient receiving antiviral treatment for hepatitis c during the measurement period

01 Jan 2017

G8462

Clinician documented that patient is not an eligible candidate for counseling regarding contraception prior to antiviral treatment; patient not receiving antiviral treatment for hepatitis c

01 Jan 2014

G8463

Patient receiving antiviral treatment for hepatitis c documented

01 Jan 2014

G8464

Clinician documented that prostate cancer patient is not an eligible candidate for adjuvant hormonal therapy; low or intermediate risk of recurrence or risk of recurrence not determined

01 Jan 2015

G8466

Clinician documented that patient is not an eligible candidate for suicide risk ,assessment; major depressive disorder, in remission

01 Jan 2011

G8467

Documentation of new diagnosis of initial or recurrent episode of major ,depressive disorder

01 Jan 2011

G8468

Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescribed for patients with a left ventricular ejection fraction (lvef) <40% or documentation of moderately or severely depressed left ventricular systolic function

01 Jan 2013

G8469

Clinician documented that patient with a left ventricular ejection fraction (lvef) <40% or documentation of moderately or severely depressed left ventricular systolic function was not an eligible candidate for angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy

01 Jan 2013

G8470

Patient with left ventricular ejection fraction (lvef) >=40% or documentation as normal or mildly depressed left ventricular systolic function

01 Jan 2013

G8471

Left ventricular ejection fraction (lvef) was not performed or documented

01 Jan 2013

G8472

Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy not prescribed for patients with a left ventricular ejection fraction (lvef) <40% or documentation of moderately or severely depressed left ventricular systolic function, reason not specified

01 Jan 2013

G8479

Clinician prescribed angiotensin converting enzyme (ace) inhibitor or ,angiotensin receptor blocker (arb) therapy

01 Jan 2011

G8480

Clinician documented that patient was not an eligible candidate for angiotensin ,converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy

01 Jan 2011

G8481

Clinician did not prescribe angiotensin converting enzyme (ace) inhibitor or ,angiotensin receptor blocker (arb) therapy, reason not specified

01 Jan 2011

G8482

Influenza immunization administered or previously received

01 Jan 2025

G8483

Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)

01 Jan 2025

G8484

Influenza immunization was not administered, reason not given

01 Jan 2025

G8485

I intend to report the diabetes mellitus (dm) measures group

01 Jan 2017

G8486

I intend to report the preventive care measures group

01 Jan 2017

G8487

I intend to report the chronic kidney disease (ckd) measures group

01 Jan 2017

G8488

Clinician intends to report the end stage renal disease (esrd) measure group

01 Jan 2011

G8489

I intend to report the coronary artery disease (cad) measures group

01 Jan 2017

G8490

I intend to report the rheumatoid arthritis (ra) measures group

01 Jan 2017

G8491

I intend to report the hiv/aids measures group

01 Jan 2017

G8492

I intend to report the perioperative care measures group

01 Jan 2015

G8493

I intend to report the back pain measures group

01 Jan 2015

G8494

All quality actions for the applicable measures in the diabetes mellitus (dm) measures group have been performed for this patient

01 Jan 2017

G8495

All quality actions for the applicable measures in the chronic kidney disease (ckd) measures group have been performed for this patient

01 Jan 2017

G8496

All quality actions for the applicable measures in the preventive care measures group have been performed for this patient

01 Jan 2017

G8497

All quality actions for the applicable measures in the coronary artery bypass graft (cabg) measures group have been performed for this patient

01 Jan 2017

G8498

All quality actions for the applicable measures in the coronary artery disease (cad) measures group have been performed for this patient

01 Jan 2017

G8499

All quality actions for the applicable measures in the rheumatoid arthritis (ra) measures group have been performed for this patient

01 Jan 2017

G8500

All quality actions for the applicable measures in the hiv/aids measures group have been performed for this patient

01 Jan 2017

G8501

All quality actions for the applicable measures in the perioperative care measures group have been performed for this patient

01 Jan 2015

G8502

All quality actions for the applicable measures in the back pain measures group have been performed for this patient

01 Jan 2015

G8503

Documentation that prophylactic antibiotic was given within one hour (if

01 Jan 2010

G8504

Documentation of order for prophylactic antibiotics to be given within one hour

01 Jan 2010

G8505

Documentation that prophylactic antibiotic was not given within one hour (if

01 Jan 2010

G8506

Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy

01 Jan 2024

G8507

Provider documentation that patient is not eligible for patient verification of ,current medications

01 Jan 2011

G8508

Documentation of pain assessment (including location, intensity and description) prior to initiation of therapy or documentation of the absence of pain as a result of assessment through discussion with the patient including the use of a standardized tool; no documentation of a follow-up plan, patient not eligible

01 Jan 2012

G8509

Pain assessment documented as positive using a standardized tool, follow-up plan not documented, reason not given

01 Jan 2021

G8512

Pain severity quantified; pain present

01 Jan 2010

G8513

Abi measured and documented

01 Jan 2010

G8514

Clinician documented that patient was not an eligible candidate for abi

01 Jan 2010

G8515

Abi measurement was not obtained

01 Jan 2010

G8516

Patient screened for future falls risk; documentation of two or more falls in

01 Jan 2010

G8517

Patient screened for future fall risk; documentation of no falls in the past

01 Jan 2010

G8518

Clinical stage prior to surgery for lung cancer and esophageal cancer resection ,was recorded

01 Jan 2011

G8519

Clinician documented that patient was not eligible for clinical stage prior to ,surgery for lung cancer and esophageal cancer resection measure

01 Jan 2011

G8520

Clinician stage prior to surgery for lung cancer and esophageal cancer ,resection was not recorded, reason not specified

01 Jan 2011

G8521

Antiplatelet therapy received (asa [81-325 mg/day] and/or clopidogrel [75

01 Jan 2010

G8522

Clinician documented that patient was not an eligible candidate for

01 Jan 2010

G8523

Antiplatelet therapy not received 48 hours prior to cea and at discharge

01 Jan 2010

G8524

Patch closure used for patient undergoing conventional cea

01 Jan 2013

G8525

Clinician documented that patient did not receive conventional cea

01 Jan 2013

G8526

Patch closure not used for patient undergoing conventional cea, reason not specified

01 Jan 2013

G8527

Descriptor not available

01 Jan 2010

G8528

Clinician documented that patient was ineligible for prophylactic antibiotic

01 Jan 2010

G8529

Order for cefazolin or cefuroxime for antimicrobial prophylaxis not documented

01 Jan 2010

G8530

Autogenous av fistula received

01 Jan 2016

G8531

Clinician documented that patient was not an eligible candidate for autogenous av fistula

01 Jan 2016

G8532

Clinician documented that patient recevied vascular access other than autogenous av fistula, reason not given

01 Jan 2016

G8533

Descriptor not available

01 Jan 2010

G8534

Documentation of an elder maltreatment screen and follow-up plan

01 Jan 2012

G8537

Elder maltreatment screen documented, follow-up plan not documented, patient not eligible

01 Jan 2012

G8538

Elder maltreatment screen documented, follow-up plan not documented, reason not specified

01 Jan 2012

G8544

I intend to report the coronary artery bypass graft (cabg) measures group

01 Jan 2017

G8545

I intend to report the hepatitis c measures group

01 Jan 2017

G8546

I intend to report the community-acquired pneumonia (cap) measures group

01 Jan 2013

G8547

I intend to report the ischemic vascular disease (ivd) measures group

01 Jan 2015

G8548

I intend to report the heart failure (hf) measures group

01 Jan 2017

G8549

All quality actions for the applicable measures in the hepatitis c measures group have been performed for this patient

01 Jan 2017

G8550

All quality actions for the applicable measures in the community-acquired pneumonia (cap) measures group have been performed for this patient

01 Jan 2013

G8551

All quality actions for the applicable measures in the heart failure (hf) measures group have been performed for this patient

01 Jan 2017

G8552

All quality actions for the applicable measures in the ischemic vascular disease (ivd) measures group have been performed for this patient

01 Jan 2015

G8553

Prescription(s) generated and transmitted via a qualified erx system

01 Jan 2014

G8556

Referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation

01 Jan 2014

G8557

Patient is not eligible for the referral for otologic evaluation measure

01 Jan 2014

G8558

Not referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation, reason not given

01 Jan 2014

G8571

Development of deep sternal wound infection/mediastinitis within 30 days postoperatively

01 Jan 2021

G8572

No deep sternal wound infection/mediastinitis

01 Jan 2021

G8573

Stroke following isolated cabg surgery

01 Jan 2021

G8574

No stroke following isolated cabg surgery

01 Jan 2021

G8579

Antiplatelet medication at discharge

01 Jan 2015

G8580

Antiplatelet medication contraindicated

01 Jan 2015

G8581

No antiplatelet medication at discharge

01 Jan 2015

G8582

Beta-blocker at discharge

01 Jan 2015

G8583

Beta-blocker contraindicated

01 Jan 2015

G8584

No beta-blocker at discharge

01 Jan 2015

G8585

Anti-lipid treatment at discharge

01 Jan 2015

G8586

Anti-lipid treatment contraindicated

01 Jan 2015

G8587

No anti-lipid treatment at discharge

01 Jan 2015

G8588

Most recent systolic blood pressure < 140 mmhg

01 Jan 2014

G8589

Most recent systolic blood pressure >= 140 mmhg

01 Jan 2014

G8590

Most recent diastolic blood pressure < 90 mmhg

01 Jan 2014

G8591

Most recent diastolic blood pressure >= 90 mmhg

01 Jan 2014

G8592

No documentation of blood pressure measurement, reason not given

01 Jan 2014

G8593

Lipid profile results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c)

01 Jan 2015

G8594

Lipid profile not performed, reason not given

01 Jan 2015

G8595

Most recent ldl-c < 100 mg/dl

01 Jan 2015

G8596

Ldl-c was not performed

01 Jan 2014

G8597

Most recent ldl-c >= 100 mg/dl

01 Jan 2015

G8603

Score on the spoken language comprehension functional communication measure at discharge was higher than at admission

01 Jan 2014

G8604

Score on the spoken language comprehension functional communication measure at discharge was not higher than at admission, reason not given

01 Jan 2014

G8605

Patient treated for spoken language comprehension but not scored on the spoken language comprehension functional communication measure either at admission or at discharge

01 Jan 2014

G8606

Score on the attention functional communication measure at discharge was higher than at admission

01 Jan 2014

G8607

Score on the attention functional communication measure at discharge was not higher than at admission, reason not given

01 Jan 2014

G8608

Patient treated for attention but not scored on the attention functional communication measure either at admission or at discharge

01 Jan 2014

G8609

Score on the memory functional communication measure at discharge was higher than at admission

01 Jan 2014

G8610

Score on the memory functional communication measure at discharge was not higher than at admission, reason not given

01 Jan 2014

G8611

Patient treated for memory but not scored on the memory functional communication measure either at admission or at discharge

01 Jan 2014

G8612

Score on the motor speech functional communication measure at discharge was higher than at admission

01 Jan 2014

G8613

Score on the motor speech functional communication measure at discharge was not higher than at admission, reason not given

01 Jan 2014

G8614

Patient treated for motor speech but not scored on the motor speech comprehension functional communication measure either at admission or at discharge

01 Jan 2014

G8615

Score on the reading functional communication measure at discharge was higher than at admission

01 Jan 2014

G8616

Score on the reading functional communication measure at discharge was not higher than at admission, reason not given

01 Jan 2014

G8617

Patient treated for reading but not scored on the reading functional communication measure either at admission or at discharge

01 Jan 2014

G8618

Score on the spoken language expression functional communication measure at discharge was higher than at admission

01 Jan 2014

G8619

Score on the spoken language expression functional communication measure at discharge was not higher than at admission, reason not given

01 Jan 2014

G8620

Patient treated for spoken language expression but not scored on the spoken language expression functional communication measure either at admission or at discharge

01 Jan 2014

G8621

Score on the writing functional communication measure at discharge was higher than at admission

01 Jan 2014

G8622

Score on the writing functional communication measure at discharge was not higher than at admission, reason not given

01 Jan 2014

G8623

Patient treated for writing but not scored on the writing functional communication measure either at admission or at discharge

01 Jan 2014

G8624

Score on the swallowing functional communication measure at discharge was higher than at admission

01 Jan 2014

G8625

Score on the swallowing functional communication measure at discharge was not higher than at admission, reason not given

01 Jan 2014

G8626

Patient treated for swallowing but not scored on the swallowing functional communication measure at admission or at discharge

01 Jan 2014

G8627

Surgical procedure performed within 30 days following cataract surgery for major complications (e.g., retained nuclear fragments, endophthalmitis, dislocated or wrong power iol, retinal detachment, or wound dehiscence)

01 Jan 2021

G8628

Surgical procedure not performed within 30 days following cataract surgery for major complications (e.g., retained nuclear fragments, endophthalmitis, dislocated or wrong power iol, retinal detachment, or wound dehiscence)

01 Jan 2021

G8629

Documentation of order for prophylactic parenteral antibiotic to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required)

01 Jan 2015

G8630

Documentation that administration of prophylactic parenteral antibiotics was initiated within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required), as ordered

01 Jan 2015

G8631

Clinician documented that patient was not an eligible candidate for ordering prophylactic parenteral antibiotics to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required)

01 Jan 2015

G8632

Prophylactic parenteral antibiotics were not ordered to be given or given within one hour (if fluoroquinolone or vancomycin, two hours) prior to the surgical incision (or start of procedure when no incision is required), reason not given

01 Jan 2015

G8634

Clinician documented patient not an eligible candidate to receive pharmacologic therapy for osteoporosis

01 Jan 2017

G8636

Influenza immunization administered or previously received

01 Jan 2012

G8637

Clinician documented that patient is not eligible to receive the influenza immunization

01 Jan 2012

G8638

Influenza immunization not administered or previously received, reason not otherwise specified

01 Jan 2012

G8639

Influenza immunization was administered or previously received

01 Jan 2012

G8640

Clinician has documented that patient is not eligible to receive the influenza immunization

01 Jan 2012

G8641

Influenza immunization was not administered or previously received, reason not otherwise specified

01 Jan 2012

G8642

The eligible professional practices in a rural area without sufficient high speed internet access and requests a hardship exemption from the application of the payment adjustment under section 1848(a)(5)(a) of the social security act

01 Jan 2014

G8643

The eligible professional practices in an area without sufficient available pharmacies for electronic prescribing and requests a hardship exemption for the application of the payment adjustment under section 1848(a)(5)(a) of the social security act

01 Jan 2014

G8644

Eligible professional does not have prescribing privileges

01 Jan 2014

G8645

I intend to report the asthma measures group

01 Jan 2017

G8646

All quality actions for the applicable measures in the asthma measures group have been performed for this patient

01 Jan 2017

G8649

Risk-adjusted functional status change residual score for the knee impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate

01 Jan 2020

G8653

Risk-adjusted functional status change residual scores for the hip impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate

01 Jan 2020

G8657

Risk-adjusted functional status change residual score for the lower leg, foot or ankle impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate

01 Jan 2020

G8665

Risk-adjusted functional status change residual score for the shoulder impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate

01 Jan 2020

G8669

Risk-adjusted functional status change residual score for the elbow, wrist or hand impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate

01 Jan 2020

G8671

Risk-adjusted functional status change residual score for the neck, cranium, mandible, thoracic spine, ribs or other general orthopedic impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0)

01 Jan 2021

G8672

Risk-adjusted functional status change residual score for the neck, cranium, mandible, thoracic spine, ribs or other general orthopedic impairment successfully calculated and the score was less than zero (< 0)

01 Jan 2021

G8673

Risk-adjusted functional status change residual score for the neck, cranium, mandible, thoracic spine, ribs or other general orthopedic impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate

01 Jan 2020

G8674

Risk-adjusted functional status change residual score for the neck, cranium, mandible, thoracic spine, ribs or other general orthopedic impairment not measured because the patient did not complete the general orthopedic fs prom at initial evaluation and/or near discharge, reason not given

01 Jan 2021

G8675

Most recent systolic blood pressure >= 140 mm hg

01 Jan 2012

G8676

Most recent diastolic blood pressure >= 90 mm hg

01 Jan 2012

G8677

Most recent systolic blood pressure < 130 mm hg

01 Jan 2012

G8678

Most recent systolic blood pressure 130 to 139 mm hg

01 Jan 2012

G8679

Most recent diastolic blood pressure < 80 mm hg

01 Jan 2012

G8680

Most recent diastolic blood pressure 80 - 89 mm hg

01 Jan 2012

G8681

Patient hospitalized with principal diagnosis of heart failure during the measurement period

01 Jan 2012

G8682

Lvf testing documented as being performed prior to discharge or in the previous 12 months

01 Jan 2015

G8683

Lvf testing not performed prior to discharge or in the previous 12 months for a medical or patient documented reason

01 Jan 2015

G8684

Patient not hospitalized with principal diagnosis of heart failure during the measurement period

01 Jan 2012

G8685

Lvf testing not documented as being performed prior to discharge or in the previous 12 months, reason not given

01 Jan 2015

G8686

Currently a tobacco smoker or current exposure to secondhand smoke

01 Jan 2012

G8687

Currently a tobacco non-user and no exposure to secondhand smoke

01 Jan 2012

G8688

Currently a smokeless tobacco user (eg, chew, snuff) and no exposure to secondhand smoke

01 Jan 2012

G8689

Tobacco use not assessed, reason not otherwise specified

01 Jan 2012

G8690

Current tobacco smoker or current exposure to secondhand smoke

01 Jan 2012

G8691

Current tobacco non-user and no exposure to secondhand smoke

01 Jan 2012

G8692

Current smokeless tobacco user (eg, chew, snuff) and no exposure to secondhand smoke

01 Jan 2012

G8693

Tobacco use not assessed, reason not specified

01 Jan 2012

G8695

Left ventricular ejection fraction (lvef) >= 40% or documentation as mildly depressed left ventricular systolic function or normal

01 Jan 2013

G8696

Antithrombotic therapy prescribed at discharge

01 Jan 2018

G8697

Antithrombotic therapy not prescribed for documented reasons (e.g., patient had stroke during hospital stay, patient expired during inpatient stay, other medical reason(s)); (e.g., patient left against medical advice, other patient reason(s))

01 Jan 2018

G8698

Antithrombotic therapy was not prescribed at discharge, reason not given

01 Jan 2018

G8699

Rehabilitation services (occupational, physical or speech) ordered at or prior to discharge

01 Jan 2015

G8700

Rehabilitation services (occupational, physical or speech) not indicated at or prior to discharge

01 Jan 2015

G8701

Rehabilitation services were not ordered, reason not otherwise specified

01 Jan 2015

G8702

Documentation that prophylactic antibiotics were given within 4 hours prior to surgical incision or intraoperatively

01 Jan 2015

G8703

Documentation that prophylactic antibiotics were neither given within 4 hours prior to surgical incision nor intraoperatively

01 Jan 2015

G8704

12-lead electrocardiogram (ecg) performed

01 Jan 2015

G8705

Documentation of medical reason(s) for not performing a 12-lead electrocardiogram (ecg)

01 Jan 2015

G8706

Documentation of patient reason(s) for not performing a 12-lead electrocardiogram (ecg)

01 Jan 2015

G8707

12-lead electrocardiogram (ecg) not performed, reason not given

01 Jan 2015

G8713

Spkt/v greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v])

01 Jan 2016

G8714

Hemodialysis treatment performed exactly three times per week for > 90 days

01 Jan 2016

G8715

Hemodialysis treatment performed less than three times per week or greater than three times per week

01 Jan 2013

G8716

Documentation of reason(s) for patient not having greater than or equal to 1. 2 (single-pool clearance of urea [kt] / volume [v])

01 Jan 2013

G8717

Spkt/v less than 1.2 (single-pool clearance of urea [kt] / volume [v]), reason not given

01 Jan 2016

G8718

Total kt/v greater than or equal to 1.7 per week (total clearance of urea [kt] / volume [v])

01 Jan 2016

G8720

Total kt/v less than 1.7 per week (total clearance of urea [kt] / volume [v])

01 Jan 2016

G8725

Fasting lipid profile performed (triglycerides, ldl-c, hdl-c and total cholesterol)

01 Jan 2017

G8726

Clinician has documented reason for not performing fasting lipid profile (e.g., patient declined, other patient reasons)

01 Jan 2017

G8727

Patient receiving hemodialysis, peritoneal dialysis or kidney transplantation

01 Jan 2013

G8728

Fasting lipid profile not performed, reason not given

01 Jan 2017

G8730

Pain assessment documented as positive using a standardized tool and a follow-up plan is documented

01 Jan 2021

G8731

Pain assessment using a standardized tool is documented as negative, no follow-up plan required

01 Jan 2021

G8732

No documentation of pain assessment, reason not given

01 Jan 2021

G8736

Most current ldl-c <100mg/dl

01 Jan 2015

G8737

Most current ldl-c >=100mg/dl

01 Jan 2015

G8738

Left ventricular ejection fraction (lvef) < 40% or documentation of severely or moderately depressed left ventricular systolic function

01 Jan 2015

G8739

Left ventricular ejection fraction (lvef) >= 40% or documentation as normal or mildly depressed left ventricular systolic function

01 Jan 2015

G8740

Left ventricular ejection fraction (lvef) not performed or assessed, reason not given

01 Jan 2015

G8741

Patient not treated for spoken language comprehension disorder

01 Jan 2014

G8742

Patient not treated for attention disorder

01 Jan 2014

G8743

Patient not treated for memory disorder

01 Jan 2014

G8744

Patient not treated for motor speech disorder

01 Jan 2014

G8745

Patient not treated for reading disorder

01 Jan 2014

G8746

Patient not treated for spoken language expression disorder

01 Jan 2014

G8747

Patient not treated for writing disorder

01 Jan 2014

G8748

Patient not treated for swallowing disorder

01 Jan 2014

G8750

Presence of signs of melanoma (cough, dyspnea, tenderness, localized neurologic signs such as weakness, jaundice or any other sign suggesting systemic spread) or presence of symptoms of melanoma (pain, paresthesia, or any other symptom suggesting the possibility of systemic spread of melanoma)

01 Jan 2013

G8751

Smoking status and exposure to second hand smoke in the home not assessed, reason not given

01 Jan 2015

G8757

All quality actions for the applicable measures in the chronic obstructive pulmonary disease (copd) measures group have been performed for this patient

01 Jan 2017

G8758

All quality actions for the applicable measures in the inflammatory bowel disease (ibd) measures group have been performed for this patient

01 Jan 2017

G8759

All quality actions for the applicable measures in the sleep apnea measures group have been performed for this patient

01 Jan 2017

G8760

All quality actions for the applicable measures in the epilepsy measures group have been performed for this patient

01 Jan 2013

G8761

All quality actions for the applicable measures in the dementia measures group have been performed for this patient

01 Jan 2017

G8762

All quality actions for the applicable measures in the parkinson's disease measures group have been performed for this patient

01 Jan 2017

G8763

All quality actions for the applicable measures in the hypertension (htn) measures group have been performed for this patient

01 Jan 2015

G8764

All quality actions for the applicable measures in the cardiovascular prevention measures group have bee performed for this patient

01 Jan 2015

G8765

All quality actions for the applicable measures in the cataract measures group have been performed for this patient

01 Jan 2017

G8767

Lipid panel results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c)

01 Jan 2015

G8768

Documentation of medical reason(s) for not performing lipid profile (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)

01 Jan 2015

G8769

Lipid profile not performed, reason not given

01 Jan 2015

G8770

Urine protein test result documented and reviewed

01 Jan 2015

G8771

Documentation of diagnosis of chronic kidney disease

01 Jan 2015

G8772

Documentation of medical reason(s) for not performing urine protein test (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not cllinically appropriate)

01 Jan 2015

G8773

Urine protein test was not performed, reason not given

01 Jan 2015

G8774

Serum creatinine test result documented and reviewed

01 Jan 2015

G8775

Documentation of medical reason(s) for not performing serum creatinine test (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)

01 Jan 2015

G8776

Serum creatinine test not performed, reason not given

01 Jan 2015

G8777

Diabetes screening test performed

01 Jan 2015

G8778

Documentation of medical reason(s) for not performing diabetes screening test (e.g., patients with a diagnosis of diabetes, or with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)

01 Jan 2015

G8779

Diabetes screening test not performed, reason not given

01 Jan 2015

G8780

Counseling for diet and physical activity performed

01 Jan 2015

G8781

Documentation of medical reason(s) for patient not receiving counseling for diet and physical activity (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)

01 Jan 2015

G8782

Counseling for diet and physical activity not performed, reason not given

01 Jan 2015

G8784

Patient not eligible (e.g., documentation the patient is not eligible due to active diagnosis of hypertension, patient refuses, urgent or emergent situation)

01 Jan 2017

G8786

Severity of angina assessed according to level of activity

01 Jan 2013

G8787

Angina assessed as present

01 Jan 2013

G8788

Angina assessed as absent

01 Jan 2013

G8789

Severity of angina not assessed according to level of activity

01 Jan 2013

G8790

Most recent office visit systolic blood pressure <130 mm hg

01 Jan 2014

G8791

Most recent office visit systolic blood pressure, 130 to 139 mm hg

01 Jan 2014

G8792

Most recent office visit systolic blood pressure >=140 mm hg

01 Jan 2014

G8793

Most recent office visit diastolic blood pressure, <80 mm hg

01 Jan 2014

G8794

Most recent office visit diastolic blood pressure, 80 - 89 mm hg

01 Jan 2014

G8795

Most recent office visit diastolic blood pressure >=90 mm hg

01 Jan 2014

G8796

Blood pressure measurement not documented, reason not given

01 Jan 2014

G8799

Anticoagulation ordered

01 Jan 2014

G8800

Anticoagulation not ordered for reasons documented by clinician

01 Jan 2014

G8801

Anticoagulation was not ordered, reason not given

01 Jan 2014

G8802

Pregnancy test (urine or serum) ordered

01 Jan 2013

G8803

Pregnancy test (urine or serum) not ordered for reasons documented by clinician

01 Jan 2013

G8805

Pregnancy test (urine or serum) was not ordered, reason not specified

01 Jan 2013

G8809

Rh-immunoglobulin (rhogam) ordered

01 Jan 2021

G8810

Rh-immunoglobulin (rhogam) not ordered for reasons documented by clinician (e.g., patient had prior documented receipt of rhogam within 12 weeks, patient refusal)

01 Jan 2021

G8811

Documentation rh-immunoglobulin (rhogam) was not ordered, reason not given

01 Jan 2021

G8812

Patient is not eligible for follow-up cta, duplex, or mra (e.g., patient death, failure to return for scheduled follow-up exam, planned follow-up study which will meet numerator criteria has not yet occurred at the time of reporting)

01 Jan 2014

G8813

Follow-up cta, duplex, or mra of the abdomen and pelvis performed

01 Jan 2014

G8814

Follow-up cta, duplex, or mra of the abdomen and pelvis not performed

01 Jan 2014

G8818

Patient discharge to home no later than post-operative day #7

01 Jan 2024

G8819

Aneurysm minor diameter <= 5. 5 cm

01 Jan 2013

G8820

Aneurysm minor diameter 5. 6-6. 0 cm

01 Jan 2013

G8821

Abdominal aortic aneurysm is not infarenal

01 Jan 2013

G8822

Male patients with aneurysms minor diameter >6 cm

01 Jan 2013

G8823

Female patients with aneurysm minor diameter >6cm

01 Jan 2013

G8824

Female patients with aneurysm minor diameter 5. 6-6. 0 cm

01 Jan 2013

G8825

Patient not discharged to home by post-operative day #7

01 Jan 2024

G8827

Aneurysm minor diameter <= 5.5 cm for women

01 Jan 2014

G8828

Aneurysm minor diameter <= 5. 5 cm for men

01 Jan 2013

G8829

Aneurysm minor diameter 5. 6-6. 0 cm for men

01 Jan 2013

G8830

Aneurysm minor diameter >6cm for men

01 Jan 2013

G8831

Aneurysm minor diameter >6cm for women

01 Jan 2013

G8832

Aneurysm minor diameter 5. 6-6. 0 cm for women

01 Jan 2013

G8835

Asymptomatic patient with no history of any transient ischemic attack or stroke in any carotid or vertebrobasilar territory

01 Jan 2014

G8836

Symptomatic patient with ipsilateral stroke or tia within 120 days prior to cea

01 Jan 2013

G8837

Other symptomatic patient with ipsilateral carotid territory tia or stroke > 120 days prior to cea, or contralateral carotid territory tia or stroke or vertebrobasilar tia or stroke

01 Jan 2013

G8847

Positive airway pressure therapy not prescribed

01 Jan 2013

G8848

Mild obstructive sleep apnea (apnea hypopnea index (ahi) or respiratory disturbance index (rdi) of less than 15)

01 Jan 2017

G8852

Positive airway pressure therapy was prescribed

01 Jan 2024

G8853

Positive airway pressure therapy not prescribed

01 Jan 2017

G8859

Patient receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days

01 Jan 2015

G8860

Patients who have received dose of corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days

01 Jan 2015

G8861

Within the past 2 years, central dual-energy x-ray absorptiometry (dxa) ordered and documented, review of systems and medication history or pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribed

01 Jan 2020

G8862

Patients not receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days

01 Jan 2015

G8868

Patients receiving a first course of anti-tnf therapy

01 Jan 2017

G8870

Hepatitis b vaccine injection administered or previously received and is receiving a first course of anti-tnf therapy

01 Jan 2016

G8871

Patient not receiving a first course of anti-tnf therapy

01 Jan 2016

G8872

Excised tissue evaluated by imaging intraoperatively to confirm successful inclusion of targeted lesion

01 Jan 2021

G8873

Patients with needle localization specimens which are not amenable to intraoperative imaging such as mri needle wire localization, or targets which are tentatively identified on mammogram or ultrasound which do not contain a biopsy marker but which can be verified on intraoperative inspection or pathology (e.g., needle biopsy site where the biopsy marker is remote from the actual biopsy site)

01 Jan 2021

G8874

Excised tissue not evaluated by imaging intraoperatively to confirm successful inclusion of targeted lesion

01 Jan 2021

G8879

Clinically node negative (t1n0m0 or t2n0m0) invasive breast cancer

01 Jan 2018

G8883

Biopsy results reviewed, communicated, tracked and documented

01 Jan 2024

G8884

Clinician documented reason that patient's biopsy results were not reviewed

01 Jan 2024

G8885

Biopsy results not reviewed, communicated, tracked or documented

01 Jan 2024

G8886

Most recent blood pressure under control

01 Jan 2015

G8887

Documentation of medical reason(s) for most recent blood pressure not being under control (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)

01 Jan 2015

G8888

Most recent blood pressure not under control, results documented and reviewed

01 Jan 2015

G8889

No documentation of blood pressure measurement, reason not given

01 Jan 2015

G8890

Most recent ldl-c under control, results documented and reviewed

01 Jan 2015

G8891

Documentation of medical reason(s) for most recent ldl-c not under control (e.g., patients with palliative goals for for whom treatment of hypertension with standard treatment goals is not clinically appropriate)

01 Jan 2015

G8892

Documentation of medical reason(s) for not performing ldl-c test (e.g. patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)

01 Jan 2015

G8893

Most recent ldl-c not under control, results documented and reviewed

01 Jan 2015

G8894

Ldl-c not performed, reason not given

01 Jan 2015

G8895

Oral aspirin or other antithrombotic therapy prescribed

01 Jan 2015

G8896

Documentation of medical reason(s) for not prescribing oral aspirin or other antthrombotic therapy (e.g., patient documented to be low risk or patient with terminal illness or treatment of hypertension with standard treatment goals is not clinically appropriate, or for whom risk of aspirin or other antithrombotic therapy exceeds potential benefits such as for individuals whose blood pressure is poorly controlled)

01 Jan 2015

G8897

Oral aspirin or other antithrombotic therapy was not prescribed, reason not given

01 Jan 2015

G8898

I intend to report the chronic obstructive pulmonary disease (copd) measures group

01 Jan 2017

G8899

I intend to report the inflammatory bowel disease (ibd) measures group

01 Jan 2017

G8900

I intend to report the sleep apnea measures group

01 Jan 2017

G8901

I intend to report the epilepsy measures group

01 Jan 2013

G8902

I intend to report the dementia measures group

01 Jan 2017

G8903

I intend to report the parkinson's disease measures group

01 Jan 2017

G8904

I intend to report the hypertension (htn) measures group

01 Jan 2015

G8905

I intend to report the cardiovascular prevention measures group

01 Jan 2015

G8906

I intend to report the cataract measures group

01 Jan 2017

G8919

Most recent systolic blood pressure < 140 mmhg

01 Jan 2014

G8920

Most recent systolic blood pressure >= 140 mmhg

01 Jan 2014

G8921

Most recent diastolic blood pressure < 90 mmhg

01 Jan 2014

G8922

Most recent diastolic blood pressure >= 90 mmhg

01 Jan 2014

G8925

Spirometry test results demonstrate fev1 >= 60% fev1/fvc >= 70%, predicted or patient does not have copd symptoms

01 Jan 2022

G8926

Spirometry test not performed or documented, reason not given

01 Jan 2022

G8927

Adjuvant chemotherapy referred, prescribed or previously received for ajcc stage iii, colon cancer

01 Jan 2017

G8928

Adjuvant chemotherapy not prescribed or previously received, for documented reasons (e.g., medical co-morbidities, diagnosis date more than 5 years prior to the current visit date, patient's diagnosis date is within 120 days of the end of the 12 month reporting period, patient's cancer has metastasized, medical contraindication/allergy, poor performance status, other medical reasons, patient refusal, other patient reasons, patient is currently enrolled in a clinical trial that precludes prescription of chemotherapy, other system reasons)

01 Jan 2017

G8929

Adjuvant chemotherapy not prescribed or previously received, reason not given

01 Jan 2017

G8930

Assessment of depression severity at the initial evaluation

01 Jan 2015

G8931

Assessment of depression severity not documented, reason not given

01 Jan 2015

G8932

Suicide risk assessed at the initial evaluation

01 Jan 2015

G8933

Suicide risk not assessed at the initial evaluation, reason not given

01 Jan 2015

G8938

Bmi is documented as being outside of normal parameters, follow-up plan is not documented, documentation the patient is not eligible

01 Jan 2022

G8939

Pain assessment documented as positive, follow-up plan not documented, documentation the patient is not eligible at the time of the encounter

01 Jan 2021

G8940

Screening for depression documented as positive, a follow-up plan not completed, documented reason

01 Jan 2017

G8941

Elder maltreatment screen documented as positive, follow-up plan not documented, documentation the patient is not eligible for follow-up plan at the time of the encounter

01 Jan 2024

G8943

Ldl-c result not present or not within 12 months prior

01 Jan 2015

G8945

Aneurysm minor diameter <= 6 cm for men

01 Jan 2014

G8947

One or more neuropsychiatric symptoms

01 Jan 2018

G8948

No neuropsychiatric symptoms

01 Jan 2017

G8949

Documentation of patient reason(s) for patient not receiving counseling for diet and physical activity (e.g., patient is not willing to discuss diet or exercise interventions to help control blood pressure, or the patient said he/she refused to make these changes)

01 Jan 2015

G8951

Pre-hypertensive or hypertensive blood pressure reading documented, indicated follow-up not documented, documentation the patient is not eligible

01 Jan 2016

G8953

All quality actions for the applicable measures in the oncology measures group have been performed for this patient

01 Jan 2017

G8954

Complete and appropriate patient data were reported to a qualified clinical database registry

01 Jan 2014

G8957

Patient not receiving maintenance hemodialysis in an outpatient dialysis facility

01 Jan 2015

G8959

Clinician treating major depressive disorder communicates to clinician treating comorbid condition

01 Jan 2021

G8960

Clinician treating major depressive disorder did not communicate to clinician treating comorbid condition, reason not given

01 Jan 2021

G8963

Cardiac stress imaging performed primarily for monitoring of asymptomatic patient who had pci within 2 years

01 Jan 2024

G8964

Cardiac stress imaging test performed primarily for any other reason than monitoring of asymptomatic patient who had pci within 2 years (e.g., symptomatic patient, patient greater than 2 years since pci, initial evaluation, etc)

01 Jan 2024

G8965

Cardiac stress imaging test primarily performed on low chd risk patient for initial detection and risk assessment

01 Jan 2025

G8966

Cardiac stress imaging test performed on symptomatic or higher than low chd risk patient or for any reason other than initial detection and risk assessment

01 Jan 2025

G8971

Warfarin or another oral anticoagulant that is fda approved not prescribed, reason not given

01 Jan 2018

G8972

One or more high risk factors for thromboembolism or more than one moderate risk factor for thromboembolism

01 Jan 2018

G8973

Most recent hemoglobin (hgb) level < 10 g/dl

01 Jan 2021

G8974

Hemoglobin level measurement not documented, reason not given

01 Jan 2021

G8975

Documentation of medical reason(s) for patient having a hemoglobin level < 10 g/dl (e.g., patients who have non-renal etiologies of anemia [e.g., sickle cell anemia or other hemoglobinopathies, hypersplenism, primary bone marrow disease, anemia related to chemotherapy for diagnosis of malignancy, postoperative bleeding, active bloodstream or peritoneal infection], other medical reasons)

01 Jan 2021

G8976

Most recent hemoglobin (hgb) level >= 10 g/dl

01 Jan 2021

G8977

I intend to report the oncology measures group

01 Jan 2017

G8978

Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals

01 Jan 2020

G8979

Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting

01 Jan 2020

G8980

Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting

01 Jan 2020

G8981

Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals

01 Jan 2020

G8982

Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting

01 Jan 2020

G8983

Changing & maintaining body position functional limitation, discharge status, at discharge from therapy or to end reporting

01 Jan 2020

G8984

Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals

01 Jan 2020

G8985

Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting

01 Jan 2020

G8986

Carrying, moving & handling objects functional limitation, discharge status, at discharge from therapy or to end reporting

01 Jan 2020

G8987

Self care functional limitation, current status, at therapy episode outset and at reporting intervals

01 Jan 2020

G8988

Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting

01 Jan 2020

G8989

Self care functional limitation, discharge status, at discharge from therapy or to end reporting

01 Jan 2020

G8990

Other physical or occupational therapy primary functional limitation, current status, at therapy episode outset and at reporting intervals

01 Jan 2020

G8991

Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting

01 Jan 2020

G8992

Other physical or occupational therapy primary functional limitation, discharge status, at discharge from therapy or to end reporting

01 Jan 2020

G8993

Other physical or occupational therapy subsequent functional limitation, current status, at therapy episode outset and at reporting intervals

01 Jan 2020

G8994

Other physical or occupational therapy subsequent functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting

01 Jan 2020

G8995

Other physical or occupational therapy subsequent functional limitation, discharge status, at discharge from therapy or to end reporting

01 Jan 2020

G8996

Swallowing functional limitation, current status at therapy episode outset and at reporting intervals

01 Jan 2020

G8997

Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting

01 Jan 2020

G8998

Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting

01 Jan 2020

G8999

Motor speech functional limitation, current status at therapy episode outset and at reporting intervals

01 Jan 2020

G9015

Descriptor not available

01 Apr 2003

G9017

Amantadine hydrochloride, oral, per 100 mg (for use in a medicare-approved demonstration project)

01 Jan 2020

G9018

Zanamivir, inhalation powder, administered through inhaler, per 10 mg (for use in a medicare-approved demonstration project)

01 Jan 2020

G9019

Oseltamivir phosphate, oral, per 75 mg (for use in a medicare-approved demonstration project)

01 Jan 2020

G9020

Rimantadine hydrochloride, oral, per 100 mg (for use in a medicare-approved demonstration project)

01 Jan 2020

G9021

Chemotherapy assessment for nausea and/or vomiting

01 Jan 2006

G9022

Chemotherapy assessment for nausea and/or vomiting

01 Jan 2006

G9023

Chemotherapy assessment for nausea and/or vomiting

01 Jan 2006

G9024

Chemotherapy assessment for nausea and/or vomiting

01 Jan 2006

G9025

Chemotherapy assessment for pain

01 Jan 2006

G9026

Chemotherapy assessment for pain

01 Jan 2006

G9027

Chemotherapy assessment for pain

01 Jan 2006

G9028

Chemotherapy assessment for pain

01 Jan 2006

G9029

Chemotherapy assessment for lack of energy (fatigue)

01 Jan 2006

G9030

Chemotherapy assessment for lack of energy (fatigue)

01 Jan 2006

G9031

Chemotherapy assessment for lack of energy (fatigue)

01 Jan 2006

G9032

Chemotherapy assessment for lack of energy (fatigue)

01 Jan 2006

G9033

Amantadine hydrochloride, oral brand, per 100 mg (for use in a medicare-approved demonstration project)

01 Jan 2020

G9034

Zanamivir, inhalation powder, administered through inhaler, brand, per 10 mg (for use in a medicare-approved demonstration project)

01 Jan 2020

G9035

Oseltamivir phosphate, oral, brand, per 75 mg (for use in a medicare-approved demonstration project)

01 Jan 2020

G9036

Rimantadine hydrochloride, oral, brand, per 100 mg (for use in a medicare-approved demonstration project)

01 Jan 2020

G9041

Rehabilitation services for low vision by qualified occupational therapist, direct one-on-one contact, each 15 minutes

01 Jan 2012

G9042

Rehabilitation services for low vision by certified orientation and mobility specialists, direct one-on-one contact, each 15 minutes

01 Jan 2012

G9043

Rehabilitation services for low vision by certified low vision rehabilitation therapist, direct one-on-one contact, each 15 minutes

01 Jan 2012

G9044

Rehabilitation services for low vision by certified low vision rehabilitation teacher, direct one-on-one contact, each 15 minutes

01 Jan 2012

G9076

Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; extent of disease unknown

01 Jan 2007

G9081

Oncology; disease status; prostate cancer

01 Jan 2007

G9082

Oncology; disease status; prostate cancer

01 Jan 2007

G9118

Descriptor not available

01 Jan 2007

G9119

Descriptor not available

01 Jan 2007

G9120

Descriptor not available

01 Jan 2007

G9121

Descriptor not available

01 Jan 2007

G9122

Descriptor not available

01 Jan 2007

G9127

Oncology; disease status; chronic myelogenous leukemia

01 Jan 2007

G9141

Influenza a (h1n1) immunization administration (includes the physician counseling the patient/family)

01 Jan 2013

G9142

Influenza a (h1n1) vaccine, any route of administration

01 Jan 2013

G9158

Motor speech functional limitation, discharge status, at discharge from therapy or to end reporting

01 Jan 2020

G9159

Spoken language comprehension functional limitation, current status at therapy episode outset and at reporting intervals

01 Jan 2020

G9160

Spoken language comprehension functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

01 Jan 2020

G9161

Spoken language comprehension functional limitation, discharge status, at discharge from therapy or to end reporting

01 Jan 2020

G9162

Spoken language expression functional limitation, current status at therapy episode outset and at reporting intervals

01 Jan 2020

G9163

Spoken language expression functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

01 Jan 2020

G9164

Spoken language expression functional limitation, discharge status at discharge from therapy or to end reporting

01 Jan 2020

G9165

Attention functional limitation, current status at therapy episode outset and at reporting intervals

01 Jan 2020

G9166

Attention functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

01 Jan 2020

G9167

Attention functional limitation, discharge status at discharge from therapy or to end reporting

01 Jan 2020

G9168

Memory functional limitation, current status at therapy episode outset and at reporting intervals

01 Jan 2020

G9169

Memory functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

01 Jan 2020

G9170

Memory functional limitation, discharge status at discharge from therapy or to end reporting

01 Jan 2020

G9171

Voice functional limitation, current status at therapy episode outset and at reporting intervals

01 Jan 2020

G9172

Voice functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

01 Jan 2020

G9173

Voice functional limitation, discharge status at discharge from therapy or to end reporting

01 Jan 2020

G9174

Other speech language pathology functional limitation, current status at therapy episode outset and at reporting intervals

01 Jan 2020

G9175

Other speech language pathology functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

01 Jan 2020

G9176

Other speech language pathology functional limitation, discharge status at discharge from therapy or to end reporting

01 Jan 2020

G9186

Motor speech functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

01 Jan 2020

G9192

Documentation of system reason(s) for not prescribing beta-blocker therapy (eg, other reasons attributable to the health care system)

01 Jan 2024

G9193

Clinician documented that patient with a diagnosis of major depression was not an eligible candidate for antidepressant medication treatment or patient did not have a diagnosis of major depression

01 Jan 2015

G9194

Patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 180 day (6 month) continuation treatment phase

01 Jan 2015

G9195

Patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 180 day (6 months) continuation treatment phase

01 Jan 2015

G9196

Documentation of medical reason(s) for not ordering a first or second generation cephalosporin for antimicrobial prophylaxis (e.g., patients enrolled in clinical trials, patients with documented infection prior to surgical procedure of interest, patients who were receiving antibiotics more than 24 hours prior to surgery [except colon surgery patients taking oral prophylactic antibiotics], patients who were receiving antibiotics within 24 hours prior to arrival [except colon surgery patients taking oral prophylactic antibiotics], other medical reason(s))

01 Jan 2023

G9197

Documentation of order for first or second generation cephalosporin for antimicrobial prophylaxis

01 Jan 2023

G9198

Order for first or second generation cephalosporin for antimicrobial prophylaxis was not documented, reason not given

01 Jan 2023

G9199

Venous thromboembolism (vte) prophylaxis not administered the day of or the day after hospital admission for documented reasons (eg, patient is ambulatory, patient expired during inpatient stay, patient already on warfarin or another anticoagulant, other medical reason(s) or eg, patient left against medical advice, other patient reason(s))

01 Jan 2015

G9200

Venous thromboembolism (vte) prophylaxis was not administered the day of or the day after hospital admission, reason not given

01 Jan 2015

G9201

Venous thromboembolism (vte) prophylaxis administered the day of or the day after hospital admission

01 Jan 2015

G9202

Patients with a positive hepatitis c antibody test

01 Jan 2015

G9203

Rna testing for hepatitis c documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c

01 Jan 2017

G9204

Rna testing for hepatitis c was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given

01 Jan 2017

G9205

Patient starting antiviral treatmentfor hepatitis c during the measurement period

01 Jan 2017

G9206

Patient starting antiviral treatment for hepatitis c during the measurement period

01 Jan 2017

G9207

Hepatitis c genotype testing documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c

01 Jan 2017

G9208

Hepatitis c genotype testing was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given

01 Jan 2017

G9209

Hepatitis c quantitative rna testing documented as performed between 4-12 weeks after the initiation of antiviral treatment

01 Jan 2017

G9210

Hepatitis c quantitative rna testing not performed between 4-12 weeks after the initiation of antiviral treatment for documented reason(s) (e.g., patients whose treatment was discontinued during the testing period prior to testing, other medical reasons, patient declined, other patient reasons)

01 Jan 2017

G9211

Hepatitis c quantitative rna testing was not documented as performed between 4-12 weeks after the initiation of antiviral treatment, reason not given

01 Jan 2017

G9214

Cd4+ cell count or cd4+ cell percentage results documented

01 Jan 2015

G9215

Cd4+ cell count or percentage not documented as performed, reason not given

01 Jan 2015

G9216

Pcp prophylaxis was not prescribed at time of diagnosis of hiv, reason not given

01 Jan 2015

G9217

Pcp prophylaxis was not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3, reason not given

01 Jan 2017

G9218

Pcp prophylaxis was not prescribed within 3 months oflow cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%, reason not given

01 Jan 2015

G9219

Pneumocystis jiroveci pneumonia prophylaxis not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3 for medical reason (i.e., patient's cd4+ cell count above threshold within 3 months after cd4+ cell count below threshold, indicating that the patient's cd4+ levels are within an acceptable range and the patient does not require pcp prophylaxis)

01 Jan 2017

G9220

Pneumocystis jiroveci pneumonia prophylaxis not prescribed within 3 months of low cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15% for medical reason (i.e., patient's cd4+ cell count above threshold within 3 months after cd4+ cell count below threshold, indicating that the patient's cd4+ levels are within an acceptable range and the patient does not require pcp prophylaxis)

01 Jan 2015

G9221

Pneumocystis jiroveci pneumonia prophlaxis prescribed

01 Jan 2015

G9222

Pneumocystis jiroveci pneumonia prophylaxis prescribed wthin 3 months of low cd4+ cell count below 200 cells/mm3

01 Jan 2017

G9224

Documentation of medical reason for not performing foot exam (e.g., patient with bilateral foot/leg amputation)

01 Jan 2015

G9229

Chlamydia, gonorrhea, and syphilis screening results not documented (patient refusal is the only allowed exception)

01 Jan 2024

G9232

Clinician treating major depressive disorder did not communicate to clinician treating comorbid condition for specified patient reason (e.g., patient is unable to communicate the diagnosis of a comorbid condition; the patient is unwilling to communicate the diagnosis of a comorbid condition; or the patient is unaware of the comorbid condition, or any other specified patient reason)

01 Jan 2021

G9233

All quality actions for the applicable measures in the total knee replacement measures group have been performed for this patient

01 Jan 2017

G9234

I intend to report the total knee replacement measures group

01 Jan 2017

G9235

All quality actions for the applicable measures in the general surgery measures group have been performed for this patient

01 Jan 2017

G9236

All quality actions for the applicable measures in the optimizing patient exposure to ionizing radiation measures group have been performed for this patient

01 Jan 2017

G9237

I intend to report the general surgery measures group

01 Jan 2017

G9238

I intend to report the optimizing patient exposure to ionizing radiation measures group

01 Jan 2017

G9239

Documentation of reasons for patient initiating maintenance hemodialysis with a catheter as the mode of vascular access (e.g., patient has a maturing arteriovenous fistula (avf)/arteriovenous graft (avg), time-limited trial of hemodialysis, other medical reasons, patient declined avf/avg, other patient reasons, patient followed by reporting nephrologist for fewer than 90 days, other system reasons)

01 Jan 2021

G9240

Patient whose mode of vascular access is a catheter at the time maintenance hemodialysis is initiated

01 Jan 2021

G9241

Patient whose mode of vascular access is not a catheter at the time maintenance hemodialysis is initiated

01 Jan 2021

G9244

Antiretroviral thereapy not prescribed

01 Jan 2017

G9245

Antiretroviral therapy prescribed

01 Jan 2017

G9248

Patient did not have a medical visit in the last 6 months

01 Jan 2015

G9249

Patient had a medical visit in the last 6 months

01 Jan 2015

G9250

Documentation of patient pain brought to a comfortable level within 48 hours from initial assessment

01 Jan 2023

G9251

Documentation of patient with pain not brought to a comfortable level within 48 hours from initial assessment

01 Jan 2023

G9252

Adenoma(s) or other neoplasm detected during screening colonoscopy

01 Jan 2015

G9253

Adenoma(s) or other neoplasm not detected during screening colonoscopy

01 Jan 2015

G9256

Documentation of patient death following cas

01 Jan 2021

G9257

Documentation of patient stroke following cas

01 Jan 2021

G9258

Documentation of patient stroke following cea

01 Jan 2021

G9259

Documentation of patient survival and absence of stroke following cas

01 Jan 2021

G9260

Documentation of patient death following cea

01 Jan 2021

G9261

Documentation of patient survival and absence of stroke following cea

01 Jan 2021

G9262

Documentation of patient death in the hospital following endovascular aaa repair

01 Jan 2021

G9263

Documentation of patient discharged alive following endovascular aaa repair

01 Jan 2021

G9264

Documentation of patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter for documented reasons (e.g., other medical reasons, patient declined arteriovenous fistula (avf)/arteriovenous graft (avg), other patient reasons)

01 Jan 2021

G9265

Patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter as the mode of vascular access

01 Jan 2021

G9266

Patient receiving maintenance hemodialysis for greater than or equal to 90 days without a catheter as the mode of vascular access

01 Jan 2021

G9267

Documentation of patient with one or more complications or mortality within 30 days

01 Jan 2022

G9268

Documentation of patient with one or more complications within 90 days

01 Jan 2022

G9269

Documentation of patient without one or more complications and without mortality within 30 days

01 Jan 2022

G9270

Documentation of patient without one or more complications within 90 days

01 Jan 2022

G9271

Ldl value < 100

01 Jan 2015

G9272

Ldl value >= 100

01 Jan 2015

G9300

Documentation of medical reason(s) for not completely infusing the prophylactic antibiotic prior to the inflation of the proximal tourniquet (e.g., a tourniquet was not used)

01 Jan 2021

G9301

Patients who had the prophylactic antibiotic completely infused prior to the inflation of the proximal tourniquet

01 Jan 2021

G9302

Prophylactic antibiotic not completely infused prior to the inflation of the proximal tourniquet, reason not given

01 Jan 2021

G9303

Operative report does not identify the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant, reason not given

01 Jan 2021

G9304

Operative report identifies the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant

01 Jan 2021

G9320

Documentation of medical reason(s) for not naming ct studies according to a standardized nomenclature provided (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)

01 Jan 2016

G9323

Documentation of medical reason(s) for not counting previous ct and cardiac nuclear medicine (myocardial perfusion) studies (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)

01 Jan 2016

G9324

All necessary data elements not included, reason not given

01 Jan 2017

G9325

Ct studies not reported to a radiation dose index registry due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)

01 Jan 2016

G9326

Ct studies performed not reported to a radiation dose index registry that is capable of collecting at a minimum all necessary data elements, reason not given

01 Jan 2021

G9327

Ct studies performed reported to a radiation dose index registry that is capable of collecting at a minimum all necessary data elements

01 Jan 2021

G9328

Dicom format image data availability not documented in final report due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)

01 Jan 2016

G9329

Dicom format image data available to non-affiliated external healthcare facilities or entities on a secure, media free, reciprocally searchable basis with patient authorization for at least a 12-month period after the study not documented in final report, reason not given

01 Jan 2021

G9340

Final report documented that dicom format image data available to non-affiliated external healthcare facilities or entities on a secure, media free, reciprocally searchable basis with patient authorization for at least a 12-month period after the study

01 Jan 2021

G9343

Due to medical reasons, search not conducted for dicom format images for prior patient ct imaging studies completed at non-affiliated external heatlhcare facilities or entities within the past 12 months that are available through a secure, authorized, media-free, shared archive (e.g., ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)

01 Jan 2016

G9346

Follow-up recommendations not documented according to recommended guidelines for incidentally detected pulmonary nodules due to medical reasons (e.g., patients with known malignant disease, patients with unexplained fever, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)

01 Jan 2016

G9348

Ct scan of the paranasal sinuses ordered at the time of diagnosis for documented reasons

01 Jan 2022

G9349

Ct scan of the paranasal sinuses ordered at the time of diagnosis or received within 28 days after date of diagnosis

01 Jan 2022

G9350

Ct scan of the paranasal sinuses not ordered at the time of diagnosis or received within 28 days after date of diagnosis

01 Jan 2022

G9359

Documentation of negative or managed positive tb screen with further evidence that tb is not active prior to treatment with a biologic immune response modifier

01 Jan 2023

G9360

No documentation of negative or managed positive tb screen

01 Jan 2023

G9362

Duration of monitored anesthesia care (mac) or peripheral nerve block (pnb) without the use of general anesthesia during an applicable procedure 60 minutes or longer, as documented in the anesthesia record

01 Jan 2016

G9363

Duration of monitored anesthesia care (mac) or peripheral nerve block (pnb) without the use of general anesthesia during an applicable procedure or general or neuraxial anesthesia less than 60 minutes, as documented in the anesthesia record

01 Jan 2016

G9365

One high-risk medication ordered

01 Jan 2021

G9366

One high-risk medication not ordered

01 Jan 2021

G9369

Individual filled at least two prescriptions for any antipsychotic medication and had a pdc of 0.8 or greater

01 Jan 2016

G9370

Individual who did not fill at least two prescriptions for any antipsychotic medication or did not have a pdc of 0.8 or greater

01 Jan 2016

G9376

Patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month) following only one surgery

01 Jan 2016

G9377

Patient did not have the retina attached after 6 months following only one surgery

01 Jan 2016

G9378

Patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month)

01 Jan 2016

G9379

Patient did not achieve flat retinas six months post surgery

01 Jan 2016

G9381

Documentation of medical reason(s) for not offering assistance with end of life issues (e.g., patient in hospice care, patient in terminal phase) during the measurement period

01 Jan 2018

G9389

Unplanned rupture of the posterior capsule requiring vitrectomy during cataract surgery

01 Jan 2021

G9390

No unplanned rupture of the posterior capsule requiring vitrectomy during cataract surgery

01 Jan 2021

G9391

Patient achieves refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visit

01 Jan 2016

G9392

Patient does not achieve refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visit

01 Jan 2016

G9399

Documentation in the patient record of a discussion between the physician/clinician and the patient that includes all of the following: treatment choices appropriate to genotype, risks and benefits, evidence of effectiveness, and patient preferences toward the outcome of the treatment

01 Jan 2022

G9400

Documentation of medical or patient reason(s) for not discussing treatment options; medical reasons: patient is not a candidate for treatment due to advanced physical or mental health comorbidity (including active substance use); currently receiving antiviral treatment; successful antiviral treatment (with sustained virologic response) prior to reporting period; other documented medical reasons; patient reasons: patient unable or unwilling to participate in the discussion or other patient reasons

01 Jan 2022

G9401

No documentation in the patient record of a discussion between the physician or other qualified healthcare professional and the patient that includes all of the following: treatment choices appropriate to genotype, risks and benefits, evidence of effectiveness, and patient preferences toward treatment

01 Jan 2022

G9402

Patient received follow-up within 30 days after discharge

01 Jan 2025

G9403

Clinician documented reason patient was not able to complete 30 day follow-up from acute inpatient setting discharge (e.g., patient death prior to follow-up visit, patient non-compliant for visit follow-up)

01 Jan 2025

G9404

Patient did not receive follow-up within 30 days after discharge

01 Jan 2025

G9405

Patient received follow-up within 7 days after discharge

01 Jan 2025

G9406

Clinician documented reason patient was not able to complete 7 day follow-up from acute inpatient setting discharge (i.e patient death prior to follow-up visit, patient non-compliance for visit follow-up)

01 Jan 2025

G9407

Patient did not receive follow-up within 7 days after discharge

01 Jan 2025

G9433

Death, permanent nursing home resident or receiving hospice or palliative care any time during the measurement period

01 Jan 2016

G9435

Aspirin prescribed at discharge

01 Jan 2017

G9436

Aspirin not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)

01 Jan 2017

G9437

Aspirin not prescribed at discharge

01 Jan 2017

G9438

P2y inhibitor prescribed at discharge

01 Jan 2017

G9439

P2y inhibitor not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)

01 Jan 2017

G9440

P2y inhibitor not prescribed at discharge

01 Jan 2017

G9441

Statin prescribed at discharge

01 Jan 2017

G9442

Statin not prescribed for documented reasons (e.g., allergy, medical intolerance)

01 Jan 2017

G9443

Statin not prescribed at discharge

01 Jan 2017

G9448

Patients who were born in the years 1945 to 1965

01 Jan 2022

G9449

History of receiving blood transfusions prior to 1992

01 Jan 2022

G9450

History of injection drug use

01 Jan 2022

G9451

Patient received one-time screening for hcv infection

01 Jan 2024

G9453

Documentation of patient reason(s) for not receiving one-time screening for hcv infection (e.g., patient declined, other patient reasons)

01 Jan 2024

G9454

One-time screening for hcv infection not received within 12-month reporting period and no documentation of prior screening for hcv infection, reason not given

01 Jan 2024

G9458

Patient documented as tobacco user and received tobacco cessation intervention (must include at least one of the following: advice given to quit smoking or tobacco use, counseling on the benefits of quitting smoking or tobacco use, assistance with or referral to external smoking or tobacco cessation support programs, or current enrollment in smoking or tobacco use cessation program) if identified as a tobacco user

01 Jan 2025

G9459

Currently a tobacco non-user

01 Jan 2025

G9460

Tobacco assessment or tobacco cessation intervention not performed, reason not given

01 Jan 2025

G9463

I intend to report the sinusitis measures group

01 Jan 2017

G9464

All quality actions for the applicable measures in the sinusitis measures group have been performed for this patient

01 Jan 2017

G9465

I intend to report the acute otitis externa (aoe) measures group

01 Jan 2017

G9466

All quality actions for the applicable measures in the aoe measures group have been performed for this patient

01 Jan 2017

G9467

Patient who have received or are receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills within the last twelve months

01 Jan 2017

G9469

Patients who have received or are receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 90 or greater consecutive days or a single prescription equating to 900 mg prednisone or greater for all fills

01 Jan 2021

G9472

Within the past 2 years, central dual-energy x-ray absorptiometry (dxa) not ordered and documented, no review of systems and no medication history or pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribed

01 Jan 2020

G9496

Documentation of reason for not detecting adenoma(s) or other neoplasm. (e.g., neoplasm detected is only diagnosed as traditional serrated adenoma, sessile serrated polyp, or sessile serrated adenoma

01 Jan 2018

G9499

Patient did not start or is not receiving antiviral treatment for hepatitis c during the measurement period

01 Jan 2017

G9503

Patient taking tamsulosin hydrochloride

01 Jan 2021

G9506

Biologic immune response modifier prescribed

01 Jan 2023

G9523

Patient discontinued from hemodialysis or peritoneal dialysis

01 Jan 2021

G9524

Patient was referred to hospice care

01 Jan 2021

G9525

Documentation of patient reason(s) for not referring to hospice care (e.g., patient declined, other patient reasons)

01 Jan 2021

G9526

Patient was not referred to hospice care, reason not given

01 Jan 2021

G9532

Patient had a head ct for trauma ordered by someone other than an emergency care provider or was ordered for a reason other than trauma

01 Jan 2021

G9534

Advanced brain imaging (cta, ct, mra or mri) was not ordered

01 Jan 2019

G9535

Patients with a normal neurological examination

01 Jan 2019

G9536

Documentation of medical reason(s) for ordering an advanced brain imaging study (i.e., patient has an abnormal neurological examination; patient has the coexistence of seizures, or both; recent onset of severe headache; change in the type of headache; signs of increased intracranial pressure (e.g., papilledema, absent venous pulsations on funduscopic examination, altered mental status, focal neurologic deficits, signs of meningeal irritation); hiv-positive patients with a new type of headache; immunocompromised patient with unexplained headache symptoms; patient on coagulopathy/anti-coagulation or anti-platelet therapy; very young patients with unexplained headache symptoms)

01 Jan 2019

G9538

Advanced brain imaging (cta, ct, mra or mri) was ordered

01 Jan 2019

G9558

Patient treated with a beta-lactam antibiotic as definitive therapy

01 Jan 2021

G9559

Documentation of medical reason(s) for not prescribing a beta-lactam antibiotic (e.g., allergy, intolerance to beta-lactam antibiotics)

01 Jan 2021

G9560

Patient not treated with a beta-lactam antibiotic as definitive therapy, reason not given

01 Jan 2021

G9561

Patients prescribed opiates for longer than six weeks

01 Jan 2022

G9562

Patients who had a follow-up evaluation conducted at least every three months during opioid therapy

01 Jan 2022

G9563

Patients who did not have a follow-up evaluation conducted at least every three months during opioid therapy

01 Jan 2022

G9572

Index date phq-score greater than 9 documented during the twelve month denominator identification period

01 Jan 2017

G9573

Adult patients 18 years of age or older with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five

01 Jan 2021

G9574

Adult patients 18 years of age or older with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five; either phq-9 or phq-9m score was not assessed or is greater than or equal to five

01 Jan 2021

G9577

Patients prescribed opiates for longer than six weeks

01 Jan 2022

G9578

Documentation of signed opioid treatment agreement at least once during opioid therapy

01 Jan 2022

G9579

No documentation of signed an opioid treatment agreement at least once during opioid therapy

01 Jan 2022

G9581

Door to puncture time of greater than 2 hours for reasons documented by clinician (e.g., patients who are transferred from one institution to another with a known diagnosis of cva for endovascular stroke treatment; hospitalized patients with newly diagnosed cva considered for endovascular stroke treatment)

01 Jan 2017

G9583

Patients prescribed opiates for longer than six weeks

01 Jan 2022

G9584

Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy

01 Jan 2022

G9585

Patient not evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient not interviewed at least once during opioid therapy

01 Jan 2022

G9596

Pediatric patient had a head ct for trauma ordered by someone other than an emergency care provider or was ordered for a reason other than trauma

01 Jan 2024

G9600

Symptomatic aaas that required urgent/emergent (non-elective) repair

01 Jan 2021

G9601

Patient discharge to home no later than post-operative day #7

01 Jan 2021

G9602

Patient not discharged to home by post-operative day #7

01 Jan 2021

G9612

Photodocumentation of two or more cecal landmarks to establish a complete examination

01 Jan 2024

G9613

Documentation of post-surgical anatomy (e.g., right hemicolectomy, ileocecal resection, etc.)

01 Jan 2024

G9614

Photodocumentation of less than two cecal landmarks (i.e., no cecal landmarks or only one cecal landmark) to establish a complete examination

01 Jan 2024

G9615

Preoperative assessment documented

01 Jan 2021

G9616

Documentation of reason(s) for not documenting a preoperative assessment (e.g., patient with a gynecologic or other pelvic malignancy noted at the time of surgery)

01 Jan 2021

G9617

Preoperative assessment not documented, reason not given

01 Jan 2021

G9618

Documentation of screening for uterine malignancy or those that had an ultrasound and/or endometrial sampling of any kind

01 Jan 2023

G9619

Documentation of reason(s) for not screening for uterine malignancy (e.g., prior hysterectomy)

01 Jan 2017

G9620

Patient not screened for uterine malignancy, or those that have not had an ultrasound and/or endometrial sampling of any kind, reason not given

01 Jan 2023

G9623

Documentation of medical reason(s) for not screening for unhealthy alcohol use (e.g., limited life expectancy, other medical reasons)

01 Jan 2023

G9631

Patient sustained ureter injury at the time of surgery or discovered subsequently up to 30 days post-surgery

01 Jan 2023

G9632

Documented medical reasons for not reporting ureter injury (e.g., gynecologic or other pelvic malignancy documented, concurrent surgery involving bladder pathology, injury that occurs during a urinary incontinence procedure, patient death from non-medical causes not related to surgery, patient died during procedure without evidence of ureter injury)

01 Jan 2023

G9633

Patient did not sustain ureter injury at the time of surgery nor discovered subsequently up to 30 days post-surgery

01 Jan 2023

G9634

Health-related quality of life assessed with tool during at least two visits and quality of life score remained the same or improved

01 Jan 2022

G9635

Health-related quality of life not assessed with tool for documented reason(s) (e.g., patient has a cognitive or neuropsychiatric impairment that impairs his/her ability to complete the hrqol survey, patient has the inability to read and/or write in order to complete the hrqol questionnaire)

01 Jan 2022

G9636

Health-related quality of life not assessed with tool during at least two visits or quality of life score declined

01 Jan 2022

G9639

Major amputation or open surgical bypass not required within 48 hours of the index endovascular lower extremity revascularization procedure

01 Jan 2022

G9640

Documentation of planned hybrid or staged procedure

01 Jan 2022

G9641

Major amputation or open surgical bypass required within 48 hours of the index endovascular lower extremity revascularization procedure

01 Jan 2022

G9647

Patients in whom mrs score could not be obtained at 90 day follow-up

01 Jan 2022

G9650

Documentation that the patient declined therapy change or has documented contraindications (e.g., experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga, bsa, pasi, or dlqi

01 Jan 2017

G9652

Patient has been treated with a systemic or biologic medication for psoriasis for at least six months

01 Jan 2017

G9653

Patient has not been treated with a systemic or biologic medication for psoriasis for at least six months

01 Jan 2017

G9657

Transfer of care during an anesthetic or to the intensive care unit

01 Jan 2017

G9666

Patient's highest fasting or direct ldl-c laboratory test result in the measurement period or two years prior to the beginning of the measurement period is 70-189 mg/dl

01 Jan 2022

G9667

Documentation of medical reason(s) for not currently being a statin therapy user or receive an order (prescription) for statin therapy (e.g., patient with adverse effect, allergy or intolerance to statin medication therapy, patients who have an active diagnosis of pregnancy or who are breastfeeding, patients who are receiving palliative care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease (esrd), and patients with diabetes who have a fasting or direct ldl-c laboratory test result < 70 mg/dl and are not taking statin therapy)

01 Jan 2017

G9668

Documentation of medical reason (s) for not currently being a statin therapy user or receive an order (prescription) for statin therapy (e.g., patient with adverse effect, allergy or intolerance to statin medication therapy, patients who have an active diagnosis of pregnancy or who are breastfeeding, patients who are receiving palliative care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease (esrd), and patients with diabetes who have a fasting or direct ldl-c laboratory test result < 70 mg/dl and are not taking statin therapy)

01 Jan 2016

G9669

I intend to report the multiple chronic conditions measures group

01 Jan 2017

G9670

All quality actions for the applicable measures in the multiple chronic conditions measures group have been performed for this patient

01 Jan 2017

G9671

I intend to report the diabetic retinopathy measures group

01 Jan 2017

G9672

All quality actions for the applicable measures in the diabetic retinopathy measures group have been performed for this patient

01 Jan 2017

G9673

I intend to report the cardiovascular prevention measures group

01 Jan 2017

G9677

All quality actions for the applicable measures in the cardiovascular prevention measures group have been performed for this patient

01 Jan 2017

G9678

Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation agreement

01 Jul 2022

G9686

Onsite nursing facility conference, that is separate and distinct from an evaluation and management visit, including qualified practitioner and at least one member of the nursing facility interdisciplinary care team

01 Jan 2019

G9697

Documentation of patient reason(s) for not prescribing a long-acting inhaled bronchodilator

01 Jan 2024

G9701

Children who are taking antibiotics in the 30 days prior to the date of the encounter during which the diagnosis was established

01 Jan 2021

G9707

Patient received hospice services any time during the measurement period

01 Jan 2025

G9715

Patients who use hospice services any time during the measurement period

01 Jan 2024

G9718

Hospice services for patient provided any time during the measurement period

01 Jan 2023

G9725

Patients who use hospice services any time during the measurement period

01 Jan 2024

G9738

Patient refused to participate

01 Jan 2021

G9739

Patient unable to complete the general orthopedic fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available

01 Jan 2021

G9742

Psychiatric symptoms assessed

01 Jan 2020

G9743

Psychiatric symptoms not assessed, reason not otherwise specified

01 Jan 2020

G9747

Patient is undergoing palliative dialysis with a catheter

01 Jan 2021

G9748

Patient approved by a qualified transplant program and scheduled to receive a living donor kidney transplant

01 Jan 2021

G9749

Patient is undergoing palliative dialysis with a catheter

01 Jan 2021

G9750

Patient approved by a qualified transplant program and scheduled to receive a living donor kidney transplant

01 Jan 2021

G9751

Patient died at any time during the 24-month measurement period

01 Jan 2025

G9759

History of preoperative posterior capsule rupture

01 Jan 2021

G9760

Patients who use hospice services any time during the measurement period

01 Jan 2025

G9774

Patients who have had a hysterectomy

01 Jan 2023

G9778

Patients who have a diagnosis of pregnancy at any time during the measurement period

01 Jan 2023

G9783

Documentation of patients with diabetes who have a most recent fasting or direct ldl- c laboratory test result < 70 mg/dl and are not taking statin therapy

01 Jan 2022

G9798

Discharge(s) for ami between july 1 of the year prior measurement period to june 30 of the measurement period

01 Jan 2021

G9799

Patients with a medication dispensing event indicator of a history of asthma any time during the patient's history through the end of the measure period

01 Jan 2021

G9800

Patients who are identified as having an intolerance or allergy to beta-blocker therapy

01 Jan 2021

G9801

Hospitalizations in which the patient was transferred directly to a non-acute care facility for any diagnosis

01 Jan 2021

G9802

Patients who use hospice services any time during the measurement period

01 Jan 2021

G9803

Patient prescribed at least a 135 day treatment within the 180-day measurement interval with beta-blockers post-discharge for ami

01 Jan 2021

G9804

Patient was not prescribed at least a 135 day treatment within the 180-day measurement interval with beta-blockers post-discharge for ami

01 Jan 2021

G9808

Any patients who had no asthma controller medications dispensed during the measurement year

01 Jan 2023

G9809

Patients who use hospice services any time during the measurement period

01 Jan 2023

G9810

Patient achieved a pdc of at least 75% for their asthma controller medication

01 Jan 2023

G9811

Patient did not achieve a pdc of at least 75% for their asthma controller medication

01 Jan 2023

G9814

Death occurring during the index acute care hospitalization

01 Jan 2021

G9815

Death did not occur during the index acute care hospitalization

01 Jan 2021

G9816

Death occurring after discharge from the hospital but within 30 days post procedure

01 Jan 2021

G9817

Death did not occur after discharge from the hospital within 30 days post procedure

01 Jan 2021

G9825

Her-2/neu negative or undocumented/unknown

01 Jan 2021

G9826

Patient transferred to practice after initiation of chemotherapy

01 Jan 2021

G9827

Her2-targeted therapies not administered during the initial course of treatment

01 Jan 2021

G9828

Her2-targeted therapies administered during the initial course of treatment

01 Jan 2021

G9829

Breast adjuvant chemotherapy administered

01 Jan 2021

G9833

Patient transfer to practice after initiation of chemotherapy

01 Jan 2021

G9834

Patient has metastatic disease at diagnosis

01 Jan 2021

G9835

Trastuzumab administered within 12 months of diagnosis

01 Jan 2021

G9836

Reason for not administering trastuzumab documented (e.g. patient declined, patient died, patient transferred, contraindication or other clinical exclusion, neoadjuvant chemotherapy or radiation not complete)

01 Jan 2021

G9837

Trastuzumab not administered within 12 months of diagnosis

01 Jan 2021

G9849

Patients who died from cancer

01 Jan 2021

G9850

Patient had more than one emergency department visit in the last 30 days of life

01 Jan 2021

G9851

Patient had one or less emergency department visits in the last 30 days of life

01 Jan 2021

G9852

Patients who died from cancer

01 Jan 2024

G9853

Patient admitted to the icu in the last 30 days of life

01 Jan 2024

G9854

Patient was not admitted to the icu in the last 30 days of life

01 Jan 2024

G9855

Patients who died from cancer

01 Jan 2021

G9856

Patient was not admitted to hospice

01 Jan 2021

G9857

Patient admitted to hospice

01 Jan 2021

G9892

Documentation of patient reason(s) for not performing a dilated macular examination

01 Jan 2025

G9893

Dilated macular exam was not performed, reason not otherwise specified

01 Jan 2025

G9904

Documentation of medical reason(s) for not screening for tobacco use (e.g., limited life expectancy, other medical reason)

01 Jan 2023

G9907

Documentation of medical reason(s) for not providing tobacco cessation intervention on the date of the encounter or within the previous 12 months (e.g., limited life expectancy, other medical reason)

01 Jan 2023

G9909

Documentation of medical reason(s) for not providing tobacco cessation intervention on the date of the encounter or within the previous 12 months if identified as a tobacco user (e.g., limited life expectancy, other medical reason)

01 Jan 2023

G9921

No screening performed, partial screening performed or positive screen without recommendations and reason is not given or otherwise specified

01 Jan 2025

G9924

Documentation of medical reason(s) for not providing safety concerns screen or for not providing recommendations, orders or referrals for positive screen (e.g., patient in palliative care, other medical reason)

01 Jan 2021

G9927

Documentation of system reason(s) for not prescribing an fda-approved anticoagulation due to patient being currently enrolled in a clinical trial related to af/atrial flutter treatment

01 Jan 2024

G9932

Documentation of patient reason(s) for not having records of negative or managed positive tb screen (e.g., patient does not return for mantoux (ppd) skin test evaluation)

01 Jan 2023

G9933

Adenoma(s) or colorectal cancer detected during screening colonoscopy

01 Jan 2021

G9934

Documentation that neoplasm detected is only diagnosed as traditional serrated adenoma, sessile serrated polyp, or sessile serrated adenoma

01 Jan 2021

G9935

Adenoma(s) or colorectal cancer not detected during screening colonoscopy

01 Jan 2021

G9936

Surveillance colonoscopy - personal history of colonic polyps, colon cancer, or other malignant neoplasm of rectum, rectosigmoid junction, and anus

01 Jan 2021

G9937

Diagnostic colonoscopy

01 Jan 2021

G9941

Back pain was measured by the visual analog scale (vas) within three months preoperatively and at three months (6 - 20 weeks) postoperatively

01 Jan 2020

G9942

Patient had any additional spine procedures performed on the same date as the lumbar discectomy/laminectomy

01 Jan 2023

G9944

Back pain was measured by the visual analog scale (vas) within three months preoperatively and at one year (9 to 15 months) postoperatively

01 Jan 2020

G9947

Leg pain was measured by the visual analog scale (vas) within three months preoperatively and at three months (6 to 20 weeks) postoperatively

01 Jan 2020

G9948

Patient had any additional spine procedures performed on the same date as the lumbar discectomy/laminectomy

01 Jan 2023

G9966

Children who were screened for risk of developmental, behavioral and social delays using a standardized tool with interpretation and report

01 Jan 2021

G9967

Children who were not screened for risk of developmental, behavioral and social delays using a standardized tool with interpretation and report

01 Jan 2021

G9974

Dilated macular exam performed, including documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage and the level of macular degeneration severity

01 Jan 2025

G9975

Documentation of medical reason(s) for not performing a dilated macular examination

01 Jan 2025

G9976

Documentation of patient reason(s) for not performing a dilated macular examination

01 Apr 2018

G9977

Dilated macular exam was not performed, reason not otherwise specified

01 Apr 2018

G9989

Documentation of medical reason(s) for not administering pneumococcal vaccine (e.g., adverse reaction to vaccine)

01 Jan 2023

G9990

Patient did not receive any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period

01 Jan 2025

G9991

Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period

01 Jan 2025

G9995

Patients who use palliative care services any time during the measurement period

01 Jan 2024

GD

Units of service exceeds medically unlikely edit value and represents reasonable and necessary services

01 Jan 2020

H5000

Descriptor not available

01 Jan 1990

H5010

Descriptor not available

01 Jan 1990

H5020

Descriptor not available

01 Jan 1990

H5025

Descriptor not available

01 Jan 1990

H5030

Descriptor not available

01 Jan 1990

H5040

Descriptor not available

01 Jan 1990

H5050

Descriptor not available

01 Jan 1990

H5060

Descriptor not available

01 Jan 1990

H5070

Descriptor not available

01 Jan 1990

H5080

Descriptor not available

01 Jan 1990

H5090

Descriptor not available

01 Jan 1990

H5100

Descriptor not available

01 Jan 1990

H5110

Descriptor not available

01 Jan 1990

H5120

Descriptor not available

01 Jan 1990

H5130

Descriptor not available

01 Jan 1990

H5140

Descriptor not available

01 Jan 1990

H5150

Descriptor not available

01 Jan 1990

H5160

Descriptor not available

01 Jan 1990

H5170

Descriptor not available

01 Jan 1990

H5180

Descriptor not available

01 Jan 1990

H5190

Descriptor not available

01 Jan 1990

H5200

Descriptor not available

01 Jan 1990

H5220

Descriptor not available

01 Jan 1990

H5230

Descriptor not available

01 Jan 1990

H5240

Descriptor not available

01 Jan 1990

H5299

Descriptor not available

01 Jan 1990

H5300

Descriptor not available

01 Jan 1993

J0110

Descriptor not available

01 Jan 1996

J0128

Injection, abarelix, 10 mg

01 Jan 2011

J0135

Injection, adalimumab, 20 mg

01 Jan 2025

J0140

Descriptor not available

01 Jan 1990

J0150

Injection, adenosine for therapeutic use, 6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)

01 Jan 2015

J0151

Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)

01 Jan 2015

J0152

Injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270)

01 Jan 2014

J0160

Descriptor not available

01 Jan 1990

J0170

Injection, adrenalin, epinephrine, up to 1 ml ampule

01 Jan 2011

J0230

Descriptor not available

01 Jan 1995

J0240

Descriptor not available

01 Jan 1995

J0250

Descriptor not available

01 Jan 1990

J0255

Descriptor not available

01 Jan 1990

J0260

Descriptor not available

01 Jan 1990

J0286

Descriptor not available

01 Jan 2003

J0310

Descriptor not available

01 Jan 1990

J0320

Descriptor not available

01 Jan 1990

J0340

Descriptor not available

01 Jan 2002

J0370

Descriptor not available

01 Jan 1990

J0410

Descriptor not available

01 Jan 1990

J0420

Descriptor not available

01 Jan 1990

J0430

Descriptor not available

01 Jan 1990

J0440

Descriptor not available

01 Jan 1990

J0450

Descriptor not available

01 Jan 1990

J0460

Injection

01 Jan 2010

J0510

Descriptor not available

01 Jan 2002

J0530

Injection

01 Jan 2010

J0540

Injection

01 Jan 2010

J0550

Injection

01 Jan 2010

J0559

Injection, penicillin g benzathine and penicillin g procaine, 2500 units

01 Jan 2011

J0560

Injection, penicillin g benzathine, up to 600,000 units

01 Jan 2011

J0570

Buprenorphine implant, 74.2 mg

01 Jan 2025

J0576

Injection, buprenorphine extended-release (brixadi), 1 mg

01 Apr 2024

J0580

Injection, penicillin g benzathine, up to 2,400,000 units

01 Jan 2011

J0590

Descriptor not available

01 Jan 2002

J0610

Injection, calcium gluconate (fresenius kabi), per 10 ml

01 Apr 2023

J0611

Injection, calcium gluconate (wg critical care), per 10 ml

01 Apr 2023

J0635

Descriptor not available

01 Jan 2003

J0660

Descriptor not available

01 Jan 1990

J0680

Descriptor not available

01 Jan 1996

J0693

Injection, cefiderocol, 5 mg

01 Oct 2021

J0695-1

Descriptor not available

01 Jan 2002

J0700

Descriptor not available

01 Jan 1995

J0704

Injection, betamethasone sodium phosphate, per 4 mg

01 Jan 2011

J0718

Injection, certolizumab pegol, 1 mg

01 Jan 2014

J0730

Descriptor not available

01 Jan 2002

J0760

Injection, colchicine, per 1 mg

01 Jan 2017

J0790

Descriptor not available

01 Jan 1995

J0800

Injection, corticotropin, up to 40 units

01 Oct 2023

J0810

Descriptor not available

01 Jan 2002

J0820

Descriptor not available

01 Jan 1996

J0830

Descriptor not available

01 Jan 1995

J0833

Injection, cosyntropin, not otherwise specified, 0.25 mg

01 Jan 2019

J0835

Injection

01 Jan 2010

J0860

Descriptor not available

01 Jan 1990

J0880

Injection

01 Jan 2006

J0886

Injection, epoetin alfa, 1000 units (for esrd on dialysis)

01 Jan 2016

J0900

Injection, testosterone enanthate and estradiol valerate, up to 1 cc

01 Jan 2015

J0910

Descriptor not available

01 Jan 1990

J0920

Descriptor not available

01 Jan 1990

J0930

Descriptor not available

01 Jan 1990

J0940

Descriptor not available

01 Jan 1990

J0950

Descriptor not available

01 Jan 1990

J0960

Descriptor not available

01 Jan 1990

J0970

Injection, estradiol valerate, up to 40 mg

01 Jan 2011

J0980

Descriptor not available

01 Jan 1990

J0990

Descriptor not available

01 Jan 1990

J0995

Descriptor not available

01 Jan 1990

J1020

Injection, methylprednisolone acetate, 20 mg

01 Apr 2024

J1030

Injection, methylprednisolone acetate, 40 mg

01 Apr 2024

J1040

Injection, methylprednisolone acetate, 80 mg

01 Apr 2024

J1051

Injection, medroxyprogesterone acetate, 50 mg

01 Jan 2013

J1055

Injection, medroxyprogesterone acetate for contraceptive use, 150 mg

01 Jan 2013

J1056

Injection, medroxyprogesterone acetate / estradiol cypionate, 5mg / 25mg

01 Jan 2013

J1060

Injection, testosterone cypionate and estradiol cypionate, up to 1 ml

01 Jan 2015

J1070

Injection, testosterone cypionate, up to 100 mg

01 Jan 2015

J1080

Injection, testosterone cypionate, 1 cc, 200 mg

01 Jan 2015

J1090

Descriptor not available

01 Jan 2002

J1094

Injection, dexamethasone acetate, 1 mg

31 Mar 2025

J1140

Descriptor not available

01 Jan 1990

J1150

Descriptor not available

01 Jan 1990

J1155

Descriptor not available

01 Jan 1995

J1170

Injection, hydromorphone, up to 4 mg

01 Oct 2024

J1210

Descriptor not available

01 Jan 1990

J1220

Descriptor not available

01 Jan 1990

J1280

Descriptor not available

01 Jan 1990

J1300

Injection, eculizumab, 10 mg

31 Mar 2025

J1310

Descriptor not available

01 Jan 1990

J1340

Descriptor not available

01 Jan 1993

J1350

Descriptor not available

01 Jan 1995

J1360

Descriptor not available

01 Jan 1995

J1362

Descriptor not available

01 Jan 2002

J1370

Descriptor not available

01 Jan 1990

J1390

Injection, estradiol valerate, up to 20 mg

01 Jan 2011

J1400

Descriptor not available

01 Jan 1990

J1405

Descriptor not available

01 Jan 1990

J1420

Descriptor not available

01 Jan 1990

J1441

Injection, filgrastim (g-csf), 480 mcg

01 Jan 2014

J1446

Injection, tbo-filgrastim, 5 micrograms

01 Jan 2016

J1470

Injection, gamma globulin, intramuscular, 2 cc

01 Jan 2011

J1480

Injection, gamma globulin, intramuscular, 3 cc

01 Jan 2011

J1490

Injection, gamma globulin, intramuscular, 4 cc

01 Jan 2011

J1500

Injection, gamma globulin, intramuscular, 5 cc

01 Jan 2011

J1510

Injection, gamma globulin, intramuscular, 6 cc

01 Jan 2011

J1520

Injection, gamma globulin, intramuscular, 7 cc

01 Jan 2011

J1530

Injection, gamma globulin, intramuscular, 8 cc

01 Jan 2011

J1540

Injection, gamma globulin, intramuscular, 9 cc

01 Jan 2011

J1550

Injection, gamma globulin, intramuscular, 10 cc

01 Jan 2011

J1563

Injection

01 Jan 2006

J1564

Injection

01 Jan 2006

J1565

Injection

01 Jan 2010

J1567

Injection

01 Jan 2008

J1590

Injection, gatifloxacin, 10 mg

01 Jan 2017

J1625

Descriptor not available

01 Jan 1998

J1660

Descriptor not available

01 Jan 1996

J1680

Injection, human fibrinogen concentrate, 100 mg

01 Jan 2013

J1690

Descriptor not available

01 Jan 2002

J1725

Injection, hydroxyprogesterone caproate, 1 mg

01 Jan 2018

J1739

Descriptor not available

01 Jan 2002

J1751

Injection

01 Jan 2009

J1752

Injection

01 Jan 2009

J1755

Descriptor not available

01 Jan 2003

J1760

Descriptor not available

01 Jan 2000

J1770

Descriptor not available

01 Jan 2000

J1780

Descriptor not available

01 Jan 2000

J1785

Injection, imiglucerase, per unit

01 Jan 2011

J1810

Injection, droperidol and fentanyl citrate, up to 2 ml ampule

31 Mar 2025

J1820

Descriptor not available

01 Jan 2003

J1825

Injection, interferon beta-1a, 33 mcg

01 Jan 2011

J1840

Injection, kanamycin sulfate, up to 500 mg

01 Apr 2024

J1850

Injection, kanamycin sulfate, up to 75 mg

01 Apr 2024

J1860

Descriptor not available

01 Jan 1990

J1870

Descriptor not available

01 Jan 1990

J1880

Descriptor not available

01 Jan 1990

J1890

Injection, cephalothin sodium, up to 1 gram

31 Mar 2025

J1900

Descriptor not available

01 Jan 1990

J1910

Descriptor not available

01 Jan 2004

J1940

Injection, furosemide, up to 20 mg

31 Mar 2025

J1942

Injection, aripiprazole lauroxil, 1 mg

01 Oct 2019

J1970

Descriptor not available

01 Jan 2002

J2000

Descriptor not available

01 Jan 2004

J2001

Injection, lidocaine hcl for intravenous infusion, 10 mg

01 Oct 2024

J2030

Descriptor not available

01 Jan 1990

J2040

Descriptor not available

01 Jan 1990

J2050

Descriptor not available

01 Jan 1997

J2070

Descriptor not available

01 Jan 1990

J2080

Descriptor not available

01 Jan 1990

J2090

Descriptor not available

01 Jan 1990

J2100

Descriptor not available

01 Jan 1996

J2110

Descriptor not available

01 Jan 1990

J2120

Descriptor not available

01 Jan 1990

J2130

Descriptor not available

01 Jan 1990

J2140

Descriptor not available

01 Jan 1990

J2160

Descriptor not available

01 Jan 1995

J2190

Descriptor not available

01 Jan 1996

J2200

Descriptor not available

01 Jan 1990

J2220

Descriptor not available

01 Jan 1990

J2230

Descriptor not available

01 Jan 1990

J2240

Descriptor not available

01 Jan 2002

J2271

Injection, morphine sulfate, 100mg

01 Jan 2015

J2275

Injection, morphine sulfate (preservative-free sterile solution), per 10 mg

01 Jan 2015

J2321

Injection, nandrolone decanoate, up to 100 mg

01 Jan 2011

J2322

Injection, nandrolone decanoate, up to 200 mg

01 Jan 2011

J2324

Injection

01 Jan 2006

J2330

Descriptor not available

01 Jan 2002

J2340

Descriptor not available

01 Jan 2002

J2352

Descriptor not available

01 Jan 2004

J2370

Injection, phenylephrine hcl, up to 1 ml

01 Jul 2023

J2380

Descriptor not available

01 Jan 1990

J2390

Descriptor not available

01 Jan 1990

J2400

Injection, chloroprocaine hydrochloride, per 30 ml

01 Jan 2023

J2420

Descriptor not available

01 Jan 1990

J2450

Descriptor not available

01 Jan 1990

J2480

Descriptor not available

01 Jan 2002

J2490

Descriptor not available

01 Jan 1995

J2495

Descriptor not available

01 Jan 1996

J2500

Descriptor not available

01 Jan 2003

J2505

Injection, pegfilgrastim, 6 mg

01 Jan 2022

J2512

Descriptor not available

01 Jan 2002

J2520

Descriptor not available

01 Jan 1995

J2530

Descriptor not available

01 Jan 1990

J2570

Descriptor not available

01 Jan 1990

J2580

Descriptor not available

01 Jan 1990

J2595

Descriptor not available

01 Jan 1995

J2600

Descriptor not available

01 Jan 1995

J2610

Descriptor not available

01 Jan 1990

J2620

Descriptor not available

01 Jan 1990

J2630

Descriptor not available

01 Jan 1990

J2640

Descriptor not available

01 Jan 2002

J2655

Descriptor not available

01 Jan 1990

J2660

Descriptor not available

01 Jan 1990

J2672

Descriptor not available

01 Jan 1995

J2740

Descriptor not available

01 Jan 1990

J2750

Descriptor not available

01 Jan 1990

J2780

Injection, ranitidine hydrochloride, 25 mg

01 Jul 2024

J2796

Injection, romiplostim, 10 micrograms

01 Jan 2025

J2806

Injection, sincalide (maia), not therapeutically equivalent to j2805, 5 micrograms

01 Jan 2025

J2825

Descriptor not available

01 Jan 1995

J2830

Descriptor not available

01 Jan 1990

J2860-1

Descriptor not available

01 Jan 2002

J2870

Descriptor not available

01 Jan 1990

J2880

Descriptor not available

01 Jan 1990

J2890

Descriptor not available

01 Jan 1990

J2900

Descriptor not available

01 Jan 1990

J2912

Injection

01 Jan 2007

J2914

Descriptor not available

01 Jan 1996

J2915

Descriptor not available

01 Jan 2003

J2920

Injection, methylprednisolone sodium succinate, up to 40 mg

01 Apr 2024

J2930

Injection, methylprednisolone sodium succinate, up to 125 mg

01 Apr 2024

J2960

Descriptor not available

01 Jan 1990

J2970

Descriptor not available

01 Jan 2002

J2975

Descriptor not available

01 Jan 1990

J2980

Descriptor not available

01 Jan 1990

J2990

Descriptor not available

01 Jan 1990

J2994

Descriptor not available

01 Jan 2001

J2996

Descriptor not available

01 Jan 2001

J3005

Descriptor not available

01 Jan 1998

J3020

Descriptor not available

01 Jan 1990

J3040

Descriptor not available

01 Jan 1990

J3050

Descriptor not available

01 Jan 1995

J3080

Descriptor not available

01 Jan 2002

J3100

Injection

01 Jan 2009

J3120

Injection, testosterone enanthate, up to 100 mg

01 Jan 2015

J3130

Injection, testosterone enanthate, up to 200 mg

01 Jan 2015

J3140

Injection, testosterone suspension, up to 50 mg

01 Jan 2015

J3150

Injection, testosterone propionate, up to 100 mg

01 Jan 2015

J3160

Descriptor not available

01 Jan 1990

J3170

Descriptor not available

01 Jan 1990

J3180

Descriptor not available

01 Jan 1995

J3190

Descriptor not available

01 Jan 1990

J3200

Descriptor not available

01 Jan 1990

J3210

Descriptor not available

01 Jan 1990

J3220

Descriptor not available

01 Jan 1990

J3270

Descriptor not available

01 Jan 2002

J3290

Descriptor not available

01 Jan 1990

J3330

Descriptor not available

01 Jan 1990

J3340

Descriptor not available

01 Jan 1996

J3380-1

Descriptor not available

01 Jan 1996

J3390

Descriptor not available

01 Jan 2002

J3395

Injection

01 Jan 2005

J3440

Descriptor not available

01 Jan 1990

J3450

Descriptor not available

01 Jan 2002

J3460

Descriptor not available

01 Jan 1990

J3487

Injection, zoledronic acid (zometa), 1 mg

01 Jan 2014

J3488

Injection, zoledronic acid (reclast), 1 mg

01 Jan 2014

J3500

Descriptor not available

01 Jan 1996

J3510

Descriptor not available

01 Jan 1990

J3540

Descriptor not available

01 Jan 1993

J3550

Descriptor not available

01 Jan 1993

J3560

Descriptor not available

01 Jan 1996

J6000

Descriptor not available

01 Jan 1990

J6005

Descriptor not available

01 Jan 1990

J6010

Descriptor not available

01 Jan 1990

J6015

Descriptor not available

01 Jan 1996

J6020

Descriptor not available

01 Jan 1990

J6025

Descriptor not available

01 Jan 1990

J6030

Descriptor not available

01 Jan 1990

J6035

Descriptor not available

01 Jan 1990

J6040

Descriptor not available

01 Jan 1990

J6045

Descriptor not available

01 Jan 1990

J6065

Descriptor not available

01 Jan 1990

J7000

Descriptor not available

01 Jan 1990

J7010

Descriptor not available

01 Jan 1995

J7020

Descriptor not available

01 Jan 1995

J7051

Sterile saline or water

01 Jan 2006

J7080

Descriptor not available

01 Jan 1996

J7090

Descriptor not available

01 Jan 1996

J7130

Hypertonic saline solution, 50 or 100 meq, 20 cc vial

01 Jan 2012

J7140

Descriptor not available

01 Jan 1997

J7150

Descriptor not available

01 Jan 1997

J7160

Descriptor not available

01 Jan 1990

J7184

Wilate injection

01 Jul 2011

J7184

Injection, von willebrand factor complex (human), wilate, per 100 iu vwf:rco

01 Jan 2012

J7188-1

Injection

01 Jan 2007

J7302

Levonorgestrel-releasing intrauterine contraceptive system, 52 mg

01 Jan 2016

J7303

Contraceptive supply, hormone containing vaginal ring, each

01 Oct 2021

J7317

Sodium hyaluronate

01 Jan 2007

J7319

Hyaluronan (sodium hyaluronate) or derivative

01 Apr 2007

J7333

Hyaluronan or derivative, visco-3, for intra-articular injection, per dose

01 Apr 2021

J7335

Capsaicin 8% patch, per 10 square centimeters

01 Jan 2015

J7340-1

Dermal and epidermal

01 Jan 2009

J7341

Dermal (substitute) tissue of non-human origin

01 Jan 2009

J7343

Dermal and epidermal

01 Jan 2009

J7344

Dermal (substitute) tissue of human origin

01 Jan 2009

J7346

Dermal (substitute) tissue of human origin

01 Jan 2009

J7347

Dermal (substitute) tissue of nonhuman origin

01 Jan 2009

J7348

Dermal (substitute) tissue of nonhuman origin

01 Jan 2009

J7349

Dermal (substitute) tissue of nonhuman origin

01 Jan 2009

J7350

Dermal (substitute) tissue of human origin

01 Jan 2007

J7401

Mometasone furoate sinus implant, 10 micrograms

01 Apr 2021

J7503-1

Descriptor not available

01 Jan 2000

J7506

Prednisone, oral, per 5 mg

01 Jan 2016

J7602

Albuterol

01 Jan 2009

J7603

Albuterol

01 Jan 2009

J7616

Albuterol

01 Jan 2006

J7617

Levalbuterol

01 Jan 2006

J7618

Albuterol

01 Jan 2005

J7619

Albuterol

01 Jan 2005

J7621

Albuterol

01 Jan 2005

J7625

Descriptor not available

01 Jan 2001

J7630

Descriptor not available

01 Jan 2001

J7651

Descriptor not available

01 Jan 2001

J7652

Descriptor not available

01 Jan 2001

J7653

Descriptor not available

01 Jan 2001

J7654

Descriptor not available

01 Jan 2001

J7655

Descriptor not available

01 Jan 2001

J7672

Descriptor not available

01 Jan 2001

J7675

Descriptor not available

01 Jan 2001

J8520

Capecitabine, oral, 150 mg

01 Oct 2024

J8521

Capecitabine, oral, 500 mg

01 Oct 2024

J8561

Everolimus, oral, 0. 25 mg

01 Jan 2013

J9001

Injection, doxorubicin hydrochloride, all lipid formulations, 10 mg

01 Jan 2013

J9002

Injection, doxorubicin hydrochloride, liposomal, doxil, 10 mg

01 Jan 2014

J9010

Injection, alemtuzumab, 10 mg

01 Jan 2016

J9031

Bcg (intravesical) per instillation

30 Jun 2019

J9037

Injection, belantamab mafodotin-blmf, 0.5 mg

31 Mar 2025

J9044

Injection, bortezomib, not otherwise specified, 0.1 mg

01 Jan 2023

J9058

Injection, bendamustine hydrochloride (apotex), 1 mg

01 Jan 2025

J9059

Injection, bendamustine hydrochloride (baxter), 1 mg

01 Jan 2025

J9062

Cisplatin, 50 mg

01 Jan 2011

J9070

Cyclophosphamide, 100 mg

01 Apr 2024

J9080

Cyclophosphamide, 200 mg

01 Jan 2011

J9090

Cyclophosphamide, 500 mg

01 Jan 2011

J9091

Cyclophosphamide, 1.0 gram

01 Jan 2011

J9092

Cyclophosphamide, 2.0 gram

01 Jan 2011

J9093

Cyclophosphamide, lyophilized, 100 mg

01 Jan 2011

J9094

Cyclophosphamide, lyophilized, 200 mg

01 Jan 2011

J9095

Cyclophosphamide, lyophilized, 500 mg

01 Jan 2011

J9096

Cyclophosphamide, lyophilized, 1.0 gram

01 Jan 2011

J9097

Cyclophosphamide, lyophilized, 2.0 gram

01 Jan 2011

J9110

Injection, cytarabine, 500 mg

01 Jan 2011

J9140

Dacarbazine, 200 mg

01 Jan 2011

J9160

Injection, denileukin diftitox, 300 micrograms

01 Jan 2024

J9162

Descriptor not available

01 Jan 1990

J9170

Injection

01 Jan 2010

J9180

Descriptor not available

01 Jan 2004

J9182

Etoposide

01 Jan 2009

J9199

Injection, gemcitabine hydrochloride (infugem), 200 mg

01 Jul 2020

J9220

Descriptor not available

01 Jan 1990

J9240

Descriptor not available

01 Jan 1994

J9247

Injection, melphalan flufenamide, 1mg

31 Mar 2025

J9250

Methotrexate sodium, 5 mg

01 Apr 2024

J9258

Injection, paclitaxel protein-bound particles (teva), not therapeutically equivalent to j9264, 1 mg

01 Oct 2024

J9259

Injection, paclitaxel protein-bound particles (american regent), not therapeutically equivalent to j9264, 1 mg

01 Jan 2025

J9265

Injection, paclitaxel, 30 mg

01 Jan 2015

J9290

Mitomycin, 20 mg

01 Jan 2011

J9291

Mitomycin, 40 mg

01 Jan 2011

J9300

Injection, gemtuzumab ozogamicin, 5 mg

01 Jan 2018

J9310

Injection, rituximab, 100 mg

01 Jan 2019

J9315

Injection, romidepsin, 1 mg

01 Oct 2021

J9371

Injection, vincristine sulfate liposome, 1 mg

01 Jul 2024

J9375

Vincristine sulfate, 2 mg

01 Jan 2011

JF

Compounded drug

01 Apr 2015

JG

Drug or biological acquired with 340b drug pricing program discount, reported for informational purposes

01 Jan 2025

K0016

Descriptor not available

01 Jan 2004

K0021

Descriptor not available

01 Jan 2003

K0022

Descriptor not available

01 Jan 2004

K0023

Solid back insert

01 Jan 2005

K0024

Solid back insert

01 Jan 2005

K0025

Descriptor not available

01 Jan 2004

K0026

Descriptor not available

01 Jan 2004

K0027

Descriptor not available

01 Jan 2004

K0028

Descriptor not available

01 Jan 2004

K0029

Descriptor not available

01 Jan 2004

K0030

Descriptor not available

01 Jan 2004

K0031

Descriptor not available

01 Jan 2004

K0032

Descriptor not available

01 Jan 2004

K0033

Descriptor not available

01 Jan 2004

K0034

Descriptor not available

01 Jan 2003

K0035

Descriptor not available

01 Jan 2004

K0036

Descriptor not available

01 Jan 2004

K0048

Descriptor not available

01 Jan 2004

K0049

Descriptor not available

01 Jan 2004

K0054

Descriptor not available

01 Jan 2004

K0055

Descriptor not available

01 Jan 2004

K0057

Descriptor not available

01 Jan 2004

K0058

Descriptor not available

01 Jan 2004

K0059

Plastic coated handrim

01 Jan 2005

K0060

Steel handrim

01 Jan 2005

K0061

Aluminum handrim

01 Jan 2005

K0062

Descriptor not available

01 Jan 2004

K0063

Descriptor not available

01 Jan 2004

K0064

Zero pressure tube (flat free inserts)

01 Jan 2006

K0066

Solid tire

01 Jan 2006

K0067

Pneumatic tire

01 Jan 2006

K0068

Pneumatic tire tube

01 Jan 2006

K0074

Pneumatic caster tire

01 Jan 2006

K0075

Semi-pneumatic caster tire

01 Jan 2006

K0076

Solid caster tire

01 Jan 2006

K0078

Pneumatic caster tire tube

01 Jan 2006

K0079

Descriptor not available

01 Jan 2004

K0080

Descriptor not available

01 Jan 2004

K0081

Wheel lock assembly

01 Jan 2005

K0082

Descriptor not available

01 Jan 2004

K0083

Descriptor not available

01 Jan 2004

K0084

Descriptor not available

01 Jan 2004

K0085

Descriptor not available

01 Jan 2004

K0086

Descriptor not available

01 Jan 2004

K0087

Descriptor not available

01 Jan 2004

K0088

Descriptor not available

01 Jan 2004

K0089

Descriptor not available

01 Jan 2004

K0090

Rear wheel tire for power wheelchair

01 Jan 2007

K0091

Rear wheel tire tube other than zero pressure for power wheelchair

01 Jan 2007

K0092

Rear wheel assembly for power wheelchair

01 Jan 2007

K0093

Rear wheel

01 Jan 2007

K0094

Wheel tire for power base

01 Jan 2007

K0095

Wheel tire tube other than zero pressure for each base

01 Jan 2007

K0096

Wheel assembly for power base

01 Jan 2007

K0097

Wheel zero pressure tire tube (flat free insert) for power base

01 Jan 2007

K0099

Front caster for power wheelchair

01 Jan 2007

K0100

Descriptor not available

01 Jan 2004

K0101

Descriptor not available

01 Jan 2003

K0102

Crutch and cane holder

01 Jan 2006

K0103

Descriptor not available

01 Jan 2004

K0104

Cylinder tank carrier

01 Jan 2006

K0106

Arm trough

01 Jan 2006

K0107

Descriptor not available

01 Jan 2004

K0109

Descriptor not available

01 Jan 2000

K0110

Descriptor not available

01 Jan 1997

K0111

Descriptor not available

01 Jan 1997

K0112

Descriptor not available

01 Jan 2004

K0113

Descriptor not available

01 Jan 2004

K0114

Back support system for use with a wheelchair

01 Jan 2005

K0115

Seating system

01 Jan 2005

K0116

Seating system

01 Jan 2005

K0117

Descriptor not available

01 Jan 1996

K0118

Descriptor not available

01 Jan 1996

K0119

Descriptor not available

01 Jan 2000

K0120

Descriptor not available

01 Jan 2000

K0121

Descriptor not available

01 Jan 1998

K0122

Descriptor not available

01 Jan 2000

K0123

Descriptor not available

01 Jan 2000

K0124

Descriptor not available

01 Jan 1997

K0125

Descriptor not available

01 Jan 1997

K0126

Descriptor not available

01 Jan 1997

K0127

Descriptor not available

01 Jan 1997

K0128

Descriptor not available

01 Jan 1997

K0129

Descriptor not available

01 Jan 1997

K0130

Descriptor not available

01 Jan 1997

K0131

Descriptor not available

01 Jan 1996

K0132

Descriptor not available

01 Jan 1996

K0133

Descriptor not available

01 Jan 1996

K0134

Descriptor not available

01 Jan 1996

K0135

Descriptor not available

01 Jan 1996

K0136

Descriptor not available

01 Jan 1996

K0137

Descriptor not available

01 Jan 2000

K0138

Descriptor not available

01 Jan 2000

K0139

Descriptor not available

01 Jan 2000

K0140

Descriptor not available

01 Jan 1998

K0141

Descriptor not available

01 Jan 1998

K0142

Descriptor not available

01 Jan 1998

K0143

Descriptor not available

01 Jan 1998

K0144

Descriptor not available

01 Jan 1998

K0145

Descriptor not available

01 Jan 1998

K0146

Descriptor not available

01 Jan 1998

K0147

Descriptor not available

01 Jan 1996

K0148

Descriptor not available

01 Jan 1995

K0149

Descriptor not available

01 Jan 1995

K0150

Descriptor not available

01 Jan 1995

K0151

Descriptor not available

01 Jan 1995

K0152

Descriptor not available

01 Jan 1997

K0153

Descriptor not available

01 Jan 1995

K0154

Descriptor not available

01 Jan 1997

K0162

Descriptor not available

01 Jan 1996

K0163

Descriptor not available

01 Jan 1997

K0164

Descriptor not available

01 Jan 1996

K0165

Descriptor not available

01 Jan 1996

K0166

Descriptor not available

01 Jan 1996

K0167

Descriptor not available

01 Jan 1996

K0168

Descriptor not available

01 Jan 2000

K0169

Descriptor not available

01 Jan 2000

K0170

Descriptor not available

01 Jan 2000

K0171

Descriptor not available

01 Jan 2000

K0172

Descriptor not available

01 Jan 2000

K0173

Descriptor not available

01 Jan 2000

K0174

Descriptor not available

01 Jan 2000

K0175

Descriptor not available

01 Jan 2000

K0176

Descriptor not available

01 Jan 2000

K0177

Descriptor not available

01 Jan 2000

K0178

Descriptor not available

01 Jan 2000

K0179

Descriptor not available

01 Jan 2000

K0180

Descriptor not available

01 Jan 2000

K0181

Descriptor not available

01 Jan 2000

K0182

Descriptor not available

01 Jan 2001

K0183

Descriptor not available

01 Jan 2003

K0184

Descriptor not available

01 Jan 2003

K0185

Descriptor not available

01 Jan 2003

K0186

Descriptor not available

01 Jan 2003

K0187

Descriptor not available

01 Jan 2003

K0188

Descriptor not available

01 Jan 2003

K0189

Descriptor not available

01 Jan 2003

K0190

Descriptor not available

01 Jan 2000

K0191

Descriptor not available

01 Jan 2000

K0192

Descriptor not available

01 Jan 2000

K0193

Descriptor not available

01 Jan 2000

K0194

Descriptor not available

01 Jan 2000

K0196

Descriptor not available

01 Jan 1997

K0197

Descriptor not available

01 Jan 1997

K0198

Descriptor not available

01 Jan 1997

K0199

Descriptor not available

01 Jan 1997

K0203

Descriptor not available

01 Jan 1997

K0204

Descriptor not available

01 Jan 1997

K0205

Descriptor not available

01 Jan 1997

K0206

Descriptor not available

01 Jan 1997

K0207

Descriptor not available

01 Jan 1997

K0208

Descriptor not available

01 Jan 1997

K0209

Descriptor not available

01 Jan 1997

K0210

Descriptor not available

01 Jan 1997

K0211

Descriptor not available

01 Jan 1997

K0212

Descriptor not available

01 Jan 1997

K0213

Descriptor not available

01 Jan 1997

K0214

Descriptor not available

01 Jan 1997

K0215

Descriptor not available

01 Jan 1997

K0216

Descriptor not available

01 Jan 1995

K0217

Descriptor not available

01 Jan 1995

K0218

Descriptor not available

01 Jan 1995

K0219

Descriptor not available

01 Jan 1997

K0220

Descriptor not available

01 Jan 1997

K0221

Descriptor not available

01 Jan 1997

K0222

Descriptor not available

01 Jan 1997

K0223

Descriptor not available

01 Jan 1997

K0224

Descriptor not available

01 Jan 1997

K0228

Descriptor not available

01 Jan 1997

K0229

Descriptor not available

01 Jan 1997

K0230

Descriptor not available

01 Jan 1997

K0234

Descriptor not available

01 Jan 1997

K0235

Descriptor not available

01 Jan 1997

K0236

Descriptor not available

01 Jan 1997

K0237

Descriptor not available

01 Jan 1997

K0238

Descriptor not available

01 Jan 1997

K0239

Descriptor not available

01 Jan 1997

K0240

Descriptor not available

01 Jan 1997

K0241

Descriptor not available

01 Jan 1997

K0242

Descriptor not available

01 Jan 1997

K0243

Descriptor not available

01 Jan 1997

K0244

Descriptor not available

01 Jan 1997

K0245

Descriptor not available

01 Jan 1997

K0246

Descriptor not available

01 Jan 1997

K0247

Descriptor not available

01 Jan 1997

K0248

Descriptor not available

01 Jan 1997

K0249

Descriptor not available

01 Jan 1997

K0250

Descriptor not available

01 Jan 1997

K0251

Descriptor not available

01 Jan 1997

K0252

Descriptor not available

01 Jan 1997

K0253

Descriptor not available

01 Jan 1997

K0254

Descriptor not available

01 Jan 1997

K0255

Descriptor not available

01 Jan 1997

K0256

Descriptor not available

01 Jan 1997

K0257

Descriptor not available

01 Jan 1997

K0258

Descriptor not available

01 Jan 1997

K0259

Descriptor not available

01 Jan 1997

K0260

Descriptor not available

01 Jan 1997

K0261

Descriptor not available

01 Jan 1997

K0262

Descriptor not available

01 Jan 1997

K0263

Descriptor not available

01 Jan 1995

K0264

Descriptor not available

01 Jan 1995

K0265

Descriptor not available

01 Jan 1997

K0266

Descriptor not available

01 Jan 1997

K0267

Descriptor not available

01 Jan 1996

K0268

Descriptor not available

01 Jan 2004

K0269

Descriptor not available

01 Jan 2001

K0270

Descriptor not available

01 Jan 2001

K0271

Descriptor not available

01 Jan 1997

K0272

Descriptor not available

01 Jan 1997

K0273

Descriptor not available

01 Jan 1997

K0274

Descriptor not available

01 Jan 1997

K0275

Descriptor not available

01 Jan 1997

K0276

Descriptor not available

01 Jan 1997

K0277

Descriptor not available

01 Jan 2000

K0278

Descriptor not available

01 Jan 2000

K0279

Descriptor not available

01 Jan 2000

K0280

Descriptor not available

01 Jan 2001

K0281

Descriptor not available

01 Jan 2001

K0282

Descriptor not available

01 Jan 1995

K0283

Descriptor not available

01 Jan 2001

K0284

Descriptor not available

01 Jan 2000

K0285

Descriptor not available

01 Jan 1997

K0400

Descriptor not available

01 Jan 2000

K0401

Descriptor not available

01 Jan 2000

K0402

Descriptor not available

01 Jan 1997

K0403

Descriptor not available

01 Jan 1997

K0404

Descriptor not available

01 Jan 1997

K0405

Descriptor not available

01 Jan 1997

K0406

Descriptor not available

01 Jan 1997

K0407

Descriptor not available

01 Jan 2001

K0408

Descriptor not available

01 Jan 2001

K0409

Descriptor not available

01 Jan 2001

K0410

Descriptor not available

01 Jan 2001

K0411

Descriptor not available

01 Jan 2001

K0412

Descriptor not available

01 Jan 2000

K0413

Descriptor not available

01 Jan 1996

K0414

Descriptor not available

01 Jan 1998

K0415

Prescription antiemetic drug

01 Jan 2006

K0416

Prescription antiemetic drug

01 Jan 2006

K0417

Descriptor not available

01 Jan 2000

K0418

Descriptor not available

01 Jan 2000

K0419

Descriptor not available

01 Jan 2000

K0420

Descriptor not available

01 Jan 2000

K0421

Descriptor not available

01 Jan 2000

K0422

Descriptor not available

01 Jan 2000

K0423

Descriptor not available

01 Jan 2000

K0424

Descriptor not available

01 Jan 2000

K0425

Descriptor not available

01 Jan 2000

K0426

Descriptor not available

01 Jan 2000

K0427

Descriptor not available

01 Jan 2000

K0428

Descriptor not available

01 Jan 2000

K0429

Descriptor not available

01 Jan 2000

K0430

Descriptor not available

01 Jan 2000

K0431

Descriptor not available

01 Jan 2000

K0432

Descriptor not available

01 Jan 2000

K0433

Descriptor not available

01 Jan 2000

K0434

Descriptor not available

01 Jan 2000

K0435

Descriptor not available

01 Jan 2000

K0436

Descriptor not available

01 Jan 2000

K0437

Descriptor not available

01 Jan 2000

K0438

Descriptor not available

01 Jan 2000

K0439

Descriptor not available

01 Jan 2000

K0440

Descriptor not available

01 Jan 2001

K0441

Descriptor not available

01 Jan 2001

K0442

Descriptor not available

01 Jan 2001

K0443

Descriptor not available

01 Jan 2001

K0444

Descriptor not available

01 Jan 2001

K0445

Descriptor not available

01 Jan 2001

K0446

Descriptor not available

01 Jan 2001

K0447

Descriptor not available

01 Jan 2001

K0448

Descriptor not available

01 Jan 2001

K0449

Descriptor not available

01 Jan 2001

K0450

Descriptor not available

01 Jan 2001

K0451

Descriptor not available

01 Jan 2001

K0452

Wheelchair bearings

01 Jan 2006

K0453

Descriptor not available

01 Jan 1999

K0454

Descriptor not available

01 Jan 1998

K0456

Descriptor not available

01 Jan 2001

K0457

Descriptor not available

01 Jan 2001

K0458

Descriptor not available

01 Jan 2001

K0459

Descriptor not available

01 Jan 2001

K0460

Descriptor not available

01 Jan 2004

K0461

Descriptor not available

01 Jan 2004

K0501

Descriptor not available

01 Jan 2001

K0503

Descriptor not available

01 Jan 2000

K0504

Descriptor not available

01 Jan 2000

K0505

Descriptor not available

01 Jan 2000

K0506

Descriptor not available

01 Jan 2000

K0507

Descriptor not available

01 Jan 2000

K0508

Descriptor not available

01 Jan 2000

K0509

Descriptor not available

01 Jan 2000

K0511

Descriptor not available

01 Jan 2000

K0512

Descriptor not available

01 Jan 2000

K0513

Descriptor not available

01 Jan 2000

K0514

Descriptor not available

01 Jan 2000

K0515

Descriptor not available

01 Jan 2000

K0516

Descriptor not available

01 Jan 2000

K0518

Descriptor not available

01 Jan 2000

K0519

Descriptor not available

01 Jan 2000

K0520

Descriptor not available

01 Jan 2000

K0521

Descriptor not available

01 Jan 2000

K0522

Descriptor not available

01 Jan 2000

K0523

Descriptor not available

01 Jan 2000

K0524

Descriptor not available

01 Jan 2000

K0525

Descriptor not available

01 Jan 2000

K0526

Descriptor not available

01 Jan 2000

K0527

Descriptor not available

01 Jan 2000

K0528

Descriptor not available

01 Jan 2000

K0529

Descriptor not available

01 Jan 2001

K0530

Descriptor not available

01 Jan 2000

K0531

Descriptor not available

01 Jan 2004

K0532

Descriptor not available

01 Jan 2004

K0533

Descriptor not available

01 Jan 2004

K0534

Descriptor not available

01 Jan 2004

K0535

Descriptor not available

01 Jan 2004

K0536

Descriptor not available

01 Jan 2004

K0537

Descriptor not available

01 Jan 2004

K0538

Descriptor not available

01 Jan 2004

K0539

Descriptor not available

01 Jan 2004

K0540

Descriptor not available

01 Jan 2004

K0541

Descriptor not available

01 Jan 2004

K0542

Descriptor not available

01 Jan 2003

K0543

Descriptor not available

01 Jan 2004

K0544

Descriptor not available

01 Jan 2004

K0545

Descriptor not available

01 Jan 2004

K0546

Descriptor not available

01 Jan 2004

K0547

Descriptor not available

01 Jan 2004

K0548

Descriptor not available

01 Jan 2003

K0549

Descriptor not available

01 Jan 2004

K0550

Descriptor not available

01 Jan 2004

K0551

Descriptor not available

01 Jan 2003

K0553

Supply allowance for therapeutic continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service

01 Jan 2023

K0554

Receiver (monitor), dedicated, for use with therapeutic glucose continuous monitor system

01 Jan 2023

K0555

Nasal pillows for combination oral/nasal mask

01 Jan 2008

K0556

Descriptor not available

01 Jan 2004

K0557

Descriptor not available

01 Jan 2004

K0558

Descriptor not available

01 Jan 2004

K0559

Descriptor not available

01 Jan 2004

K0560

Descriptor not available

01 Jan 2004

K0561

Descriptor not available

01 Jan 2003

K0562

Descriptor not available

01 Jan 2003

K0563

Descriptor not available

01 Jan 2003

K0564

Descriptor not available

01 Jan 2003

K0565

Descriptor not available

01 Jan 2003

K0566

Descriptor not available

01 Jan 2003

K0567

Descriptor not available

01 Jan 2003

K0568

Descriptor not available

01 Jan 2003

K0569

Descriptor not available

01 Jan 2003

K0570

Descriptor not available

01 Jan 2003

K0571

Descriptor not available

01 Jan 2003

K0572

Descriptor not available

01 Jan 2003

K0573

Descriptor not available

01 Jan 2003

K0574

Descriptor not available

01 Jan 2003

K0575

Descriptor not available

01 Jan 2003

K0576

Descriptor not available

01 Jan 2003

K0577

Descriptor not available

01 Jan 2003

K0578

Descriptor not available

01 Jan 2003

K0579

Descriptor not available

01 Jan 2003

K0580

Descriptor not available

01 Jan 2003

K0581

Descriptor not available

01 Jan 2004

K0582

Descriptor not available

01 Jan 2004

K0583

Descriptor not available

01 Jan 2004

K0584

Descriptor not available

01 Jan 2004

K0585

Descriptor not available

01 Jan 2004

K0586

Descriptor not available

01 Jan 2004

K0587

Descriptor not available

01 Jan 2004

K0588

Descriptor not available

01 Jan 2004

K0589

Descriptor not available

01 Jan 2004

K0590

Descriptor not available

01 Jan 2004

K0591

Descriptor not available

01 Jan 2004

K0592

Descriptor not available

01 Jan 2004

K0593

Descriptor not available

01 Jan 2004

K0594

Descriptor not available

01 Jan 2004

K0595

Descriptor not available

01 Jan 2004

K0596

Descriptor not available

01 Jan 2004

K0597

Descriptor not available

01 Jan 2004

K0600

Functional neuromuscular stimulator

01 Jan 2006

K0610

Descriptor not available

01 Jan 2004

K0611

Descriptor not available

01 Jan 2004

K0612

Descriptor not available

01 Jan 2004

K0613

Descriptor not available

01 Jan 2004

K0614

Descriptor not available

01 Jan 2004

K0615

Descriptor not available

01 Jan 2004

K0616

Descriptor not available

01 Jan 2004

K0617

Descriptor not available

01 Jan 2004

K0618

Tlso

01 Jan 2006

K0619

Tlso

01 Jan 2006

K0620

Tubular elastic dressing

01 Jan 2006

K0621

Descriptor not available

01 Jan 2004

K0622

Descriptor not available

01 Jan 2005

K0623

Descriptor not available

01 Jan 2005

K0624

Descriptor not available

01 Jan 2004

K0625

Descriptor not available

01 Jan 2004

K0626

Descriptor not available

01 Jan 2004

K0627

Traction equipment

01 Jan 2005

K0628

Descriptor not available

01 Jan 2006

K0629

Descriptor not available

01 Jan 2006

K0630

Sacroiliac orthosis

01 Jan 2006

K0631

Sacroiliac orthosis

01 Jan 2006

K0632

Sacroiliac orthosis

01 Jan 2006

K0633

Sacroiliac orthosis

01 Jan 2006

K0634

Lumbar orthosis

01 Jan 2006

K0635

Lumbar orthosis

01 Jan 2006

K0636

Lumbar orthosis

01 Jan 2006

K0637

Lumbar-sacral orthosis

01 Jan 2006

K0638

Lumbar-sacral orthosis

01 Jan 2006

K0639

Lumbar-sacral orthosis

01 Jan 2006

K0640

Lumbar-sacral orthosis

01 Jan 2006

K0641

Lumbar-sacral orthosis

01 Jan 2006

K0642

Lumbar-sacral orthosis

01 Jan 2006

K0643

Lumbar-sacral orthosis

01 Jan 2006

K0644

Lumbar-sacral orthosis

01 Jan 2006

K0645

Lumbar sacral orthosis

01 Jan 2006

K0646

Lumbar-sacral orthosis

01 Jan 2006

K0647

Lumbar-sacral orthosis

01 Jan 2006

K0648

Lumbar-sacral orthosis

01 Jan 2006

K0649

Lumbar-sacral orthosis

01 Jan 2006

K0650

General use wheelchair seat cushion

01 Jan 2005

K0651

General use wheelchair seat cushion

01 Jan 2005

K0652

Skin protection wheelchair seat cushion

01 Jan 2005

K0653

Skin protection wheelchair seat cushion

01 Jan 2005

K0654

Positioning wheelchair seat cushion

01 Jan 2005

K0655

Positioning wheelchair seat cushion

01 Jan 2005

K0656

Skin protection and positioning wheelchair seat cushion

01 Jan 2005

K0657

Skin protection and positioning wheelchair seat cushion

01 Jan 2005

K0658

Custom fabricated wheelchair seat cushion

01 Jan 2005

K0659

Wheelchair seat cushion

01 Jan 2005

K0660

General use wheelchair back cushion

01 Jan 2005

K0661

General use wheelchair back cushion

01 Jan 2005

K0662

Positioning wheelchair back cushion

01 Jan 2005

K0663

Positioning wheelchair back cushion

01 Jan 2005

K0664

Positioning wheelchair back cushion

01 Jan 2005

K0665

Positioning wheelchair back cushion

01 Jan 2005

K0666

Custom fabricated wheelchair back cushion

01 Jan 2005

K0667

Mounting hardware

01 Jan 2005

K0668

Replacement cover for wheelchair seat cushion or back cushion

01 Jan 2005

K0670

Addition to lower extremity prosthesis

01 Jan 2006

K0671

Portable oxygen concentrator

01 Jan 2006

K0731

Lithium ion battery for use with cochlear implant device speech processor

01 Jan 2006

K0732

Lithium ion battery for use with cochlear implant device speech processor

01 Jan 2006

K0734

Skin protection wheelchair seat cushion, adjustable, width less than 22 inches, any depth

01 Jan 2011

K0735

Skin protection wheelchair seat cushion, adjustable, width 22 inches or ,greater, any depth

01 Jan 2011

K0736

Skin protection and positioning wheelchair seat cushion, adjustable, width less ,than 22 inches, any depth

01 Jan 2011

K0737

Skin protection and positioning wheelchair seat cushion, adjustable, width 22 ,inches or greater, any depth

01 Jan 2011

K0741

Portable gaseous oxygen system, rental, includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing, for cluster headaches

01 Jan 2013

K0742

Portable oxygen contents, gaseous, 1 month's supply = 1 unit, for cluster headaches, for initial months supply or to replace used contents

01 Jan 2013

K0901

Knee orthosis (ko), single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelf

01 Jan 2017

K0902

Knee orthosis (ko), double upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelf

01 Jan 2017

K0903

For diabetics only, multiple density insert, made by direct carving with cam technology from a rectified cad model created from a digitized scan of the patient, total contact with patient's foot, including arch, base layer minimum of 3/16 inch material of shore a 35 durometer (or higher), includes arch filler and other shaping material, custom fabricated, each

01 Jan 2019

K1001

Electronic positional obstructive sleep apnea treatment, with sensor, includes all components and accessories, any type

01 Jan 2024

K1002

Cranial electrotherapy stimulation (ces) system, any type

01 Jan 2024

K1003

Whirlpool tub, walk-in, portable

01 Jan 2024

K1005

Disposable collection and storage bag for breast milk, any size, any type, each

01 Jan 2024

K1006

Suction pump, home model, portable or stationary, electric, any type, for use with external urine management system

01 Jan 2024

K1009

Speech volume modulation system, any type, including all components and accessories

01 Jan 2024

K1010

Indwelling intraurethral drainage device with valve, patient inserted, replacement only, each

01 Apr 2021

K1011

Activation device for intraurethral drainage device with valve, replacement only, each

01 Apr 2021

K1012

Charger and base station for intraurethral activation device, replacement only

01 Apr 2021

K1013

Enema tube, with or without adapter, any type, replacement only, each

01 Jan 2024

K1014

Addition, endoskeletal knee-shin system, 4 bar linkage or multiaxial, fluid swing and stance phase control

01 Jan 2024

K1015

Foot, adductus positioning device, adjustable

01 Jan 2024

K1016

Transcutaneous electrical nerve stimulator for electrical stimulation of the trigeminal nerve

01 Jan 2024

K1017

Monthly supplies for use of device coded at k1016

01 Jan 2024

K1018

External upper limb tremor stimulator of the peripheral nerves of the wrist

01 Jan 2024

K1019

Supplies and accessories for external upper limb tremor stimulator of the peripheral nerves of the wrist

01 Jan 2024

K1020

Non-invasive vagus nerve stimulator

01 Jan 2024

K1021

Exsufflation belt, includes all supplies and accessories

01 Jan 2024

K1022

Addition to lower extremity prosthesis, endoskeletal, knee disarticulation, above knee, hip disarticulation, positional rotation unit, any type

01 Jan 2024

K1023

Distal transcutaneous electrical nerve stimulator, stimulates peripheral nerves of the upper arm

01 Jan 2024

K1024

Non-pneumatic compression controller with sequential calibrated gradient pressure

01 Jan 2024

K1025

Non-pneumatic sequential compression garment, full arm

01 Jan 2024

K1026

Mechanical allergen particle barrier/inhalation filter, cream, nasal, topical

01 Jan 2024

K1028

Power source and control electronics unit for oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, controlled by phone application

01 Jan 2024

K1029

Oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, used in conjunction with the power source and control electronics unit, controlled by phone application, 90-day supply

01 Jan 2024

K1031

Non-pneumatic compression controller without calibrated gradient pressure

01 Jan 2024

K1032

Non-pneumatic sequential compression garment, full leg

01 Jan 2024

K1033

Non-pneumatic sequential compression garment, half leg

01 Jan 2024

L0100

Cranial orthosis (helmet)

01 Jan 2007

L0110

Cranial orthosis (helmet)

01 Jan 2007

L0210

Thoracic

01 Jan 2010

L0300

Descriptor not available

01 Jan 2003

L0310

Descriptor not available

01 Jan 2003

L0315

Descriptor not available

01 Jan 2003

L0317

Descriptor not available

01 Jan 2003

L0320

Descriptor not available

01 Jan 2003

L0321

Descriptor not available

01 Jan 2003

L0330

Descriptor not available

01 Jan 2003

L0331

Descriptor not available

01 Jan 2003

L0340

Descriptor not available

01 Jan 2003

L0350

Descriptor not available

01 Jan 2003

L0360

Descriptor not available

01 Jan 2003

L0370

Descriptor not available

01 Jan 2003

L0380

Descriptor not available

01 Jan 2003

L0390

Descriptor not available

01 Jan 2003

L0391

Descriptor not available

01 Jan 2003

L0400

Descriptor not available

01 Jan 2003

L0410

Descriptor not available

01 Jan 2003

L0420

Descriptor not available

01 Jan 2003

L0430

Spinal orthosis, anterior-posterior-lateral control, with interface material, custom fitted (dewall posture protector only)

01 Jan 2014

L0440

Descriptor not available

01 Jan 2003

L0474

Descriptor not available

01 Feb 2003

L0476

Tlso

01 Jan 2005

L0478

Tlso

01 Jan 2005

L0500

Lumbar-sacral-orthosis (lso)

01 Jan 2005

L0510

Lso

01 Jan 2005

L0515

Lso

01 Jan 2005

L0520

Lso

01 Jan 2005

L0530

Lso

01 Jan 2005

L0540

Lso

01 Jan 2005

L0550

Lso

01 Jan 2005

L0560

Lso

01 Jan 2005

L0561

Lso

01 Jan 2005

L0565

Lso

01 Jan 2005

L0600

Sacroiliac

01 Jan 2005

L0610

Sacroiliac

01 Jan 2005

L0620

Sacroiliac

01 Jan 2005

L0800

Descriptor not available

01 Jan 1990

L0860

Addition to halo procedures

01 Jan 2006

L0900

Descriptor not available

01 Jan 2003

L0910

Descriptor not available

01 Jan 2003

L0920

Descriptor not available

01 Jan 2003

L0930

Descriptor not available

01 Jan 2003

L0940

Descriptor not available

01 Jan 2003

L0950

Descriptor not available

01 Jan 2003

L0960

Torso support

01 Jan 2008

L0986

Descriptor not available

01 Jan 2003

L1

Provider attestation that the hospital laboratory test(s) is not packaged under the hospital opps

01 Jan 2017

L1500

Thoracic-hip-knee-ankle orthosis (thkao), mobility frame (newington, parapodium types)

01 Jan 2012

L1510

Thkao, standing frame, with or without tray and accessories

01 Jan 2012

L1520

Thkao, swivel walker

01 Jan 2012

L1670

Descriptor not available

01 Jan 1990

L1740

Descriptor not available

01 Jan 1990

L1750

Legg perthes orthosis

01 Jan 2006

L1800

Knee orthosis

01 Jan 2010

L1815

Knee orthosis

01 Jan 2010

L1825

Descriptor not available

01 Jan 2010

L1855

Knee orthosis

01 Jan 2008

L1858

Knee orthosis

01 Jan 2008

L1870

Knee orthosis

01 Jan 2008

L1880

Knee orthosis

01 Jan 2008

L1885

Descriptor not available

01 Jan 2004

L1901

Ankle orthosis

01 Jan 2010

L2039

Knee ankle foot orthosis

01 Jan 2006

L2100

Descriptor not available

01 Jan 1990

L2102

Descriptor not available

01 Jan 2004

L2104

Descriptor not available

01 Jan 2004

L2110

Descriptor not available

01 Jan 1990

L2120

Descriptor not available

01 Jan 1990

L2122

Descriptor not available

01 Jan 2004

L2124

Descriptor not available

01 Jan 2004

L2130

Descriptor not available

01 Jan 1990

L2140

Descriptor not available

01 Jan 1990

L2150

Descriptor not available

01 Jan 1990

L2160

Descriptor not available

01 Jan 1990

L2400

Descriptor not available

01 Jan 1990

L2410

Descriptor not available

01 Jan 1990

L2420

Descriptor not available

01 Jan 1990

L2435

Addition to knee joint

01 Jan 2005

L2440

Descriptor not available

01 Jan 1990

L2450

Descriptor not available

01 Jan 1990

L2460

Descriptor not available

01 Jan 1990

L2470

Descriptor not available

01 Jan 1990

L2475

Descriptor not available

01 Jan 1990

L2480

Descriptor not available

01 Jan 1990

L2490

Descriptor not available

01 Jan 1990

L2495

Descriptor not available

01 Jan 1990

L2560

Descriptor not available

01 Jan 1990

L2626

Descriptor not available

01 Jan 1990

L2770

Addition to lower extremity orthosis

01 Jan 2010

L2860

Addition to lower extremity joint

01 Jan 2009

L3218

Descriptor not available

01 Jan 2003

L3223

Descriptor not available

01 Jan 2003

L3651

Shoulder orthosis

01 Jan 2010

L3652

Shoulder orthosis

01 Jan 2010

L3672

Shoulder orthosis, abduction positioning (airplane design), thoracic component ,and support bar, without joints, may inlcude soft interface, straps, custom ,fabricated, includes fitting and adjustment

01 Jan 2011

L3673

Shoulder orthosis, abduction positioning (airplane design), thoracic component ,and support bar, includes nontorsion joint/turnbuckle, may include soft ,interface, straps, custom fabricated, includes fitting and adjustment

01 Jan 2011

L3700

Elbow orthosis

01 Jan 2010

L3701

Elbow orthosis

01 Jan 2010

L3800

Wrist hand finger orthosis

01 Jan 2008

L3805

Wrist hand finger orthosis

01 Jan 2008

L3810

Descriptor not available

01 Jan 2008

L3815

Whfo

01 Jan 2008

L3820

Whfo

01 Jan 2008

L3825

Whfo

01 Jan 2008

L3830

Whfo

01 Jan 2008

L3835

Whfo

01 Jan 2008

L3840

Whfo

01 Jan 2008

L3845

Whfo

01 Jan 2008

L3850

Who

01 Jan 2008

L3855

Whfo

01 Jan 2008

L3860

Whfo

01 Jan 2008

L3890

Addition to upper extremity joint

01 Jan 2009

L3902

Wrist hand finger orthosis

01 Jan 2007

L3907

Wrist hand finger orthosis

01 Jan 2008

L3909

Wrist orthosis

01 Jan 2010

L3910

Wrist hand finger orthosis

01 Jan 2008

L3911

Wrist hand finger orthosis

01 Jan 2010

L3914

Wrist hand orthosis

01 Jan 2007

L3920

Hand finger orthosis

01 Jan 2008

L3922

Hand finger orthosis

01 Jan 2008

L3926

Wrist hand finger orthosis

01 Jan 2008

L3928

Hand finger orthosis

01 Jan 2008

L3932

Finger orthosis

01 Jan 2008

L3934

Finger orthosis

01 Jan 2008

L3936

Wrist hand finger orthosis

01 Jan 2008

L3938

Wrist hand finger orthosis

01 Jan 2008

L3940

Wrist hand finger orthosis

01 Jan 2008

L3942

Hand finger orthosis

01 Jan 2008

L3944

Hand finger orthosis

01 Jan 2008

L3946

Hand finger orthosis

01 Jan 2008

L3948

Finger orthosis

01 Jan 2008

L3950

Wrist hand finger orthosis

01 Jan 2008

L3952

Wrist hand finger orthosis

01 Jan 2008

L3954

Hand finger orthosis

01 Jan 2008

L3963

Shoulder elbow wrist hand orthosis

01 Jan 2006

L3964

Shoulder elbow orthosis, mobile arm support attached to wheelchair, balanced, adjustable, prefabricated, includes fitting and adjustment

01 Jan 2012

L3965

Shoulder elbow orthosis, mobile arm support attached to wheelchair, balanced, adjustable rancho type, prefabricated, includes fitting and adjustment

01 Jan 2012

L3966

Shoulder elbow orthosis, mobile arm support attached to wheelchair, balanced, reclining, prefabricated, includes fitting and adjustment

01 Jan 2012

L3968

Shoulder elbow orthosis, mobile arm support attached to wheelchair, balanced, friction arm support (friction dampening to proximal and distal joints), prefabricated, includes fitting and adjustment

01 Jan 2012

L3969

Shoulder elbow orthosis, mobile arm support, monosuspension arm and hand support, overhead elbow forearm hand sling support, yoke type suspension support, prefabricated, includes fitting and adjustment

01 Jan 2012

L3970

Seo, addition to mobile arm support, elevating proximal arm

01 Jan 2012

L3972

Seo, addition to mobile arm support, offset or lateral rocker arm with elastic balance control

01 Jan 2012

L3974

Seo, addition to mobile arm support, supinator

01 Jan 2012

L3985

Upper extremity fracture orthosis

01 Jan 2008

L3986

Descriptor not available

01 Jan 2008

L4200

Descriptor not available

01 Jan 1997

L4310

Descriptor not available

01 Jan 1999

L4320

Descriptor not available

01 Jan 1999

L4380

Pneumatic knee splint, prefabricated, includes fitting and adjustment

01 Jan 2012

L4390

Descriptor not available

01 Jan 1999

L5110

Descriptor not available

01 Jan 1990

L5300

Descriptor not available

01 Jan 2002

L5310

Descriptor not available

01 Jan 2002

L5311

Knee disarticulation (or through knee), molded socket, external knee joints, shin, sach foot, endoskeletal system

01 Jan 2012

L5320

Descriptor not available

01 Jan 2002

L5330

Descriptor not available

01 Jan 2002

L5340

Descriptor not available

01 Jan 2002

L5612

Descriptor not available

01 Jan 1990

L5660

Descriptor not available

01 Jan 2003

L5662

Descriptor not available

01 Jan 2003

L5663

Descriptor not available

01 Jan 2003

L5664

Descriptor not available

01 Jan 2003

L5667

Descriptor not available

01 Jan 2002

L5669

Descriptor not available

01 Jan 2002

L5674

Addition to lower extremity

01 Jan 2005

L5675

Addition to lower extremity

01 Jan 2005

L5708

Descriptor not available

01 Jan 1990

L5709

Descriptor not available

01 Jan 1990

L5846

Addition

01 Jan 2005

L5847

Addition

01 Jan 2005

L5989

Addition to lower extremity prosthesis

01 Jan 2005

L5993

Addition to lower extremity prosthesis

01 Jan 2009

L5994

Addition to lower extremity prosthesis

01 Jan 2009

L5995

Addition to lower extremity prosthesis

01 Jan 2009

L6025

Transcarpal/metacarpal or partial hand disarticulation prosthesis, external power, self-suspended, inner socket with removable forearm section, electrodes and cables, two batteries, charger, myoelectric control of terminal device

01 Jan 2015

L6589

Descriptor not available

01 Jan 1994

L6639

Upper extremity addition

01 Jan 2010

L6705

Terminal device

01 Jan 2007

L6710

Terminal device

01 Jan 2007

L6715-1

Terminal device

01 Jan 2007

L6720

Terminal device

01 Jan 2007

L6725

Terminal device

01 Jan 2007

L6730

Terminal device

01 Jan 2007

L6735

Terminal device

01 Jan 2007

L6740

Terminal device

01 Jan 2007

L6745

Terminal device

01 Jan 2007

L6750

Terminal device

01 Jan 2007

L6755

Terminal device

01 Jan 2007

L6760

Descriptor not available

01 Jan 1990

L6765

Terminal device

01 Jan 2007

L6770

Terminal device

01 Jan 2007

L6775

Terminal device

01 Jan 2007

L6780

Terminal device

01 Jan 2007

L6785

Descriptor not available

01 Jan 1990

L6790

Terminal device

01 Jan 2007

L6795

Terminal device

01 Jan 2007

L6800

Terminal device

01 Jan 2007

L6806

Terminal device

01 Jan 2007

L6807

Terminal device

01 Jan 2007

L6808

Terminal device

01 Jan 2007

L6809

Terminal device

01 Jan 2007

L6825

Terminal device

01 Jan 2007

L6830

Terminal device

01 Jan 2007

L6835

Terminal device

01 Jan 2007

L6840

Terminal device

01 Jan 2007

L6845

Terminal device

01 Jan 2007

L6850

Terminal device

01 Jan 2007

L6855

Terminal device

01 Jan 2007

L6860

Terminal device

01 Jan 2007

L6865

Terminal device

01 Jan 2007

L6867

Terminal device

01 Jan 2007

L6868

Terminal device

01 Jan 2007

L6869

Descriptor not available

01 Jan 1990

L6870

Terminal device

01 Jan 2007

L6872

Terminal device

01 Jan 2007

L6873

Terminal device

01 Jan 2007

L6875

Terminal device

01 Jan 2007

L6880-1

Terminal device

01 Jan 2007

L7000

Descriptor not available

01 Jan 1990

L7010

Electronic hand

01 Jan 2007

L7015

Electronic hand

01 Jan 2007

L7020

Electronic greifer

01 Jan 2007

L7025

Electronic hand

01 Jan 2007

L7030

Electronic hand

01 Jan 2007

L7035

Electronic greifer

01 Jan 2007

L7050

Descriptor not available

01 Jan 1990

L7100

Descriptor not available

01 Jan 1990

L7150

Descriptor not available

01 Jan 1990

L7160

Descriptor not available

01 Jan 1997

L7165

Descriptor not available

01 Jan 1997

L7200

Descriptor not available

01 Jan 1990

L7250

Descriptor not available

01 Jan 1990

L7260

Electronic wrist rotator, otto bock or equal

01 Jan 2015

L7261

Electronic wrist rotator, for utah arm

01 Jan 2015

L7266

Servo control, steeper or equal

01 Jan 2012

L7272

Analogue control, unb or equal

01 Jan 2012

L7274

Proportional control, 6-12 volt, liberty, utah or equal

01 Jan 2012

L7300

Descriptor not available

01 Jan 1990

L7350

Descriptor not available

01 Jan 1990

L7500

Repair of prosthetic device, hourly rate (excludes v5335 repair of oral or laryngeal prosthesis or artificial larynx)

01 Jan 2012

L7611

Terminal device

01 Jan 2009

L7612

Terminal device

01 Jan 2009

L7613

Terminal device

01 Jan 2009

L7614

Terminal device

01 Jan 2009

L7621

Terminal device

01 Jan 2009

L7622

Terminal device

01 Jan 2009

L8010

Breast prosthesis, mastectomy sleeve

31 Mar 2025

L8100

Gradient compression stocking

01 Jan 2006

L8110

Gradient compression stocking

01 Jan 2006

L8120

Gradient compression stocking

01 Jan 2006

L8130

Gradient compression stocking

01 Jan 2006

L8140

Gradient compression stocking

01 Jan 2006

L8150

Gradient compression stocking

01 Jan 2006

L8160

Gradient compression stocking

01 Jan 2006

L8170

Gradient compression stocking

01 Jan 2006

L8180

Gradient compression stocking

01 Jan 2006

L8190

Gradient compression stocking

01 Jan 2006

L8195

Gradient compression stocking

01 Jan 2006

L8200

Gradient compression stocking

01 Jan 2006

L8210

Gradient compression stocking

01 Jan 2006

L8220

Gradient compression stocking

01 Jan 2006

L8230

Gradient compression stocking

01 Jan 2006

L8239

Gradient compression stocking

01 Jan 2006

L8490

Addition to prosthetic sheath/sock

01 Jan 2005

L8611

Descriptor not available

01 Jan 1993

L8620

Lithium ion battery for use with cochlear implant device

01 Jan 2006

L8626

Descriptor not available

01 Jan 1993

L8640

Descriptor not available

01 Jan 1993

L8655

Descriptor not available

01 Jan 1993

L8656

Descriptor not available

01 Jan 1993

L8657

Descriptor not available

01 Jan 1993

L9999

Descriptor not available

01 Jan 1997

M0003

Optimal care for patients with episodic neurological conditions mips value pathways

01 Jan 2025

M0006

Descriptor not available

01 Jan 1998

M0007

Descriptor not available

01 Jan 1993

M0008

Descriptor not available

01 Jan 1998

M0009

Descriptor not available

01 Jan 1990

M0019

Descriptor not available

01 Jan 1990

M0021

Descriptor not available

01 Jan 1990

M0022

Descriptor not available

01 Jan 1990

M0023

Descriptor not available

01 Jan 1990

M0024

Descriptor not available

01 Jan 1990

M0029

Descriptor not available

01 Jan 1990

M0039

Descriptor not available

01 Jan 1990

M0049

Descriptor not available

01 Jan 1990

M0050

Descriptor not available

01 Jan 1990

M0051

Descriptor not available

01 Jan 1990

M0052

Descriptor not available

01 Jan 1990

M0053

Descriptor not available

01 Jan 1990

M0054

Descriptor not available

01 Jan 1990

M0059

Descriptor not available

01 Jan 1990

M0064

Brief office visit for the sole purpose of monitoring or changing drug prescriptions used in the treatment of mental psychoneurotic and personality disorders

01 Jan 2015

M0070

Descriptor not available

01 Jan 1990

M0071

Descriptor not available

01 Jan 1990

M0072

Descriptor not available

01 Jan 1990

M0080

Descriptor not available

01 Jan 1990

M0101

Descriptor not available

01 Jan 1999

M0220

Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring

12 Dec 2024

M0221

Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency

12 Dec 2024

M0222

Intravenous injection, bebtelovimab, includes injection and post administration monitoring

12 Dec 2024

M0223

Intravenous injection, bebtelovimab, includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency

12 Dec 2024

M0239

Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring

16 Apr 2021

M0240

Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring, subsequent repeat doses

12 Dec 2024

M0241

Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency, subsequent repeat doses

12 Dec 2024

M0243

Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring

12 Dec 2024

M0244

Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency

12 Dec 2024

M0245

Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring

13 Dec 2023

M0246

Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider based to the hospital during the covid 19 public health emergency

13 Dec 2023

M0247

Intravenous infusion, sotrovimab, includes infusion and post administration monitoring

12 Dec 2024

M0260

Descriptor not available

01 Jan 1990

M0261

Descriptor not available

01 Jan 1990

M0299

Descriptor not available

01 Jan 1990

M0302

Descriptor not available

01 Jan 2002

M0399

Descriptor not available

01 Jan 1990

M0520

Descriptor not available

01 Jan 1990

M0525

Descriptor not available

01 Jan 1990

M0526

Descriptor not available

01 Jan 1990

M0530

Descriptor not available

01 Jan 1990

M0535

Descriptor not available

01 Jan 1990

M0540

Descriptor not available

01 Jan 1990

M0560

Descriptor not available

01 Jan 1990

M0575

Descriptor not available

01 Jan 1990

M0580

Descriptor not available

01 Jan 1990

M0585

Descriptor not available

01 Jan 1990

M0590

Descriptor not available

01 Jan 1990

M0592

Descriptor not available

01 Jan 1990

M0601

Descriptor not available

01 Jan 1990

M0702

Descriptor not available

01 Jan 1994

M0704

Descriptor not available

01 Jan 1994

M0706

Descriptor not available

01 Jan 1994

M0708

Descriptor not available

01 Jan 1994

M0710

Descriptor not available

01 Jan 1994

M0722

Descriptor not available

01 Jan 1994

M0724

Descriptor not available

01 Jan 1994

M0726

Descriptor not available

01 Jan 1994

M0728

Descriptor not available

01 Jan 1994

M0730

Descriptor not available

01 Jan 1994

M0799

Descriptor not available

01 Jan 1990

M0900

Descriptor not available

01 Jan 1995

M0910

Descriptor not available

01 Jan 1990

M0916

Descriptor not available

01 Jan 1990

M0920

Descriptor not available

01 Jan 1990

M0928

Descriptor not available

01 Jan 1990

M0931

Descriptor not available

01 Jan 1990

M0932

Descriptor not available

01 Jan 1990

M0936

Descriptor not available

01 Jan 1990

M0937

Descriptor not available

01 Jan 1990

M0945

Descriptor not available

01 Jan 1990

M0974

Descriptor not available

01 Jan 1990

M0978

Descriptor not available

01 Jan 1990

M0982

Descriptor not available

01 Jan 1990

M0994

Descriptor not available

01 Jan 1990

M1000

Pain screened as moderate to severe

01 Jan 2020

M1001

Plan of care to address moderate to severe pain documented on or before the date of the second visit with a clinician

01 Jan 2020

M1002

Plan of care for moderate to severe pain not documented on or before the date of the second visit with a clinician, reason not given

01 Jan 2020

M1015

Discharge/discontinuation of the episode of care documented in the medical record

01 Jan 2021

M1017

Patient admitted to palliative care services

01 Jan 2023

M1022

Patients who were in hospice at any time during the performance period

01 Jan 2022

M1023

Adolescent patients 12 to 17 years of age with major depression or dysthymia who reached remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five

01 Jan 2021

M1024

Adolescent patients 12 to 17 years of age with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five. either phq-9 or phq-9m score was not assessed or is greater than or equal to five

01 Jan 2021

M1025

Patients who were in hospice at any time during the performance period

01 Jan 2022

M1026

Patients who were in hospice at any time during the performance period

01 Jan 2022

M1030

Patients with clinical indications for imaging of the head

01 Jan 2020

M1031

Patients with no clinical indications for imaging of the head

01 Jan 2022

M1033

Pharmacotherapy for oud initiated after june 30th of performance period

01 Jan 2021

M1042

Functional status measurement with score was obtained utilizing the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively

01 Jan 2020

M1044

Functional status was measured by the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively

01 Jan 2020

M1047

Functional status was measured by the oxford knee score (oks) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively

01 Jan 2020

M1048

Functional status measurement with score was obtained utilizing the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at three months (6 to 20 weeks) postoperatively

01 Jan 2020

M1050

Functional status was measured by the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at three months (6 to 20 weeks) postoperatively

01 Jan 2020

M1053

Leg pain was measured by the visual analog scale (vas) within three months preoperatively and at one year (9 to 15 months) postoperatively

01 Jan 2020

M1061

Patient pregnancy

01 Jan 2021

M1062

Patient immunocompromised

01 Jan 2021

M1063

Patients receiving high doses of immunosuppressive therapy

01 Jan 2021

M1064

Shingrix vaccine documented as administered or previously received

01 Jan 2021

M1065

Shingrix vaccine was not administered for reasons documented by clinician (e.g. patient administered vaccine other than shingrix, patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)

01 Jan 2021

M1066

Shingrix vaccine not documented as administered, reason not given

01 Jan 2021

M1071

Patient had any additional spine procedures performed on the same date as the lumbar discectomy/laminotomy

01 Jan 2023

M1136

The start of an episode of care documented in the medical record

01 Jan 2021

M1137

Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care

01 Jan 2021

M1138

Ongoing care not indicated, patient seen only 1-2 visits (e.g., home program only, referred to another provider or facility, consultation only)

01 Jan 2021

M1139

Ongoing care not indicated, patient self-discharged early and seen only 1-2 visits (e.g., financial or insurance reasons, transportation problems, or reason unknown)

01 Jan 2021

M1140

Ongoing care not indicated, patient discharged after only 1-2 visits due to specific medical events, documented in the medical record that make the treatment episode impossible such as the patient becomes hospitalized or scheduled for surgery for surgery or hospitalized

01 Jan 2021

M1144

Ongoing care not indicated, patient seen only 1-2 visits (e.g., home program only, referred to another provider or facility, consultation only

01 Jan 2021

M1145

Most favored nation (mfn) model drug add-on amount, per dose, (do not bill with line items that have the jw modifier)

28 Feb 2022

M1154

Hospice services provided to patient any time during the measurement period

01 Jan 2025

M1155

Patient had anaphylaxis due to the pneumococcal vaccine any time during or before the measurement period

01 Jan 2025

M1156

Patient received active chemotherapy any time during the measurement period

01 Jan 2024

M1157

Patient received bone marrow transplant any time during the measurement period

01 Jan 2024

M1158

Patient had history of immunocompromising conditions prior to or during the measurement period

01 Jan 2024

M1219

Anaphylaxis due to the vaccine on or before the date of the encounter

01 Jan 2025

M1264

Patients age 75 or older on their initiation of dialysis date

01 Jan 2025

M9999

Descriptor not available

01 Jan 1990

MA

Ordering professional is not required to consult a clinical decision support mechanism due to service being rendered to a patient with a suspected or confirmed emergency medical condition

01 Jan 2025

MB

Ordering professional is not required to consult a clinical decision support mechanism due to the significant hardship exception of insufficient internet access

01 Jan 2025

MC

Ordering professional is not required to consult a clinical decision support mechanism due to the significant hardship exception of electronic health record or clinical decision support mechanism vendor issues

01 Jan 2025

MD

Ordering professional is not required to consult a clinical decision support mechanism due to the significant hardship exception of extreme and uncontrollable circumstances

01 Jan 2025

ME

The order for this service adheres to appropriate use criteria in the clinical decision support mechanism consulted by the ordering professional

01 Jan 2025

MF

The order for this service does not adhere to the appropriate use criteria in the clinical decision support mechanism consulted by the ordering professional

01 Jan 2025

MG

The order for this service does not have applicable appropriate use criteria in the qualified clinical decision support mechanism consulted by the ordering professional

01 Jan 2025

MH

Unknown if ordering professional consulted a clinical decision support mechanism for this service, related information was not provided to the furnishing professional or provider

01 Jan 2025

P0999

Descriptor not available

01 Jan 1990

P2026

Descriptor not available

01 Jan 1990

P2027

Descriptor not available

01 Jan 1990

P2032

Descriptor not available

01 Jan 1990

P7020

Descriptor not available

01 Jan 1990

P9005

Descriptor not available

01 Jan 1990

P9006

Descriptor not available

01 Jan 1990

P9007

Descriptor not available

01 Jan 1990

P9013

Descriptor not available

01 Jan 2001

P9014

Descriptor not available

01 Jan 1999

P9015

Descriptor not available

01 Jan 1999

P9018

Descriptor not available

01 Jan 2001

P9024

Descriptor not available

01 Jan 1990

P9042

Descriptor not available

01 Jan 2002

P9072

Platelets, pheresis, pathogen reduced or rapid bacterial tested, each unit

01 Jan 2018

P9605

Descriptor not available

01 Jan 1996

P9610

Descriptor not available

01 Jan 1999

Q0004

Descriptor not available

01 Jan 1990

Q0005

Descriptor not available

01 Jan 1990

Q0006

Descriptor not available

01 Jan 1990

Q0007

Descriptor not available

01 Jan 1990

Q0008

Descriptor not available

01 Jan 1990

Q0009

Descriptor not available

01 Jan 1990

Q0010

Descriptor not available

01 Jan 1990

Q0011

Descriptor not available

01 Jan 1990

Q0012

Descriptor not available

01 Jan 1990

Q0013

Descriptor not available

01 Jan 1990

Q0014

Descriptor not available

01 Jan 1990

Q0015

Descriptor not available

01 Jan 1990

Q0016

Descriptor not available

01 Jan 1990

Q0017

Descriptor not available

01 Jan 1990

Q0018

Descriptor not available

01 Jan 1990

Q0019

Descriptor not available

01 Jan 1990

Q0020

Descriptor not available

01 Jan 1990

Q0021

Descriptor not available

01 Jan 1990

Q0022

Descriptor not available

01 Jan 1990

Q0023

Descriptor not available

01 Jan 1990

Q0024

Descriptor not available

01 Jan 1990

Q0025

Descriptor not available

01 Jan 1990

Q0026

Descriptor not available

01 Jan 1990

Q0027

Descriptor not available

01 Jan 1990

Q0028

Descriptor not available

01 Jan 1990

Q0029

Descriptor not available

01 Jan 1990

Q0030

Descriptor not available

01 Jan 1990

Q0031

Descriptor not available

01 Jan 1990

Q0032

Descriptor not available

01 Jan 1990

Q0033

Descriptor not available

01 Jan 1990

Q0034

Descriptor not available

01 Jan 2001

Q0036

Descriptor not available

01 Jan 1993

Q0037

Descriptor not available

01 Jan 1993

Q0038

Descriptor not available

01 Jan 1993

Q0039

Descriptor not available

01 Jan 1993

Q0040

Descriptor not available

01 Jan 1993

Q0041

Descriptor not available

01 Jan 1993

Q0042

Descriptor not available

01 Jan 1993

Q0043

Descriptor not available

01 Jan 1993

Q0044

Descriptor not available

01 Jan 1993

Q0045

Descriptor not available

01 Jan 1993

Q0046

Descriptor not available

01 Jan 1993

Q0047

Descriptor not available

01 Jan 1994

Q0048

Descriptor not available

01 Jan 1990

Q0049

Descriptor not available

01 Jan 1990

Q0050

Descriptor not available

01 Jan 1990

Q0051

Descriptor not available

01 Jan 1990

Q0052

Descriptor not available

01 Jan 1990

Q0053

Descriptor not available

01 Jan 1990

Q0054

Descriptor not available

01 Jan 1990

Q0055

Descriptor not available

01 Jan 1990

Q0056

Descriptor not available

01 Jan 1990

Q0057

Descriptor not available

01 Jan 1990

Q0059

Descriptor not available

01 Jan 1990

Q0060

Descriptor not available

01 Jan 1990

Q0061

Descriptor not available

01 Jan 1990

Q0062

Descriptor not available

01 Jan 1990

Q0063

Descriptor not available

01 Jan 1990

Q0064

Descriptor not available

01 Jan 1990

Q0065

Descriptor not available

01 Jan 1990

Q0066

Descriptor not available

01 Jan 1990

Q0067

Descriptor not available

01 Jan 1990

Q0068

Descriptor not available

01 Jan 2000

Q0069

Descriptor not available

01 Jan 1990

Q0070

Descriptor not available

01 Jan 1990

Q0071

Descriptor not available

01 Jan 1990

Q0072

Descriptor not available

01 Jan 1990

Q0073

Descriptor not available

01 Jan 1990

Q0074

Descriptor not available

01 Jan 1990

Q0076

Descriptor not available

01 Jan 1990

Q0077

Descriptor not available

01 Jan 1990

Q0078

Descriptor not available

01 Jan 1990

Q0079

Descriptor not available

01 Jan 1990

Q0080

Descriptor not available

01 Jan 1990

Q0082

Descriptor not available

01 Jan 2001

Q0086

Descriptor not available

01 Jan 2004

Q0087

Descriptor not available

01 Jan 1990

Q0088

Descriptor not available

01 Jan 1990

Q0089

Descriptor not available

01 Jan 1990

Q0090

Levonorgestrel-releasing intrauterine contraceptive system, (skyla), 13.5 mg

01 Jan 2014

Q0093

Descriptor not available

01 Jan 1994

Q0094

Descriptor not available

01 Jan 1994

Q0095

Descriptor not available

01 Jan 1994

Q0096

Descriptor not available

01 Jan 1994

Q0097

Descriptor not available

01 Jan 1994

Q0098

Descriptor not available

01 Jan 1994

Q0100

Descriptor not available

01 Jan 1994

Q0101

Descriptor not available

01 Jan 1994

Q0102

Descriptor not available

01 Jan 1994

Q0103

Descriptor not available

01 Jan 1993

Q0104

Descriptor not available

01 Jan 1993

Q0105

Descriptor not available

01 Jan 1994

Q0106

Descriptor not available

01 Jan 1994

Q0107

Descriptor not available

01 Jan 1994

Q0108

Descriptor not available

01 Jan 1990

Q0109

Descriptor not available

01 Jan 1993

Q0110

Descriptor not available

01 Jan 1993

Q0116

Descriptor not available

01 Jan 1997

Q0117

Descriptor not available

01 Jan 1995

Q0118

Descriptor not available

01 Jan 1995

Q0119

Descriptor not available

01 Jan 1995

Q0120

Descriptor not available

01 Jan 1995

Q0121

Descriptor not available

01 Jan 1995

Q0122

Descriptor not available

01 Jan 1995

Q0123

Descriptor not available

01 Jan 1995

Q0124

Descriptor not available

01 Jan 1995

Q0125

Descriptor not available

01 Jan 1990

Q0126

Descriptor not available

01 Jan 1996

Q0127

Descriptor not available

01 Jan 1990

Q0128

Descriptor not available

01 Jan 1990

Q0129

Descriptor not available

01 Jan 1990

Q0130

Descriptor not available

01 Jan 1990

Q0132

Descriptor not available

01 Jan 2000

Q0133

Descriptor not available

01 Jan 1990

Q0134

Descriptor not available

01 Jan 1990

Q0135

Descriptor not available

01 Jan 1990

Q0136

Injection

01 Jan 2006

Q0137

Injection

01 Jan 2006

Q0140

Descriptor not available

01 Jan 1990

Q0141

Descriptor not available

01 Jan 1990

Q0142

Descriptor not available

01 Jan 1990

Q0143

Descriptor not available

01 Jan 1990

Q0156

Descriptor not available

01 Jan 2001

Q0157

Descriptor not available

01 Jan 2001

Q0158

Descriptor not available

01 Jan 1998

Q0159

Descriptor not available

01 Jan 1999

Q0160

Descriptor not available

01 Jan 2002

Q0165

Prochlorperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen

01 Jan 2014

Q0168

Dronabinol, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen

01 Jan 2014

Q0170

Promethazine hydrochloride, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen

01 Jan 2014

Q0171

Chlorpromazine hydrochloride, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen

01 Jan 2014

Q0172

Chlorpromazine hydrochloride, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen

01 Jan 2014

Q0176

Perphenazine, 8mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen

01 Jan 2014

Q0178

Hydroxyzine pamoate, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen

01 Jan 2014

Q0179

Ondansetron hydrochloride 8 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen

01 Jan 2012

Q0182

Dermal and epidermal

01 Jan 2005

Q0183

Dermal tissue

01 Jan 2005

Q0184

Descriptor not available

01 Jan 2003

Q0185

Descriptor not available

01 Jan 2002

Q0186

Descriptor not available

01 Jan 1999

Q0187

Factor viia (coagulation factor

01 Jan 2006

Q0188

Descriptor not available

01 Jan 2004

Q0220

Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mg

12 Dec 2024

Q0221

Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 600 mg

12 Dec 2024

Q0222

Injection, bebtelovimab, 175 mg

12 Dec 2024

Q0239

Injection, bamlanivimab-xxxx, 700 mg

16 Apr 2021

Q0240

Injection, casirivimab and imdevimab, 600 mg

12 Dec 2024

Q0243

Injection, casirivimab and imdevimab, 2400 mg

12 Dec 2024

Q0244

Injection, casirivimab and imdevimab, 1200 mg

12 Dec 2024

Q0245

Injection, bamlanivimab and etesevimab, 2100 mg

13 Dec 2023

Q0247

Injection, sotrovimab, 500 mg

12 Dec 2024

Q0505

Miscellaneous supply or accessory for use with ventricular assist device

01 Apr 2013

Q0516

Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 30-days

01 Jan 2025

Q0517

Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 60-days

01 Jan 2025

Q0518

Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 90-days

01 Jan 2025

Q0519

Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 30-days

01 Jan 2025

Q0520

Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 60-days

01 Jan 2025

Q1001

New technology intraocular lens category 1 as defined in federal register notice

01 Jul 2005

Q1002

New technology intraocular lens category 2 as defined in federal register notice

01 Jul 2005

Q1003

Descriptor not available.

01 Apr 2011

Q2001

Oral

01 Jan 2006

Q2002

Injection

01 Jan 2006

Q2003

Injection

01 Jan 2006

Q2005

Injection

01 Jan 2006

Q2006

Injection

01 Jan 2006

Q2007

Injection

01 Jan 2006

Q2008

Injection

01 Jan 2006

Q2010

Descriptor not available

01 Jan 2004

Q2011

Injection

01 Jan 2006

Q2012

Injection

01 Jan 2006

Q2013

Injection

01 Jan 2006

Q2014

Injection

01 Jan 2006

Q2015

Descriptor not available

01 Jan 2002

Q2016

Descriptor not available

01 Jan 2002

Q2018

Injection

01 Jan 2006

Q2019

Injection

01 Jan 2006

Q2020

Injection

01 Jan 2006

Q2021

Injection

01 Jan 2006

Q2022

Von willebrand factor complex

01 Jan 2006

Q2023

Injection

01 Jan 2010

Q2024

Injection

01 Jan 2010

Q2024

Injection

01 Jan 2010

Q2025

Fludarabine phosphate, oral, 1 mg

01 Jan 2011

Q2027

Injection, sculptra, 0.1 ml

01 Jan 2014

Q2033

Influenza vaccine, recombinant hemagglutinin antigens, for intramuscular use (flublok)

01 Jan 2014

Q2040

Tisagenlecleucel, up to 250 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusion

01 Jan 2019

Q2044

Injection, belimumab, 10 mg

01 Jan 2012

Q2045

Injection, human fibrinogen concentrate, 1 mg

01 Jan 2013

Q2046

Injection, aflibercept, 1 mg

01 Jan 2013

Q2047

Injection, peginesatide, 0. 1 mg (for esrd on dialysis)

01 Jan 2013

Q2048

Injection, doxorubicin hydrochloride, liposomal, doxil, 10 mg

01 Jan 2013

Q2051

Injection, zoledronic acid, not otherwise specified, 1mg

01 Jan 2014

Q3000

Supply of radiopharmaceutical diagnostic imaging agent

01 Jan 2006

Q3002

Supply of radiopharmaceutical diagnostic imaging agent

01 Jan 2006

Q3003

Supply of radiopharmaceutical diagnostic imaging agent

01 Jan 2006

Q3004

Supply of radiopharmaceutical diagnostic imaging agent

01 Jan 2006

Q3005

Supply of radiopharmaceutical diagnostic imaging agent

01 Jan 2006

Q3006

Supply of radiopharmaceutical diagnostic imaging agent

01 Jan 2006

Q3007

Supply of radiopharmaceutical diagnostic imaging agent

01 Jan 2006

Q3008

Supply of radiopharmaceutical diagnostic imaging agent

01 Jan 2006

Q3009

Supply of radiopharmaceutical diagnostic imaging agent

01 Jan 2006

Q3010

Supply of radiopharmaceutical diagnostic imaging agent

01 Jan 2006

Q3011

Supply of radiopharmaceutical diagnostic imaging agent

01 Jan 2006

Q3012

Supply of oral radiopharmaceutical diagnostic imaging agent

01 Jan 2006

Q3013

Descriptor not available

01 Jan 2002

Q3017

Descriptor not available

01 Jan 2003

Q3019

Als vehicle used

01 Apr 2006

Q3020

Als vehicle used

01 Apr 2006

Q3021

Descriptor not available

01 Jan 2003

Q3022

Descriptor not available

01 Jan 2003

Q3023

Descriptor not available

01 Jan 2003

Q3025

Injection, interferon beta-1a, 11 mcg for intramuscular use

01 Jan 2014

Q3026

Injection, interferon beta-1a, 11 mcg for subcutaneous use

01 Jan 2014

Q3030

Descriptor not available

01 Jan 2003

Q4052

Descriptor not available

01 Jan 2004

Q4053

Descriptor not available

01 Jan 2004

Q4054

Injection

01 Jan 2006

Q4055

Injection

01 Jan 2006

Q4075

Injection

01 Jan 2006

Q4076

Injection

01 Jan 2006

Q4077

Injection

01 Jan 2006

Q4078

Descriptor not available

01 Jan 2004

Q4079

Injection

01 Jan 2008

Q4080

Iloprost

01 Jan 2010

Q4083

Hyaluronan or derivative

01 Jan 2008

Q4084

Hyaluronan or derivative

01 Jan 2008

Q4085

Hyaluronan or derivative

01 Jan 2008

Q4086

Hyaluronan or derivative

01 Jan 2008

Q4087

Injection

01 Jan 2008

Q4088

Injection

01 Jan 2008

Q4089

Injection

01 Jan 2008

Q4090

Injection

01 Jan 2008

Q4091

Injection

01 Jan 2008

Q4092

Injection

01 Jan 2008

Q4093

Albuterol

01 Jan 2008

Q4094

Albuterol

01 Jan 2008

Q4095

Injection

01 Jan 2008

Q4096

Injection

01 Jan 2009

Q4097

Injection

01 Jan 2009

Q4098

Injection

01 Jan 2009

Q4099

Formoterol fumarate

01 Jan 2009

Q4109

Skin substitute, tissuemend, per square centimeter

01 Jan 2011

Q4119

Matristem wound matrix, per square centimeter

01 Jan 2017

Q4120

Matristem burn matrix, per square centimeter

01 Jan 2017

Q4129

Unite biomatrix, per square centimeter

01 Jan 2017

Q4131

Epifix or epicord, per square centimeter

01 Jan 2019

Q4172

Puraply or puraply am, per square centimeter

01 Jan 2019

Q4210

Axolotl graft or axolotl dualgraft, per square centimeter

01 Jul 2024

Q4228

Bionextpatch, per square centimeter

01 Oct 2021

Q4231

Corplex p, per cc

31 Mar 2025

Q4244

Procenta, per 200 mg

01 Apr 2024

Q4277

Woundplus membrane or e-graft, per square centimeter

01 Jul 2024

Q5102

Injection, infliximab, biosimilar, 10 mg

01 Apr 2018

Q5131

Injection, adalimumab-aacf (idacio), biosimilar, 20 mg

01 Jan 2025

Q5132

Injection, adalimumab-afzb (abrilada), biosimilar, 10 mg

01 Jan 2025

Q5139

Injection, eculizumab-aeeb (bkemv), biosimilar, 10 mg

31 Mar 2025

Q9920

Descriptor not available

01 Jan 2004

Q9921

Descriptor not available

01 Jan 2004

Q9922

Descriptor not available

01 Jan 2004

Q9923

Descriptor not available

01 Jan 2004

Q9924

Descriptor not available

01 Jan 2004

Q9925

Descriptor not available

01 Jan 2004

Q9926

Descriptor not available

01 Jan 2004

Q9927

Descriptor not available

01 Jan 2004

Q9928

Descriptor not available

01 Jan 2004

Q9929

Descriptor not available

01 Jan 2004

Q9930

Descriptor not available

01 Jan 2004

Q9931

Descriptor not available

01 Jan 2004

Q9932

Descriptor not available

01 Jan 2004

Q9933

Descriptor not available

01 Jan 2004

Q9934

Descriptor not available

01 Jan 2004

Q9935

Descriptor not available

01 Jan 2004

Q9936

Descriptor not available

01 Jan 2004

Q9937

Descriptor not available

01 Jan 2004

Q9938

Descriptor not available

01 Jan 2004

Q9939

Descriptor not available

01 Jan 2004

Q9940

Descriptor not available

01 Jan 2004

Q9941

Injection

01 Jan 2006

Q9942

Injection

01 Jan 2006

Q9943

Injection

01 Jan 2006

Q9944

Injection

01 Jan 2006

Q9945

Low osmolar contrast material

01 Jan 2008

Q9946

Low osmolar contrast material

01 Jan 2008

Q9947

Low osmolar contrast material

01 Jan 2008

Q9948

Low osmolar contrast material

01 Jan 2008

Q9949

Low osmolar contrast material

01 Jan 2008

Q9950-1

Low osmolar contrast material

01 Jan 2008

Q9952

Injection

01 Jan 2008

Q9970

Injection, ferric carboxymaltose, 1mg

01 Jan 2015

Q9972

Injection, epoetin beta, 1 microgram, (for esrd on dialysis)

01 Jan 2015

Q9973

Injection, epoetin beta, 1 microgram, (non-esrd use)

01 Jan 2015

Q9974

Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg

01 Jan 2015

Q9975

Injection, factor viii fc fusion (recombinant), per iu

01 Jan 2016

Q9976

Injection, ferric pyrophosphate citrate solution, 0.1 mg of iron

01 Jan 2016

Q9977

Compounded drug, not otherwise classified

01 Jan 2016

Q9978

Netupitant 300 mg and palonosetron 0.5 mg

01 Jan 2016

Q9979

Injection, alemtuzumab, 1 mg

01 Jan 2016

Q9980

Hyaluronan or derivative, genvisc 850, for intra-articular injection, 1 mg

01 Jan 2017

Q9981

Rolapitant, oral, 1 mg

01 Jan 2017

Q9984

Levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mg

01 Jan 2018

Q9985

Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg

01 Jan 2018

Q9986

Injection, hydroxyprogesterone caproate, (makena), 10 mg

01 Jan 2018

Q9987

Pathogen(s) test for platelets

01 Jan 2018

Q9988

Platelets, pheresis, pathogen-reduced, each unit

01 Jan 2018

Q9989

Ustekinumab, for intravenous injection, 1 mg

01 Jan 2018

Q9993

Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg

01 Jan 2019

Q9994

In-line cartridge containing digestive enzyme(s) for enteral feeding, each

01 Jan 2019

Q9995

Injection, emicizumab-kxwh, 0.5 mg

01 Jan 2019

QQ

Ordering professional consulted a qualified clinical decision support mechanism for this service and the related data was provided to the furnishing professional

01 Jan 2025

R0009

Descriptor not available

01 Jan 1990

R0059

Descriptor not available

01 Jan 1990

R0065

Descriptor not available

01 Jan 1990

R0085

Descriptor not available

01 Jan 1990

R0109

Descriptor not available

01 Jan 1990

R0129

Descriptor not available

01 Jan 1990

R0159

Descriptor not available

01 Jan 1990

R0209

Descriptor not available

01 Jan 1990

R0259

Descriptor not available

01 Jan 1990

R0309

Descriptor not available

01 Jan 1990

R0359

Descriptor not available

01 Jan 1990

R0599

Descriptor not available

01 Jan 1990

S0009

Descriptor not available

01 Jan 2004

S0010

Descriptor not available

01 Jan 2001

S0011

Descriptor not available

01 Jan 2001

S0016

Injection

01 Apr 2005

S0017

Injection, aminocaproic acid, 5 grams

31 Mar 2025

S0020

Injection, bupivicaine hydrochloride, 30 ml

01 Jul 2023

S0024

Descriptor not available

01 Jan 2002

S0028

Injection, famotidine, 20 mg

31 Mar 2025

S0029

Descriptor not available

01 Jan 2002

S0030

Injection, metronidazole, 500 mg

01 Jul 2023

S0032

Injection, nafcillin sodium, 2 grams

31 Mar 2025

S0039

Injection, sulfamethoxazole and trimethoprim, 10 ml

31 Mar 2025

S0071

Injection

01 Jan 2006

S0072

Injection

01 Jan 2006

S0073

Injection, aztreonam, 500 mg

01 Jul 2023

S0077

Injection, clindamycin phosphate, 300 mg

01 Jul 2023

S0079

Descriptor not available

01 Jan 2004

S0085

Descriptor not available

01 Jan 2003

S0086

Descriptor not available

01 Jan 2002

S0087

Descriptor not available

01 Jan 2003

S0096

Descriptor not available

01 Jan 2002

S0097

Descriptor not available

01 Jan 2001

S0098

Descriptor not available

01 Jan 2001

S0107

Injection

01 Apr 2005

S0112

Descriptor not available

01 Jan 2004

S0114

Injection

01 Jan 2006

S0115

Bortezomib

01 Jan 2005

S0116

Bevacizumab

01 Jul 2006

S0118

Injection

01 Jan 2006

S0124

Descriptor not available

01 Jan 2004

S0125

Descriptor not available

01 Jan 2008

S0130

Descriptor not available

01 Jan 2004

S0133

Histrelin

01 Apr 2006

S0135

Descriptor not available

01 Jan 2004

S0141

Zalcitabine (ddc)

01 Oct 2008

S0143

Aztreonam

01 Jan 2009

S0144

Injection, propofol, 10 mg

01 Jan 2015

S0146

Injection, pegylated interferon alfa-2b, 10 mcg per 0.5 ml

01 Oct 2010

S0147

Injection

01 Jan 2008

S0158

Injection

01 Apr 2005

S0159

Injection

01 Apr 2005

S0161

Calcitrol, 0.25 mg

01 Oct 2010

S0162

Descriptor not available

01 Oct 2009

S0163

Injection

01 Jan 2005

S0164

Injection, pantoprazole sodium, 40 mg

01 Jul 2024

S0165

Injection

01 Jan 2005

S0166

Injection, olanzapine, 2.5 mg

01 Oct 2023

S0167

Injection

01 Apr 2007

S0168

Injection

01 Jan 2006

S0171

Injection, bumetanide, 0.5 mg

01 Jan 2024

S0173

Dexamethasone

01 Jan 2006

S0180

Etonogestrel (contraceptive) implant system

01 Jan 2008

S0181

Ondansetron hydrochloride, oral, 4mg (for circumstances falling under the medicare statute, use q0179)

01 Jan 2012

S0193

Descriptor not available

01 Jan 2004

S0195

Pneumococcal conjugate vaccine, polyvalent, intramuscular, for children from five years to nine years of age who have not previously received the vaccine

01 Jan 2016

S0196

Injectable poly-l-lactic acid, restorative implant, 1 ml, face (deep dermis, subcutaneous layers)

01 Oct 2010

S0198

Injection

01 Jul 2006

S0206

Descriptor not available

01 Jan 2003

S0345

Descriptor not available

01 Jan 2010

S0346

Electrocardiographic monitoring utilizing a home computerized telemetry station

01 Jan 2010

S0347

Electrocardiographic monitoring utilizing a home computerized telemetry station

01 Jan 2010

S0605

Digital rectal examination

01 Jan 2010

S0625

Retinal telescreening by digital imaging of multiple different fundus areas to screen for vision-threatening conditions, including imaging, interpretation and report

01 Jan 2012

S0820

Computerized corneal topography

01 Apr 2007

S0830

Ultrasound pachymetry to determine corneal thickness

01 Apr 2004

S1025

Inhaled nitric oxide for the treatment of hypoxic respiratory failure in the neonate; per diem

01 Apr 2007

S1090

Mometasone furoate sinus implant, 370 micrograms

01 Oct 2019

S2050

Descriptor not available

01 Jan 2001

S2052

Descriptor not available

01 Jan 2002

S2075

Laparoscopy

01 Jan 2009

S2076

Laparoscopy

01 Jan 2009

S2077

Laparoscopy

01 Jan 2009

S2078

Laparoscopic supracervical hysterectomy (subtotal hysterectomy)

01 Jul 2007

S2082

Laparoscopy

01 Jan 2006

S2085

Laparoscopy

01 Jan 2005

S2090

Ablation

01 Jan 2006

S2091

Ablation

01 Jan 2006

S2109

Descriptor not available

01 Jan 2001

S2113

Arthroscopy

01 Jan 2005

S2114

Arthroscopy

01 Jan 2008

S2130

Endoluminal radiofrequency ablation of refluxing saphenous veins

01 Jan 2005

S2131

Endovascular laser ablation of long or short saphenous vein

01 Jan 2005

S2135

Neurolysis

01 Jan 2009

S2180

Descriptor not available

01 Jan 2003

S2190

Descriptor not available

01 Jan 2001

S2204

Descriptor not available

01 Jan 2001

S2210

Descriptor not available

01 Jan 2002

S2211

Transcatheter placement of intravascular stent(s)

01 Jan 2005

S2213

Implantation of gastric electrical stimulation device

01 Apr 2007

S2215

Upper gastrointestinal endoscopy

01 Jan 2006

S2220

Descriptor not available

01 Jan 2002

S2227

Descriptor not available

01 Jan 2004

S2250

Uterine artery embolization for uterine fibroids

01 Apr 2007

S2255

Hysteroscopy

01 Jan 2005

S2262

Abortion for maternal indication

01 Jan 2007

S2270

Insertion of vaginal cylinder for application of radiation source or clinical brachytherapy (report separately in addition to radiation source delivery)

01 Apr 2011

S2344

Nasal/sinus endoscopy, surgical; with enlargement of sinus ostium opening using inflatable device (i.e., balloon sinuplasty)

01 Apr 2011

S2360

Percutaneous vertebroplasty, one vertebral body, unilateral or bilateral injection; cervical

01 Jan 2016

S2361

Each additional cervical vertebral body (list separately in addition to code for primary procedure)

01 Jan 2016

S2362

Kyphoplasty

01 Apr 2006

S2363

Kyphoplasty

01 Apr 2006

S2370

Intradiscal electrothermal therapy; single interspace

01 Oct 2004

S2371

Each additional interspace (list separately in addition to code for primary procedure)

01 Oct 2004

S3618

Blood chemistry for free beta human chorionic gonadotropin (hcg)

01 Jan 2008

S3625

Maternal serum triple marker screen including alpha-fetoprotein (afp), estriol, and human chorionic gonadotropin (hcg)

01 Jan 2014

S3626

Maternal serum quadruple marker screen including alpha-fetoprotein (afp), estriol, human chorionic gonadotropin (hcg) and inhibin a

01 Jan 2014

S3628

Placental alpha microglobulin-1 rapid immunoassay for detection of rupture of fetal membranes

01 Jul 2011

S3700

Descriptor not available

01 Jan 2002

S3701

Immunoassay for nuclear matrix protein 22 (nmp-22)

01 Apr 2006

S3711

Circulating tumor cell test

01 Apr 2012

S3713

Kras mutation analysis testing

01 Apr 2012

S3721

Prostate cancer antigen 3 (pca3) testing

01 Jan 2016

S3818

Complete gene sequence analysis; brca1 gene

01 Apr 2012

S3819

Complete gene sequence analysis; brca2 gene

01 Apr 2012

S3820

Complete brca1 and brca2 gene sequence analysis for susceptibility to breast and ovarian cancer

01 Apr 2012

S3822

Single mutation analysis (in individual with a known brca1 or brca2 mutation in the family) for susceptibility to breast and ovarian cancer

01 Apr 2012

S3823

Three-mutation brca1 and brca2 analysis for susceptibility to breast and ovarian cancer in ashkenazi individuals

01 Apr 2012

S3828

Complete gene sequence analysis; mlh1 gene

01 Apr 2012

S3829

Complete gene sequence analysis; msh2 gene

01 Apr 2012

S3830

Complete mlh1 and msh2 gene sequence analysis for hereditary nonpolyposis colorectal cancer (hnpcc) genetic testing

01 Apr 2012

S3831

Single-mutation analysis (in individual with a known mlh1 and msh2 mutation in the family) for hereditary nonpolyposis colorectal cancer (hnpcc) genetic testing

01 Apr 2012

S3833

Complete apc gene sequence analysis for susceptibility to familial adenomatous polyposis (fap) and attenuated fap

01 Jan 2014

S3834

Single-mutation analysis (in individual with a known apc mutation in the family) for susceptibility to familial adenomatous polyposis (fap) and attenuated fap

01 Jan 2014

S3835

Complete gene sequence analysis for cystic fibrosis genetic testing

01 Apr 2012

S3837

Complete gene sequence analysis for hemochromatosis genetic testing

01 Apr 2012

S3843

Dna analysis of the f5 gene for susceptibility to factor v leiden thrombophilia

01 Apr 2012

S3847

Genetic testing for tay-sachs disease

01 Apr 2012

S3848

Genetic testing for gaucher disease

01 Apr 2012

S3851

Genetic testing for canavan disease

01 Apr 2012

S3855

Genetic testing for detection of mutations in the presenilin - 1 gene

01 Jan 2015

S3860

Genetic testing, comprehensive cardiac ion channel analysis, for variants in 5 major cardiac ion channel genes for individuals with high index of suspicion for familial long qt syndrome (lqts) or related syndromes

01 Apr 2012

S3862

Genetic testing, family-specific ion channel analysis, for blood-relatives of individuals (index case) who have previously tested positive for a genetic variant of a cardiac ion channel syndrome using either one of the above test configurations or confirmed results from another laboratory

01 Apr 2012

S3890

Dna analysis, fecal, for colorectal cancer screening

01 Jan 2016

S3905

Non-invasive electrodiagnostic testing with automatic computerized hand-held device to stimulate and measure neuromuscular signals in diagnosing and evaluating systemic and entrapment neuropathies

01 Apr 2011

S3906

Descriptor not available

01 Jan 2002

S4036

Intravaginal culture (ivc)

01 Jan 2007

S4980

Descriptor not available

01 Jan 2002

S4988

Penile contracture device, manual, greater than 3 lbs traction force

31 Mar 2025

S5002

Descriptor not available

01 Jan 2002

S5003

Descriptor not available

01 Jan 2002

S5011

5% dextrose in lactated ringer's, 1000 ml

01 Jan 2016

S5016

Descriptor not available

01 Jan 2002

S5017

Descriptor not available

01 Jan 2002

S5018

Descriptor not available

01 Jan 2002

S5019

Descriptor not available

01 Jan 2002

S5020

Descriptor not available

01 Jan 2002

S5021

Descriptor not available

01 Jan 2002

S5022

Descriptor not available

01 Jan 2002

S5025

Descriptor not available

01 Jan 2002

S5503

Descriptor not available

01 Jan 2002

S8001

Descriptor not available

01 Jan 2002

S8002

Descriptor not available

01 Jan 2003

S8003

Descriptor not available

01 Jan 2003

S8004

Radioimmunopharmaceutical localization of targeted cells; whole body

01 Apr 2005

S8032

Low-dose computed tomography for lung cancer screening

30 Sep 2016

S8048

Descriptor not available

01 Jan 2001

S8049

Intraoperative radiation therapy (single administration)

01 Apr 2012

S8060

Descriptor not available

01 Jan 2001

S8075

Computer analysis of full-field digital mammogram and further physician review for interpretation

01 Jul 2006

S8093

Computed tomographic angiography

01 Apr 2006

S8095

Wig (for medically-induced or congenital hair loss)

01 Jan 2006

S8105

Descriptor not available

01 Jan 2003

S8180

Descriptor not available

01 Jan 2004

S8181

Descriptor not available

01 Jan 2004

S8182

Humidifier

01 Jan 2005

S8183

Humidifier

01 Jan 2005

S8190

Electronic spirometer (or microspirometer)

01 Apr 2009

S8200

Descriptor not available

01 Jan 2003

S8205

Descriptor not available

01 Jan 2003

S8260

Oral orthotic for treatment of sleep apnea

01 Apr 2006

S8262

Mandibular orthopedic repositioning device, each

30 Jun 2015

S8300

Descriptor not available

01 Jan 2001

S8400

Descriptor not available

01 Jan 2002

S8401

Descriptor not available

01 Jan 2003

S8402

Descriptor not available

01 Jan 2002

S8403

Descriptor not available

01 Jan 2003

S8404

Descriptor not available

01 Jan 2003

S8405

Descriptor not available

01 Jan 2003

S8433

Descriptor not available

01 Jan 2003

S8434

Interim post-operative orthotic device for upper extremity

01 Jan 2006

S8470

Descriptor not available

01 Jan 2004

S8945

Descriptor not available

01 Apr 2003

S9015

Automated eeg monitoring

01 Jan 2016

S9022

Digital subtraction angiography (use in addition to cpt code for the procedure for further identification)

01 Jul 2006

S9023

Descriptor not available

01 Jan 2002

S9033

Descriptor not available

01 Jan 2001

S9035

Descriptor not available

01 Jan 2002

S9075

Smoking cessation treatment

01 Jul 2011

S9085

Descriptor not available

01 Jan 2002

S9092

Canolith repositioning

01 Jan 2009

S9105

Descriptor not available

01 Jan 1990

S9109

Congestive heart failure telemonitoring, equipment rental, including telescale, computer system and software, telephone connections, and maintenance, per month

01 Jan 2013

S9200

Descriptor not available

01 Jan 2002

S9210

Descriptor not available

01 Jan 2002

S9216

Descriptor not available

01 Jan 2003

S9217

Descriptor not available

01 Jan 2003

S9218

Descriptor not available

01 Jan 2003

S9220

Descriptor not available

01 Jan 2002

S9225

Descriptor not available

01 Jan 2002

S9230

Descriptor not available

01 Jan 2002

S9300

Descriptor not available

01 Jan 2002

S9308

Descriptor not available

01 Jan 2002

S9310

Descriptor not available

01 Jan 2002

S9395

Descriptor not available

01 Jan 2002

S9420

Descriptor not available

01 Jan 2002

S9423

Descriptor not available

01 Jan 2002

S9425

Descriptor not available

01 Jan 2002

S9524

Descriptor not available

01 Apr 2003

S9526

Descriptor not available

01 Jan 2002

S9527

Descriptor not available

01 Jan 2002

S9528

Descriptor not available

01 Jan 2002

S9533

Descriptor not available

01 Jan 2002

S9535

Descriptor not available

01 Jan 2002

S9539

Descriptor not available

01 Jan 2002

S9543

Descriptor not available

01 Jan 2003

S9545

Descriptor not available

01 Jan 2002

S9546

Descriptor not available

01 Oct 2003

S9550

Descriptor not available

01 Jan 2002

S9555

Descriptor not available

01 Jan 2002

S9800

Descriptor not available

01 Jan 2003

S9802

Descriptor not available

01 Jul 2003

S9803

Descriptor not available

01 Jul 2003

S9806

Descriptor not available

01 Jan 2004

SZ

Habilitative services

01 Jan 2018

T1008

Descriptor not available

01 Jan 2003

T1011

Descriptor not available

01 Jan 2003

T1500

Diaper/incontinent pant

01 Jan 2005

T1501

Descriptor not available

01 Jan 2004

T2006

Ambulance response and treatment

01 Jan 2006

U0003

Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r

11 May 2023

U0004

2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r

11 May 2023

U0005

Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2

11 May 2023

V2116

Descriptor not available

01 Jan 2004

V2117

Descriptor not available

01 Jan 2004

V2216

Descriptor not available

01 Jan 2004

V2217

Descriptor not available